ý
|
Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 [Fee Required]
|
¨
|
Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 [No Fee Required]
|
Delaware
|
|
63-1261433
|
(State of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
100 Brookwood Place,
Birmingham, AL
|
|
35209
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Title of Each Class
|
|
Name of Each Exchange On Which Registered
|
Common Stock, par value $0.01 per share
|
|
New York Stock Exchange
|
Large accelerated filer
|
|
ý
|
|
Accelerated filer
|
|
¨
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
Emerging growth company
|
|
¨
|
|
|
|
|
(i)
|
The definitive proxy statement for the
2018
Annual Meeting of the Stockholders of ProAssurance Corporation (File No. 001-16533) is incorporated by reference into Part III of this report.
|
Term
|
Meaning
|
ACA
|
The Affordable Care Act
|
ALAE
|
Allocated loss adjustment expense
|
AOCI
|
Accumulated other comprehensive income (loss)
|
BEAT
|
Base erosion anti-abuse tax
|
Board
|
Board of Directors of ProAssurance Corporation
|
BOLI
|
Business owned life insurance
|
CIMA
|
Cayman Islands Monetary Authority
|
Council of Lloyd's
|
The governing body for Lloyd's of London
|
COSO
|
Committee of Sponsoring Organizations of the Treadway Commission
|
Commutation
|
An agreement between a ceding insurer and the reinsurer that provides for the valuation, payment, and complete discharge of all obligations between the parties under a particular reinsurance contract
|
DDR
|
Death, disability and retirement
|
Dodd-Frank Act
|
The Dodd-Frank Wall Street Reform and Consumer Protection Act
|
DPAC
|
Deferred policy acquisition costs
|
Eastern Re
|
Eastern Re, LTD, S.P.C.
|
EBUB
|
Earned but unbilled premium
|
ERM
|
Enterprise Risk Management
|
FAL
|
Funds at Lloyd's
|
FASB
|
Financial Accounting Standards Board
|
FHLB
|
Federal Home Loan Bank
|
FHLMC
|
Federal Home Loan Mortgage Corporation
|
FIO
|
Federal Insurance Office
|
FNMA
|
Federal National Mortgage Association
|
GAAP
|
Generally accepted accounting principles in the United States of America
|
GNMA
|
Government National Mortgage Association
|
HCPL
|
Healthcare professional liability
|
IBNR
|
Incurred but not reported
|
IRS
|
Internal Revenue Service
|
LAE
|
Loss adjustment expense
|
LIBOR
|
London Interbank Offered Rate
|
LLC
|
Limited liability company
|
Lloyd's
|
Lloyd's of London market
|
LP
|
Limited partnership
|
Medical technology liability
|
Medical technology and life sciences products liability
|
Model Holding Co. Law
|
Model Insurance and Holding Company System Regulatory Act and Regulation
|
NAIC
|
National Association of Insurance Commissioners
|
NAV
|
Net asset value
|
NFIP
|
National Flood Insurance Program
|
NOL
|
Net operating loss
|
NRSRO
|
Nationally recognized statistical rating organization
|
NYDFS
|
New York Department of Financial Services
|
NYSE
|
New York Stock Exchange
|
Term
|
Meaning
|
OCI
|
Other comprehensive income (loss)
|
ORSA
|
Risk Management and Own Risk and Solvency Assessment Model Act
|
OTTI
|
Other-than-temporary impairment
|
PCAOB
|
Public Company Accounting Oversight Board
|
ProAssurance Plan
|
Non-qualified deferred compensation plan
|
ProAssurance Savings Plan
|
Defined contribution savings and retirement plan
|
Revolving Credit Agreement
|
ProAssurance's $250 million revolving credit agreement
|
ROE
|
Return on equity
|
SAB
|
Staff Accounting Bulletin, which reflects the SEC staff's views regarding accounting-related disclosure practices
|
SAP
|
Statutory accounting principles
|
SEC
|
Securities and Exchange Commission
|
SPA
|
Special Purpose Arrangement
|
SPC
|
Segregated portfolio cell
|
Specialty P&C
|
Specialty Property and Casualty
|
Syndicate 1729
|
Lloyd's of London Syndicate 1729
|
Syndicate 6131
|
Lloyd's of London Syndicate 6131, a Special Purpose Arrangement with Lloyd's of London Syndicate 1729
|
Syndicate Credit Agreement
|
Unconditional revolving credit agreement with the Premium Trust Fund of Syndicate 1729
|
TCJA
|
Tax Cuts and Jobs Act H.R.1 of 2017
|
TRIA
|
Federal Terrorism Risk Insurance Act
|
U.K.
|
United Kingdom of Great Britain and Northern Ireland
|
ULAE
|
Unallocated loss adjustment expense
|
VIE
|
Variable interest entity
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
changes in general economic conditions, including the impact of inflation or deflation and unemployment;
|
|
our ability to maintain our dividend payments;
|
|
regulatory, legislative and judicial actions or decisions that could affect our business plans or operations;
|
|
the enactment or repeal of tort reforms;
|
|
formation or dissolution of state-sponsored insurance entities providing coverages now offered by ProAssurance which could remove or add sizable numbers of insureds from or to the private insurance market;
|
|
changes in the interest and tax rate environment;
|
|
resolution of uncertain tax matters and changes in tax laws, including the impact of the TCJA;
|
|
changes in U.S. laws or government regulations regarding financial markets or market activity that may affect the U.S. economy and our business;
|
|
changes in the ability of the U.S. government to meet its obligations that may affect the U.S. economy and our business;
|
|
performance of financial markets affecting the fair value of our investments or making it difficult to determine the value of our investments;
|
|
changes in requirements or accounting policies and practices that may be adopted by our regulatory agencies, the FASB, the SEC, the PCAOB or the NYSE that may affect our business;
|
|
changes in laws or government regulations affecting the financial services industry, the property and casualty insurance industry or particular insurance lines underwritten by our subsidiaries;
|
|
the effect on our insureds, particularly the insurance needs of our insureds, and our loss costs, of changes in the healthcare delivery system and/or changes in the U.S. political climate that may affect healthcare policy or our business;
|
|
consolidation of our insureds into or under larger entities which may be insured by competitors, or may not have a risk profile that meets our underwriting criteria or which may not use external providers for insuring or otherwise managing substantial portions of their liability risk;
|
|
uncertainties inherent in the estimate of our loss and loss adjustment expense reserve and reinsurance recoverable;
|
|
changes in the availability, cost, quality or collectability of insurance/reinsurance;
|
|
the results of litigation, including pre- or post-trial motions, trials and/or appeals we undertake;
|
|
effects on our claims costs from mass tort litigation that are different from that anticipated by us;
|
|
allegations of bad faith which may arise from our handling of any particular claim, including failure to settle;
|
|
loss or consolidation of independent agents, agencies, brokers or brokerage firms;
|
|
changes in our organization, compensation and benefit plans;
|
|
changes in the business or competitive environment may limit the effectiveness of our business strategy and impact our revenues;
|
|
our ability to retain and recruit senior management;
|
|
the availability, integrity and security of our technology infrastructure or that of our third-party providers of technology infrastructure, including any susceptibility to cyber-attacks which might result in a loss of information or operating capability;
|
|
the impact of a catastrophic event, as it relates to both our operations and our insured risks;
|
|
the impact of acts of terrorism and acts of war;
|
|
the effects of terrorism-related insurance legislation and laws;
|
|
guaranty funds and other state assessments;
|
|
our ability to achieve continued growth through expansion into new markets or through acquisitions or business combinations;
|
|
changes to the ratings assigned by rating agencies to our insurance subsidiaries, individually or as a group;
|
|
provisions in our charter documents, Delaware law and state insurance laws may impede attempts to replace or remove management or may impede a takeover;
|
|
state insurance restrictions may prohibit assets held by our insurance subsidiaries, including cash and investment securities, from being used for general corporate purposes;
|
|
taxing authorities can take exception to our tax positions and cause us to incur significant amounts of legal and accounting costs and, if our defense is not successful, additional tax costs, including interest and penalties; and
|
|
expected benefits from completed and proposed acquisitions may not be achieved or may be delayed longer than expected due to business disruption; loss of customers, employees or key agents; increased operating costs or inability to achieve cost savings; and assumption of greater than expected liabilities, among other reasons.
|
Additional risks, assumptions and uncertainties that could arise from our membership in the Lloyd's of London market and our participation in Lloyd's Syndicates include, but are not limited to, the following:
|
|
|
members of Lloyd's are subject to levies by the Council of Lloyd's based on a percentage of the member's underwriting capacity, currently a maximum of 3%, but can be increased by Lloyd's;
|
|
Syndicate operating results can be affected by decisions made by the Council of Lloyd's which the management of Syndicate 1729 and Syndicate 6131 have little ability to control, such as a decision to not approve the business plan of Syndicate 1729 or Syndicate 6131, or a decision to increase the capital required to continue operations, and by our obligation to pay levies to Lloyd's;
|
|
Lloyd's insurance and reinsurance relationships and distribution channels could be disrupted or Lloyd's trading licenses could be revoked making it more difficult for a Lloyd's Syndicate to distribute and market its products;
|
|
rating agencies could downgrade their ratings of Lloyd's as a whole; and
|
|
Syndicate 1729 and Syndicate 6131 operations are dependent on a small, specialized management team and the loss of their services could adversely affect the Syndicate’s business. The inability to identify, hire and retain other highly qualified personnel in the future, could adversely affect the quality and profitability of Syndicate 1729’s or Syndicate 6131's business.
|
•
|
Medmarc Mutual Insurance Company and subsidiaries, acquired January 1, 2013, and
|
•
|
Eastern Insurance Holdings, Inc., acquired January 1, 2014.
|
•
|
Provide specialized healthcare-centric expertise to meet evolving demands in the healthcare marketplace
. Through our focus on healthcare, we provide traditional liability insurance products to healthcare providers. We also leverage our reach, expertise and financial strength to provide innovative and customized products to meet the risk management needs of larger healthcare organizations or groups.
|
•
|
Provide superior workers' compensation products and services.
We provide unique workers' compensation products and services that focus on increasing an organization's productivity while reducing costs. We do this by providing innovative programs and solutions that address the specific needs of our customers and return injured workers to wellness.
|
•
|
Effectively manage capital.
We carefully monitor use of our capital and consider various options for capital deployment, such as business expansion by our existing subsidiaries, opportunities that arise for mergers or acquisitions, share repurchases and payment of dividends.
|
•
|
Pursue profitable underwriting opportunities.
We emphasize profitability, not market share. Key elements of our approach are prudent risk selection using established underwriting guidelines, appropriate pricing and adjusting our business mix as appropriate to effectively utilize capital and achieve market synergies.
|
•
|
Emphasize risk management.
We seek to reduce risk at the corporate level by actively managing our enterprise risk and by maintaining strong internal controls. We also emphasize the importance of risk management to our insureds and offer them training in the use of risk reduction tools and techniques.
|
•
|
Manage claims effectively.
Our experienced claims teams have industry and insurance expertise that, with our extensive local knowledge, allows us to resolve claims in an effective manner, considering the circumstances of each claim. When practical, we utilize formalized claims management processes and protocols as a means of reducing claim costs.
|
•
|
Provide superior customer service.
Our mission statement, "We exist to Protect Others," goes hand-in-hand with our corporate brand promise, "Treated Fairly." Our employees demonstrate our core values of integrity, leadership, relationships and enthusiasm every day and are focused on meeting the needs of our customers.
|
•
|
Maintain a conservative investment strategy.
We believe that we follow a conservative investment strategy designed to emphasize the preservation of our capital and provide adequate liquidity for the prompt payment of claims. Our investment portfolio consists primarily of investment-grade, fixed-maturity securities of short-to medium-term duration.
|
•
|
Maintain financial stability
. We are committed to maintaining claims paying ratings of "A" or better from major rating agencies.
|
•
|
Specialty Property and Casualty Segment
- This segment includes our professional liability business and our medical technology and life sciences business.
|
•
|
Workers' Compensation Segment
- This segment includes our workers' compensation business which we provide for employers, groups and associations.
|
•
|
Lloyd's Syndicate Segment
- This segment includes operating results from our participation in
Lloyd's
Syndicates.
|
•
|
Corporate Segment -
This segment includes our investment operations, interest expense and U.S. income taxes, all of which are managed at the corporate level with the exception of investment assets solely allocated to Lloyd's Syndicate operations. This segment also includes non-premium revenues generated outside of our insurance entities and corporate expenses.
|
|
Year Ended December 31
|
||||||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
2015
|
||||||||||||
Specialty P&C
(1)
|
$
|
549,323
|
|
63
|
%
|
|
$
|
535,725
|
|
64
|
%
|
|
$
|
526,296
|
|
65
|
%
|
Workers' Compensation
|
263,391
|
|
30
|
%
|
|
247,940
|
|
30
|
%
|
|
243,608
|
|
30
|
%
|
|||
Syndicate 1729
(2)
|
70,224
|
|
8
|
%
|
|
65,157
|
|
8
|
%
|
|
56,929
|
|
7
|
%
|
|||
Inter-segment revenues
(2)
|
(8,062
|
)
|
(1
|
%)
|
|
(13,808
|
)
|
(2
|
%)
|
|
(14,615
|
)
|
(2
|
%)
|
|||
Total
|
$
|
874,876
|
|
100
|
%
|
|
$
|
835,014
|
|
100
|
%
|
|
$
|
812,218
|
|
100
|
%
|
(2)
|
Our written premium includes our
58%
share of premiums written by
Syndicate 1729
, including casualty premium assumed by
Syndicate 1729
from our
Specialty P&C
segment. We eliminate this inter-segment revenue.
|
•
|
Traditional workers' compensation insurance coverages provided to employers, generally those with 1,000 employees or less. Types of policies offered include guaranteed cost policies, policyholder dividend policies, retrospectively-rated policies and deductible policies.
|
•
|
Alternative market workers’ compensation solutions provided to individual companies, groups and associations whereby the premium written is 100% ceded to either the
SPC
s within
Eastern Re
or to unaffiliated captive insurers. Of our total alternative market premiums written, approximately
92%
in
2017
and
90%
in
2016
was ceded to
SPC
s operated through
Eastern Re
. Each
SPC
is owned, fully or in part, by an agency or insured group or association, hereafter referred to as cell participants. The
SPC
is operated solely for the benefit of cell participants of that particular cell, and the pool of assets of one
SPC
are statutorily protected from the creditors of any other
SPC
. The underwriting results and investment income of the
SPC
s are shared with the cell preferred shareholders or participants in accordance with the terms of the cell agreements. We participate as either a preferred shareholder or participant to a varying degree in the results of certain
SPC
s. As of
December 31, 2017
, our ownership interest in the
SPC
s in which we participate is as low as
25%
and as high as
85%
.
|
•
|
for reported claims, the nature of the claim and the jurisdiction in which the claim occurred;
|
•
|
trends in paid and incurred loss development;
|
•
|
trends in claim frequency and severity;
|
•
|
emerging economic and social trends;
|
•
|
trends in healthcare costs for claims involving bodily injury;
|
•
|
inflation and levels of employment; and
|
•
|
changes in the regulatory, legal and political environment.
|
•
|
licensing requirements;
|
•
|
trade practices;
|
•
|
capital and surplus requirements;
|
•
|
investment practices; and
|
•
|
rates charged to insurance customers.
|
•
|
reliance on insurance and reinsurance brokers and distribution channels to distribute and market products;
|
•
|
obligation to pay levies to
Lloyd's
;
|
•
|
obligations to maintain funds to support underwriting activities and risk-based capital requirements that are assessed periodically by
Lloyd's
and subject to variation;
|
•
|
ability to maintain liquidity to fund claims payments, when due;
|
•
|
ability to obtain reinsurance and retrocessional coverage to protect against adverse loss activity;
|
•
|
reliance on ongoing approvals from
Lloyd's
and various regulators to conduct business, including a requirement that Annual Business Plans be approved by
Lloyd's
before the start of underwriting for each account year;
|
•
|
financial strength ratings are derived from the rating assigned to
Lloyd's
, although they have limited ability to directly affect the overall
Lloyd's
rating; and
|
•
|
reliance on
Lloyd's
trading licenses in order to underwrite business outside the
U.K.
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS.
|
ITEM 2.
|
PROPERTIES.
|
ITEM 3.
|
LEGAL PROCEEDINGS.
|
W. Stancil Starnes
|
|
Mr. Starnes was appointed as Chief Executive Officer in 2007 and has served as the Chairman of the Board since 2008. In 2012 he was appointed President of ProAssurance. Mr. Starnes previously served as President, Corporate Planning and Administration of Brasfield & Gorrie, Inc., a large national commercial contractor. Prior to 2006, Mr. Starnes served as the Senior and Managing Partner of the law firm of Starnes & Atchison, LLP, where he was extensively involved with ProAssurance and its predecessors in the defense of healthcare professional liability claims for over 25 years. Mr. Starnes served as a director of Infinity Property and Casualty Corporation, a public insurance holding company, from 2008 to May 2017 where he served on the Audit and Investment Committees. Mr. Starnes currently serves on the Board of Trustees for the University of Alabama. He also serves on the Board of Directors of National Commerce Corporation, located in Birmingham, Alabama, where he serves as Chairman of the Nominating and Corporate Governance Committee, Chairman of the Pricing Committee and is a member of the Compensation Committee. (Age 69)
|
|
|
|
Howard H. Friedman
|
|
Mr. Friedman was appointed as President of our Healthcare Professional Liability Group in 2014, and is also our Chief Underwriting Officer and Chief Actuary. Mr. Friedman has previously served as a Co-President of our Professional Liability Group, Chief Financial Officer, Corporate Secretary, and as the Senior Vice President of Corporate Development. Mr. Friedman joined our predecessor in 1996. Mr. Friedman is an Associate of the Casualty Actuarial Society and a member of the American Academy of Actuaries. (Age 59)
|
|
|
|
Jeffrey P. Lisenby
|
|
Mr. Lisenby was appointed as an Executive Vice President in 2014 and is also our General Counsel, Corporate Secretary and head of the corporate Legal Department. Mr. Lisenby has previously served as Senior Vice President. Prior to joining ProAssurance, Mr. Lisenby practiced law privately in Birmingham, Alabama. Mr. Lisenby is a member of the Alabama State Bar and the United States Supreme Court Bar and is a Chartered Property Casualty Underwriter. (Age 49)
|
|
|
|
Edward L. Rand, Jr.
|
|
Mr. Rand was appointed as an Executive Vice President in 2014, President of our Medmarc subsidiary in 2016 and Chief Operating Officer in 2018. Mr. Rand is also our Chief Financial Officer and Chief Accounting Officer. Mr. Rand previously served as our Senior Vice President of Finance upon joining ProAssurance in 2004. Prior to joining ProAssurance, Mr. Rand was the Chief Accounting Officer and Head of Corporate Finance for PartnerRe Ltd. Prior to that time Mr. Rand served as the Chief Financial Officer of Atlantic American Corporation.
(Age 51)
|
|
|
|
Frank B. O’Neil
|
|
Mr. O’Neil was appointed as our Senior Vice President and Chief Communications Officer in 2001. Mr. O’Neil has previously served as our Senior Vice President of Corporate Communications, having joined our predecessor in 1987. (Age 64)
|
|
|
|
Michael L. Boguski
|
|
Mr. Boguski is President of our Eastern subsidiary. Prior to the acquisition of Eastern, Mr. Boguski served as President and Chief Executive Officer of Eastern, and first joined Eastern in 1997. (Age 55)
|
|
|
|
Ross E. Taubman
|
|
Dr. Taubman is President and Chief Medical Officer of our PICA subsidiary. Prior to joining PICA, Dr. Taubman practiced podiatry for 26 years. During that time, Dr. Taubman served as Treasurer, Vice-President and President of the Maryland Podiatric Medical Association. Dr. Taubman is a diplomate in the American Board of Podiatric Surgery. (Age 60)
|
|
|
2017
|
|
2016
|
||||||||||||||||
Quarter
|
|
High
|
|
Low
|
|
High
|
|
Low
|
||||||||||||
First
|
|
$
|
61.85
|
|
|
|
$
|
53.90
|
|
|
|
$
|
51.05
|
|
|
|
$
|
46.22
|
|
|
Second
|
|
$
|
62.45
|
|
|
|
$
|
57.80
|
|
|
|
$
|
53.55
|
|
|
|
$
|
47.73
|
|
|
Third
|
|
$
|
61.80
|
|
|
|
$
|
51.30
|
|
|
|
$
|
55.02
|
|
|
|
$
|
51.29
|
|
|
Fourth
|
|
$
|
63.00
|
|
|
|
$
|
55.00
|
|
|
|
$
|
62.85
|
|
|
|
$
|
50.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Dividends Declared
|
|
Dividends Paid
|
||||||||||||||||
Quarter
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||||||
First
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
5.00
|
|
|
|
$
|
1.31
|
|
|
Second
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
Third
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
Fourth*
|
|
$
|
5.00
|
|
|
|
$
|
5.00
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
Plan Category
|
|
Number of securities to be
issued upon exercise of outstanding options, warrants and rights |
|
Weighted-average
exercise price of outstanding options, warrants and rights |
|
Number of securities
remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
|
|
(a)
|
|
(b)
|
|
(c)
|
Equity compensation plans approved by security holders
|
|
673,227
|
|
$—
|
*
|
2,082,901
|
Equity compensation plans not approved by security holders
|
|
—
|
|
—
|
|
—
|
Period
|
|
Total Number of
Shares Purchased |
|
Average
Price Paid per Share |
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs* (In thousands)
|
October 1 - 31, 2017
|
|
—
|
|
N/A
|
|
—
|
|
$109,643
|
November 1 - 30, 2017
|
|
—
|
|
N/A
|
|
—
|
|
$109,643
|
December 1 - 31, 2017
|
|
—
|
|
N/A
|
|
—
|
|
$109,643
|
Total
|
|
—
|
|
$—
|
|
—
|
|
|
|
|
Year Ended December 31
|
||||||||||||||||||
(In thousands except per share data)
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Selected Financial Data
(1)
|
|
|
||||||||||||||||||
Gross premiums written
|
|
$
|
874,876
|
|
|
$
|
835,014
|
|
|
$
|
812,218
|
|
|
$
|
779,609
|
|
|
$
|
567,547
|
|
Net premiums earned
|
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
$
|
694,149
|
|
|
$
|
699,731
|
|
|
$
|
527,919
|
|
Net investment income
|
|
$
|
95,662
|
|
|
$
|
100,012
|
|
|
$
|
108,660
|
|
|
$
|
125,557
|
|
|
$
|
129,265
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
|
$
|
8,033
|
|
|
$
|
(5,762
|
)
|
|
$
|
3,682
|
|
|
$
|
3,986
|
|
|
$
|
7,539
|
|
Net realized investment gains (losses)
|
|
$
|
16,409
|
|
|
$
|
34,875
|
|
|
$
|
(41,639
|
)
|
|
$
|
14,654
|
|
|
$
|
67,904
|
|
Other income
|
|
$
|
7,514
|
|
|
$
|
7,808
|
|
|
$
|
7,227
|
|
|
$
|
8,398
|
|
|
$
|
7,551
|
|
Total revenues
|
|
$
|
866,149
|
|
|
$
|
870,214
|
|
|
$
|
772,079
|
|
|
$
|
852,326
|
|
|
$
|
740,178
|
|
Net losses and loss adjustment expenses
|
|
$
|
469,158
|
|
|
$
|
443,229
|
|
|
$
|
410,711
|
|
|
$
|
363,084
|
|
|
$
|
224,761
|
|
Net income
(2)
|
|
$
|
107,264
|
|
|
$
|
151,081
|
|
|
$
|
116,197
|
|
|
$
|
196,565
|
|
|
$
|
297,523
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
2.01
|
|
|
$
|
2.84
|
|
|
$
|
2.12
|
|
|
$
|
3.32
|
|
|
$
|
4.82
|
|
Diluted
|
|
$
|
2.00
|
|
|
$
|
2.83
|
|
|
$
|
2.11
|
|
|
$
|
3.30
|
|
|
$
|
4.80
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
53,393
|
|
|
53,216
|
|
|
54,795
|
|
|
59,285
|
|
|
61,761
|
|
|||||
Diluted
|
|
53,611
|
|
|
53,448
|
|
|
55,017
|
|
|
59,525
|
|
|
62,020
|
|
|||||
Balance Sheet Data, as of December 31
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total investments
|
|
$
|
3,686,528
|
|
|
$
|
3,925,696
|
|
|
$
|
3,650,130
|
|
|
$
|
4,009,707
|
|
|
$
|
3,941,045
|
|
Total assets
(3)
|
|
$
|
4,929,197
|
|
|
$
|
5,065,181
|
|
|
$
|
4,906,021
|
|
|
$
|
5,167,375
|
|
|
$
|
5,147,794
|
|
Reserve for losses and loss adjustment expenses
|
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
$
|
2,005,326
|
|
|
$
|
2,058,266
|
|
|
$
|
2,072,822
|
|
Debt less debt issuance costs
(3)
|
|
$
|
411,811
|
|
|
$
|
448,202
|
|
|
$
|
347,858
|
|
|
$
|
248,215
|
|
|
$
|
247,695
|
|
Total liabilities
(3)
|
|
$
|
3,334,402
|
|
|
$
|
3,266,479
|
|
|
$
|
2,947,667
|
|
|
$
|
3,009,431
|
|
|
$
|
2,753,380
|
|
Total capital
|
|
$
|
1,594,795
|
|
|
$
|
1,798,702
|
|
|
$
|
1,958,354
|
|
|
$
|
2,157,944
|
|
|
$
|
2,394,414
|
|
Total capital per share of common stock outstanding
|
|
$
|
29.83
|
|
|
$
|
33.78
|
|
|
$
|
36.88
|
|
|
$
|
38.17
|
|
|
$
|
39.13
|
|
Common stock outstanding, period end
|
|
53,457
|
|
|
53,251
|
|
|
53,101
|
|
|
56,534
|
|
|
61,197
|
|
(1)
|
Includes acquired entities since date of acquisition only.
|
(2)
|
Includes a gain on acquisition of
$32.3 million
for the year ended December 31, 2013.
|
(3)
|
For all periods presented, debt is shown net of unamortized debt issuance costs which were previously reported as a part of other assets.
|
•
|
The
net loss ratio
is calculated as net losses incurred divided by net premiums earned and is a component of underwriting profitability.
|
•
|
The
underwriting expense ratio
is calculated as underwriting, policy acquisition and operating expenses incurred divided by net premiums earned and is a component of underwriting profitability.
|
•
|
The
combined ratio
is the sum of the net loss ratio and the underwriting expense ratio and measures underwriting profitability.
|
•
|
The
investment income ratio
is calculated as net investment income divided by net premiums earned and measures the contribution investment earnings provide to our overall profitability.
|
•
|
The
operating ratio
is the combined ratio, less the investment income ratio. This ratio provides the combined effect of underwriting profitability and investment income.
|
•
|
The
tax ratio
is calculated as total income tax expense divided by income (loss) before income taxes and measures our effective tax rate.
|
•
|
ROE
is calculated as net income for the period divided by the average of beginning and ending shareholders’ equity. This ratio measures our overall after-tax profitability and shows how efficiently capital is being used.
|
•
|
Book value per share
is calculated as total shareholders’ equity at the balance sheet date divided by the total number of common shares outstanding. This ratio measures the net worth of the company to shareholders on a per-share basis. The declaration of dividends decreases book value per share. Growth in book value per share, adjusted for dividends declared, is an indicator of overall profitability.
|
•
|
Bornhuetter-Ferguson (Paid and Reported) Method
|
•
|
Paid Development Method
|
•
|
Reported Development Method
|
•
|
Average Paid Value Method
|
•
|
Average Reported Value Method
|
•
|
Backward Recursive Development Method
|
•
|
The Adjusted Reported and the Adjusted Paid Methods
|
($ in thousands)
|
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||||
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance, December 31, 2017
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|||||||||||
2017
|
$
|
390,001
|
|
|
N/A
|
|
|
20.4
|
%
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|||
2016
|
$
|
392,518
|
|
|
$
|
3,413
|
|
|
48.2
|
%
|
|
N/A
|
|
|
17.6
|
%
|
|
N/A
|
|
|
N/A
|
|
||
2015
|
$
|
396,426
|
|
|
$
|
1,510
|
|
|
68.7
|
%
|
|
$
|
304
|
|
|
47.5
|
%
|
|
N/A
|
|
|
18.0
|
%
|
|
2014
|
$
|
369,472
|
|
|
$
|
(15,782
|
)
|
|
82.3
|
%
|
|
$
|
(11,358
|
)
|
|
71.8
|
%
|
|
$
|
1,546
|
|
|
51.7
|
%
|
2013
|
$
|
392,286
|
|
|
$
|
(23,164
|
)
|
|
90.4
|
%
|
|
$
|
(10,501
|
)
|
|
83.4
|
%
|
|
$
|
(9,564
|
)
|
|
72.8
|
%
|
2012
|
$
|
402,348
|
|
|
$
|
(17,187
|
)
|
|
95.3
|
%
|
|
$
|
(24,988
|
)
|
|
92.0
|
%
|
|
$
|
(21,199
|
)
|
|
85.1
|
%
|
2011
|
$
|
391,722
|
|
|
$
|
(18,277
|
)
|
|
96.4
|
%
|
|
$
|
(15,977
|
)
|
|
94.0
|
%
|
|
$
|
(24,147
|
)
|
|
90.6
|
%
|
2010
|
$
|
384,737
|
|
|
$
|
(17,224
|
)
|
|
98.7
|
%
|
|
$
|
(14,532
|
)
|
|
97.6
|
%
|
|
$
|
(17,966
|
)
|
|
95.7
|
%
|
2009
|
$
|
341,409
|
|
|
$
|
(8,380
|
)
|
|
99.0
|
%
|
|
$
|
(19,920
|
)
|
|
98.4
|
%
|
|
$
|
(25,851
|
)
|
|
97.1
|
%
|
2008
|
$
|
342,026
|
|
|
$
|
(1,744
|
)
|
|
99.4
|
%
|
|
$
|
(10,391
|
)
|
|
99.1
|
%
|
|
$
|
(16,758
|
)
|
|
98.3
|
%
|
Prior to 2008
|
$
|
6,879,660
|
|
|
$
|
(12,384
|
)
|
|
|
|
$
|
(18,283
|
)
|
|
|
|
$
|
(33,349
|
)
|
|
|
($ in millions)
|
2017
|
|
2016
|
|
2015
|
Prior accident years
|
2014-2016
|
|
2013-2015
|
|
2012-2014
|
Net favorable development recognized for the specified years
|
$10.9
|
|
$21.6
|
|
$29.2
|
Development as a % of established ultimates, prior calendar year end
|
0.9%
|
|
1.8%
|
|
2.3%
|
($ in thousands)
|
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||||
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance, December 31, 2017
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|||||||||||
2017
|
$
|
14,923
|
|
|
N/A
|
|
|
42.2
|
%
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|||
2016
|
$
|
13,587
|
|
|
$
|
(537
|
)
|
|
53.3
|
%
|
|
N/A
|
|
|
26.4
|
%
|
|
N/A
|
|
|
N/A
|
|
||
2015
|
$
|
12,342
|
|
|
$
|
(1,755
|
)
|
|
79.5
|
%
|
|
$
|
(440
|
)
|
|
60.0
|
%
|
|
N/A
|
|
|
38.3
|
%
|
|
2014
|
$
|
13,497
|
|
|
$
|
(187
|
)
|
|
92.5
|
%
|
|
$
|
(845
|
)
|
|
81.7
|
%
|
|
$
|
608
|
|
|
72.6
|
%
|
2013
|
$
|
6,839
|
|
|
$
|
(2,622
|
)
|
|
96.4
|
%
|
|
$
|
(2,400
|
)
|
|
87.7
|
%
|
|
$
|
(171
|
)
|
|
86.5
|
%
|
2012
|
$
|
9,281
|
|
|
$
|
(1,251
|
)
|
|
96.9
|
%
|
|
$
|
(1,826
|
)
|
|
90.5
|
%
|
|
$
|
(1,097
|
)
|
|
93.3
|
%
|
2011
|
$
|
14,881
|
|
|
$
|
92
|
|
|
73.9
|
%
|
|
$
|
(1,591
|
)
|
|
72.0
|
%
|
|
$
|
(2,315
|
)
|
|
77.4
|
%
|
2010
|
$
|
22,882
|
|
|
$
|
(1,385
|
)
|
|
96.3
|
%
|
|
$
|
(800
|
)
|
|
90.6
|
%
|
|
$
|
(2,104
|
)
|
|
94.2
|
%
|
2009
|
$
|
21,629
|
|
|
$
|
(1,178
|
)
|
|
95.7
|
%
|
|
$
|
(1,382
|
)
|
|
92.2
|
%
|
|
$
|
(1,551
|
)
|
|
95.1
|
%
|
2008
|
$
|
42,007
|
|
|
$
|
(351
|
)
|
|
99.9
|
%
|
|
$
|
(947
|
)
|
|
97.2
|
%
|
|
$
|
(3,341
|
)
|
|
99.7
|
%
|
Prior to 2008
|
$
|
495,064
|
|
|
$
|
(899
|
)
|
|
|
|
$
|
(1,282
|
)
|
|
|
|
$
|
(1,726
|
)
|
|
|
($ in thousands)
|
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||||||
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance, December 31, 2017
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
% of Known Claims Closed
|
|||||||||||
2017
|
$
|
150,772
|
|
|
N/A
|
|
|
37
|
%
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
N/A
|
|
|||
2016
|
$
|
139,397
|
|
|
$
|
(7,546
|
)
|
|
82.5
|
%
|
|
N/A
|
|
|
41.3
|
%
|
|
N/A
|
|
N/A
|
|
||
2015
|
$
|
134,234
|
|
|
$
|
(5,773
|
)
|
|
92.4
|
%
|
|
$
|
(3,452
|
)
|
|
82.6
|
%
|
|
N/A
|
|
45.7
|
%
|
|
2014
|
$
|
126,421
|
|
|
$
|
(1,428
|
)
|
|
97.0
|
%
|
|
$
|
77
|
|
|
92.5
|
%
|
|
$
|
(85
|
)
|
83.1
|
%
|
2013
|
$
|
120,610
|
|
|
$
|
441
|
|
|
98.3
|
%
|
|
$
|
944
|
|
|
97.1
|
%
|
|
$
|
1,520
|
|
93.0
|
%
|
2012
|
$
|
100,509
|
|
|
$
|
(308
|
)
|
|
99.3
|
%
|
|
$
|
(577
|
)
|
|
98.4
|
%
|
|
$
|
(739
|
)
|
96.5
|
%
|
2011
|
$
|
95,441
|
|
|
$
|
241
|
|
|
99.0
|
%
|
|
$
|
156
|
|
|
98.9
|
%
|
|
$
|
(263
|
)
|
98.8
|
%
|
2010
|
$
|
75,793
|
|
|
$
|
(42
|
)
|
|
99.4
|
%
|
|
$
|
(820
|
)
|
|
99.3
|
%
|
|
$
|
605
|
|
99.1
|
%
|
Prior to 2010
|
$
|
423,493
|
|
|
$
|
1,710
|
|
|
|
|
$
|
(782
|
)
|
|
|
|
$
|
(1,685
|
)
|
|
|
Low End Point
|
|
Carried Net Reserve
|
|
High End Point
|
80% Confidence Level
|
$1.351 billion
|
|
$1.713 billion
|
|
$2.122 billion
|
60% Confidence Level
|
$1.452 billion
|
|
$1.713 billion
|
|
$1.956 billion
|
|
Distribution by GAAP Fair Value Hierarchy
|
|
|
|
|
||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Not Categorized
|
|
Total
Investments |
Investments recorded at:
|
|
|
|
|
|
|
|
|
|
Fair value
|
24%
|
|
63%
|
|
1%
|
|
6%
|
|
94%
|
Other valuations
|
|
|
|
|
|
|
|
|
6%
|
Total Investments
|
|
|
|
|
|
|
|
|
100%
|
(In millions)
|
Carrying Value
|
|
GAAP Measurement Method
|
||
Other investments:
|
|
|
|
||
Investments in LPs
|
$
|
55.1
|
|
|
Cost
|
Other, principally FHLB capital stock
|
3.5
|
|
|
Principally Cost
|
|
|
58.6
|
|
|
|
|
Investment in unconsolidated subsidiaries:
|
|
|
|
||
Investments in tax credit partnerships
|
90.7
|
|
|
Equity
|
|
Equity method investments, primarily LPs/LLCs
|
29.1
|
|
|
Equity
|
|
|
119.8
|
|
|
|
|
BOLI
|
62.1
|
|
|
Cash surrender value
|
|
Total investments - Other valuation methodologies
|
$
|
240.5
|
|
|
|
•
|
if there is intent to sell the security;
|
•
|
if it is more likely than not that the security will be required to be sold before full recovery of its amortized cost basis; and
|
•
|
if the entire amortized basis of the security is not expected to be recovered.
|
•
|
third-party research and credit rating reports;
|
•
|
the current credit standing of the issuer, including credit rating downgrades, whether before or after the balance sheet date;
|
•
|
the extent to which the decline in fair value is attributable to credit risk specifically associated with the security or its issuer;
|
•
|
internal assessments and the assessments of external portfolio managers regarding specific circumstances surrounding an investment, which indicate the investment is more or less likely to recover its amortized cost than other investments with a similar structure;
|
•
|
for asset-backed securities, the origination date of the underlying loans, the remaining average life, the probability that credit performance of the underlying loans will deteriorate in the future, and our assessment of the quality of the collateral underlying the loan;
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
•
|
any changes to the rating of the security by a rating agency; and
|
•
|
recoveries or additional declines in fair value subsequent to the balance sheet date.
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2017 vs 2016
|
|
2016 vs 2015
|
|
2015 vs 2014
|
||||||
Increase (decrease) in net cash provided (used) by:
|
|
|
|
|
|
||||||
Operating activities
|
$
|
(20,124
|
)
|
|
$
|
57,996
|
|
|
$
|
15,122
|
|
Investing activities
|
503,606
|
|
|
(506,726
|
)
|
|
(39,193
|
)
|
|||
Financing activities
|
(342,581
|
)
|
|
280,917
|
|
|
474
|
|
|||
Increase (decrease) in cash and cash equivalents
|
$
|
140,901
|
|
|
$
|
(167,813
|
)
|
|
$
|
(23,597
|
)
|
•
|
The line entitled “Reserve for losses, undiscounted and net of reinsurance recoverables” reflects our reserve for losses and loss adjustment expense, less the receivables from reinsurers, each as reported in our consolidated financial statements at the end of each year (the Balance Sheet Reserves).
|
•
|
The section entitled “Cumulative net paid, as of” reflects the cumulative amounts paid as of the end of each succeeding year with respect to the previously recorded Balance Sheet Reserves.
|
•
|
The section entitled “Re-estimated net liability as of” reflects the re-estimated amount of the liability previously recorded as Balance Sheet Reserves that includes the cumulative amounts paid and an estimate of the remaining net liability based upon claims experience as of the end of each succeeding year (the Net Re-estimated Liability).
|
•
|
The line entitled “Net cumulative redundancy (deficiency)” reflects the difference between the previously recorded Balance Sheet Reserve for each applicable year and the Net Re-estimated Liability relating thereto as of the end of the most recent fiscal year.
|
Analysis of Reserve Development
|
|||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
|
December 31
|
||||||||||||||||||||||||||||||||||||||||||
(In thousands)
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
2017
|
||||||||||||||||||||||
Reserve for losses, undiscounted and net of reinsurance recoverables
|
$
|
2,232,596
|
|
|
$
|
2,111,112
|
|
|
$
|
2,159,571
|
|
|
$
|
2,136,664
|
|
|
$
|
2,000,114
|
|
|
$
|
1,860,076
|
|
|
$
|
1,825,304
|
|
|
$
|
1,820,300
|
|
|
$
|
1,755,976
|
|
|
$
|
1,719,953
|
|
|
$
|
1,712,796
|
|
Cumulative net paid, as of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
One Year Later
|
312,348
|
|
|
278,655
|
|
|
291,654
|
|
|
264,597
|
|
|
300,703
|
|
|
311,835
|
|
|
343,197
|
|
|
390,849
|
|
|
383,062
|
|
|
369,682
|
|
|
|
||||||||||||
Two Years Later
|
550,042
|
|
|
468,277
|
|
|
476,682
|
|
|
491,657
|
|
|
526,903
|
|
|
563,805
|
|
|
571,690
|
|
|
646,878
|
|
|
633,246
|
|
|
|
|
|
|||||||||||||
Three Years Later
|
694,113
|
|
|
584,410
|
|
|
614,369
|
|
|
639,220
|
|
|
682,576
|
|
|
704,795
|
|
|
732,892
|
|
|
804,624
|
|
|
|
|
|
|
|
||||||||||||||
Four Years Later
|
777,114
|
|
|
666,105
|
|
|
706,091
|
|
|
737,253
|
|
|
763,703
|
|
|
800,189
|
|
|
826,384
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Five Years Later
|
833,471
|
|
|
724,377
|
|
|
761,659
|
|
|
789,965
|
|
|
821,742
|
|
|
852,873
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Six Years Later
|
874,479
|
|
|
758,863
|
|
|
793,528
|
|
|
828,043
|
|
|
852,119
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Seven Years Later
|
898,646
|
|
|
778,795
|
|
|
811,333
|
|
|
844,810
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Eight Years Later
|
911,961
|
|
|
790,950
|
|
|
821,435
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Nine Years Later
|
917,797
|
|
|
796,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Ten Years Later
|
921,129
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Re-estimated net liability as of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
End of Year
|
2,232,596
|
|
|
2,111,112
|
|
|
2,159,571
|
|
|
2,136,664
|
|
|
2,000,114
|
|
|
1,860,076
|
|
|
1,825,304
|
|
|
1,820,300
|
|
|
1,755,976
|
|
|
1,719,953
|
|
|
|
||||||||||||
One Year Later
|
2,047,344
|
|
|
1,903,812
|
|
|
1,925,581
|
|
|
1,810,799
|
|
|
1,728,076
|
|
|
1,644,203
|
|
|
1,644,516
|
|
|
1,659,120
|
|
|
1,612,198
|
|
|
1,585,593
|
|
|
|
||||||||||||
Two Years Later
|
1,829,140
|
|
|
1,665,832
|
|
|
1,615,603
|
|
|
1,543,650
|
|
|
1,498,158
|
|
|
1,472,259
|
|
|
1,483,378
|
|
|
1,519,078
|
|
|
1,485,357
|
|
|
|
|
|
|||||||||||||
Three Years Later
|
1,596,508
|
|
|
1,383,189
|
|
|
1,362,538
|
|
|
1,324,906
|
|
|
1,342,996
|
|
|
1,331,828
|
|
|
1,358,560
|
|
|
1,396,130
|
|
|
|
|
|
|
|
||||||||||||||
Four Years Later
|
1,357,126
|
|
|
1,154,552
|
|
|
1,172,091
|
|
|
1,205,737
|
|
|
1,224,597
|
|
|
1,231,337
|
|
|
1,252,605
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Five Years Later
|
1,185,051
|
|
|
1,019,407
|
|
|
1,086,027
|
|
|
1,111,591
|
|
|
1,148,793
|
|
|
1,157,493
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Six Years Later
|
1,084,422
|
|
|
961,808
|
|
|
1,012,597
|
|
|
1,050,549
|
|
|
1,091,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Seven Years Later
|
1,041,623
|
|
|
915,935
|
|
|
961,987
|
|
|
1,010,802
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Eight Years Later
|
1,011,674
|
|
|
885,698
|
|
|
940,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Nine Years Later
|
992,015
|
|
|
871,466
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Ten Years Later
|
978,633
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Net cumulative redundancy (deficiency)
|
$
|
1,253,963
|
|
|
$
|
1,239,646
|
|
|
$
|
1,219,536
|
|
|
$
|
1,125,862
|
|
|
$
|
908,468
|
|
|
$
|
702,583
|
|
|
$
|
572,699
|
|
|
$
|
424,170
|
|
|
$
|
270,619
|
|
|
$
|
134,360
|
|
|
|
||
Original gross liability - end of year
|
$
|
2,559,707
|
|
|
$
|
2,379,468
|
|
|
$
|
2,422,230
|
|
|
$
|
2,414,100
|
|
|
$
|
2,247,772
|
|
|
$
|
2,051,428
|
|
|
$
|
2,072,822
|
|
|
$
|
2,058,266
|
|
|
$
|
2,005,326
|
|
|
$
|
1,993,428
|
|
|
|
||
Reinsurance recoverables
|
(327,111
|
)
|
|
(268,356
|
)
|
|
(262,659
|
)
|
|
(277,436
|
)
|
|
(247,658
|
)
|
|
(191,352
|
)
|
|
(247,518
|
)
|
|
(237,966
|
)
|
|
(249,350
|
)
|
|
(273,475
|
)
|
|
|
||||||||||||
Original net liability - end of year
|
$
|
2,232,596
|
|
|
$
|
2,111,112
|
|
|
$
|
2,159,571
|
|
|
$
|
2,136,664
|
|
|
$
|
2,000,114
|
|
|
$
|
1,860,076
|
|
|
$
|
1,825,304
|
|
|
$
|
1,820,300
|
|
|
$
|
1,755,976
|
|
|
$
|
1,719,953
|
|
|
|
||
Gross re-estimated liability - latest
|
$
|
1,214,306
|
|
|
$
|
1,016,303
|
|
|
$
|
1,066,624
|
|
|
$
|
1,142,569
|
|
|
$
|
1,226,131
|
|
|
$
|
1,287,377
|
|
|
$
|
1,423,461
|
|
|
$
|
1,590,748
|
|
|
$
|
1,714,529
|
|
|
$
|
1,858,768
|
|
|
|
||
Re-estimated reinsurance recoverables
|
(235,673
|
)
|
|
(144,837
|
)
|
|
(126,589
|
)
|
|
(131,767
|
)
|
|
(134,485
|
)
|
|
(129,884
|
)
|
|
(170,856
|
)
|
|
(194,618
|
)
|
|
(229,172
|
)
|
|
(273,175
|
)
|
|
|
||||||||||||
Net re-estimated liability - latest
|
$
|
978,633
|
|
|
$
|
871,466
|
|
|
$
|
940,035
|
|
|
$
|
1,010,802
|
|
|
$
|
1,091,646
|
|
|
$
|
1,157,493
|
|
|
$
|
1,252,605
|
|
|
$
|
1,396,130
|
|
|
$
|
1,485,357
|
|
|
$
|
1,585,593
|
|
|
|
||
Gross cumulative redundancy (deficiency)
|
$
|
1,345,401
|
|
|
$
|
1,363,165
|
|
|
$
|
1,355,606
|
|
|
$
|
1,271,531
|
|
|
$
|
1,021,641
|
|
|
$
|
764,051
|
|
|
$
|
649,361
|
|
|
$
|
467,518
|
|
|
$
|
290,797
|
|
|
$
|
134,660
|
|
|
|
•
|
Reserves for 2009 and thereafter include gross and net reserves acquired in 2009 business combinations of
$169.4 million
and
$163.9 million
, respectively.
|
•
|
Reserves for 2010 and thereafter include gross and net reserves acquired in 2010 business combinations of
$88.1 million
and
$82.2 million
, respectively.
|
•
|
Reserves for 2012 and thereafter include gross and net reserves acquired in 2012 business combinations of
$21.8 million
and
$19.2 million
, respectively, which considers reductions of
$3.6 million
and
$3.3 million
, respectively, recorded in 2013 due to the re-estimation of the fair value of the acquired reserves.
|
•
|
Reserves for 2013 include gross and net reserves acquired in 2013 business combinations of
$201.1 million
and
$126.0 million
, respectively.
|
•
|
Reserves for 2014 include gross and net reserves acquired in 2014 business combinations of
$153.2 million
and
$139.5 million
, respectively.
|
•
|
The
HCPL
legal environment deteriorated in the late 1990’s and severity began to increase at a greater pace than anticipated in our rates and reserve estimates. We addressed the adverse severity trends through increased rates, stricter underwriting and modifications to claims handling procedures, and reflected this adverse severity trend when we established our initial reserves for subsequent years.
|
•
|
These adverse severity trends later moderated, with that moderation becoming more pronounced beginning in 2009. We have been cautious in giving full recognition to indications that the pace of severity increase had slowed, however we have given measured recognition of the improved trend in our reserve estimates, as discussed more fully under the heading “Reserve for Losses and Loss Adjustment Expenses" in the Critical Accounting Estimates section (reserve for losses or reserve). The favorable development was most pronounced for years 2004 to 2008, as the initial reserves for these accident years were established prior to substantial indication that severity trends were moderating. We have given stronger recognition to the lower severity trend as time has elapsed and a greater percentage of claims have closed.
|
•
|
A general decline in claim frequency has also been a contributor to favorable loss development. A significant portion of our policies through 2003 were issued on an occurrence basis, and a smaller portion of our ongoing business results from the issuance of extended reporting endorsements which have occurrence-like exposure. As claim frequency declined, the number of reported claims related to these coverages was less than originally expected.
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2017
|
|
2016
|
|
2015
|
||||||
Balance, beginning of year
|
$
|
1,993,428
|
|
|
$
|
2,005,326
|
|
|
$
|
2,058,266
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
273,475
|
|
|
249,350
|
|
|
237,966
|
|
|||
Net balance, beginning of year
|
1,719,953
|
|
|
1,755,976
|
|
|
1,820,300
|
|
|||
Net losses:
|
|
|
|
|
|
||||||
Current year
|
603,518
|
|
|
587,007
|
|
|
571,891
|
|
|||
Favorable development of reserves established in prior years, net
|
(134,360
|
)
|
|
(143,778
|
)
|
|
(161,180
|
)
|
|||
Total
|
469,158
|
|
|
443,229
|
|
|
410,711
|
|
|||
Paid related to:
|
|
|
|
|
|
||||||
Current year
|
(106,633
|
)
|
|
(96,190
|
)
|
|
(84,186
|
)
|
|||
Prior years
|
(369,682
|
)
|
|
(383,062
|
)
|
|
(390,849
|
)
|
|||
Total paid
|
(476,315
|
)
|
|
(479,252
|
)
|
|
(475,035
|
)
|
|||
Net balance, end of year
|
1,712,796
|
|
|
1,719,953
|
|
|
1,755,976
|
|
|||
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
335,585
|
|
|
273,475
|
|
|
249,350
|
|
|||
Balance, end of year
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
$
|
2,005,326
|
|
|
Professional
Liability
|
|
Medical Technology & Life Sciences Products
|
|
Workers'
Compensation - Traditional
|
Per Occurrence Coverage
|
|
Aggregate Coverage
|
•
|
Reinsurance is utilized on a per risk basis for the property insurance and casualty coverages in order to mitigate risk volatility.
|
•
|
Catastrophic protection is utilized on both our property insurance and casualty coverages to protect against losses in excess of policy limits as well as natural catastrophes.
|
•
|
Both quota share reinsurance and excess of loss reinsurance are utilized to manage the net loss exposure on our property reinsurance coverages.
|
•
|
Property umbrella excess of loss reinsurance is utilized for peak catastrophe and frequency of catastrophe exposures.
|
•
|
Beginning in 2018, external excess of loss reinsurance will be utilized by
Syndicate 1729
to manage the net loss exposure on our specialty property and contingency coverages ceded to
Syndicate 6131
(see further discussion in Segment Operating Results - Lloyd’s Syndicate section that follows).
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||
($ in thousands)
|
Carrying
Value |
% of Total Investment
|
|
Carrying
Value |
% of Total Investment
|
||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
||||||
U.S. Treasury obligations
|
$
|
133,627
|
|
4
|
%
|
|
$
|
146,539
|
|
4
|
%
|
U.S. Government-sponsored enterprise obligations
|
20,956
|
|
1
|
%
|
|
30,235
|
|
1
|
%
|
||
State and municipal bonds
|
632,243
|
|
17
|
%
|
|
800,463
|
|
20
|
%
|
||
Corporate debt
|
1,167,158
|
|
31
|
%
|
|
1,278,991
|
|
33
|
%
|
||
Residential mortgage-backed securities
|
197,844
|
|
5
|
%
|
|
217,906
|
|
5
|
%
|
||
Commercial mortgage-backed securities
|
26,703
|
|
1
|
%
|
|
32,394
|
|
1
|
%
|
||
Other asset-backed securities
|
101,711
|
|
3
|
%
|
|
106,878
|
|
3
|
%
|
||
Total fixed maturities, available for sale
|
2,280,242
|
|
62
|
%
|
|
2,613,406
|
|
67
|
%
|
||
|
|
|
|
|
|
||||||
Equity securities, trading
|
470,609
|
|
13
|
%
|
|
387,274
|
|
10
|
%
|
||
Short-term investments
|
432,126
|
|
12
|
%
|
|
442,084
|
|
11
|
%
|
||
BOLI
|
62,113
|
|
1
|
%
|
|
60,134
|
|
1
|
%
|
||
Investment in unconsolidated subsidiaries
|
330,591
|
|
9
|
%
|
|
340,906
|
|
9
|
%
|
||
Other investments
|
110,847
|
|
3
|
%
|
|
81,892
|
|
2
|
%
|
||
Total Investments
|
$
|
3,686,528
|
|
100
|
%
|
|
$
|
3,925,696
|
|
100
|
%
|
(In thousands)
|
2017
|
|
2016
|
|
2015
|
|||
Treasury shares at the beginning of the period
|
9,409
|
|
|
9,403
|
|
|
5,763
|
|
Shares reacquired, at cost of $2 million and $170 million for 2016 and 2015, respectively
|
—
|
|
|
44
|
|
|
3,680
|
|
Shares reissued, primarily those reissued pursuant to the ProAssurance 2011 Employee Stock Ownership Plan, fair value of approximately $2 million in each period presented
|
(41
|
)
|
|
(38
|
)
|
|
(40
|
)
|
Treasury shares at the end of the period
|
9,368
|
|
|
9,409
|
|
|
9,403
|
|
|
|
Payments due by period
|
||||||||||||||||||
(In thousands)
|
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than
5 years
|
||||||||||
Losses and loss adjustment expenses
|
|
$
|
2,048,381
|
|
|
$
|
553,033
|
|
|
$
|
766,605
|
|
|
$
|
364,215
|
|
|
$
|
364,528
|
|
Debt obligations including interest and fees
|
|
507,014
|
|
|
18,285
|
|
|
158,364
|
|
|
31,680
|
|
|
298,685
|
|
|||||
Operating lease obligations
|
|
28,401
|
|
|
5,021
|
|
|
8,285
|
|
|
5,883
|
|
|
9,212
|
|
|||||
Funding commitments primarily related to non-public investment entities
|
|
172,749
|
|
|
88,609
|
|
|
70,728
|
|
|
13,252
|
|
|
160
|
|
|||||
Total
|
|
$
|
2,756,545
|
|
|
$
|
664,948
|
|
|
$
|
1,003,982
|
|
|
$
|
415,030
|
|
|
$
|
672,585
|
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Net Premiums Earned
|
|
|
|
|
|
|
|
|||||||
Specialty P&C
|
$
|
453,921
|
|
|
$
|
457,816
|
|
|
$
|
(3,895
|
)
|
|
(0.9
|
%)
|
Workers' Compensation
|
227,408
|
|
|
220,815
|
|
|
6,593
|
|
|
3.0
|
%
|
|||
Lloyd's Syndicate
|
57,202
|
|
|
54,650
|
|
|
2,552
|
|
|
4.7
|
%
|
|||
Consolidated total
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
$
|
5,250
|
|
|
0.7
|
%
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Net investment income
|
$
|
95,662
|
|
|
$
|
100,012
|
|
|
$
|
(4,350
|
)
|
|
(4.3
|
%)
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
8,033
|
|
|
(5,762
|
)
|
|
13,795
|
|
|
239.4
|
%
|
|||
Net investment result
|
$
|
103,695
|
|
|
$
|
94,250
|
|
|
$
|
9,445
|
|
|
10.0
|
%
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Net impairment losses recognized in earnings
|
$
|
(12,952
|
)
|
|
$
|
(9,766
|
)
|
|
$
|
(3,186
|
)
|
|
(32.6
|
%)
|
Other net realized investment gains (losses)
|
29,361
|
|
|
44,641
|
|
|
(15,280
|
)
|
|
(34.2
|
%)
|
|||
Net realized investment gains (losses)
|
$
|
16,409
|
|
|
$
|
34,875
|
|
|
$
|
(18,466
|
)
|
|
(52.9
|
%)
|
|
Year Ended December 31
|
|||||||||||
($ in millions)
|
2017
|
|
2016
|
|
Change
|
|||||||
Current accident year net loss ratio
|
|
|
|
|
|
|
||||||
Consolidated ratio
|
81.7
|
%
|
|
80.1
|
%
|
|
1.6
|
|
pts
|
|||
Specialty P&C
|
89.9
|
%
|
|
88.6
|
%
|
|
1.3
|
|
pts
|
|||
Workers' Compensation
|
66.2
|
%
|
|
66.4
|
%
|
|
(0.2
|
)
|
pts
|
|||
Lloyd's Syndicate
|
78.7
|
%
|
|
63.3
|
%
|
|
15.4
|
|
pts
|
|||
Calendar year net loss ratio
|
|
|
|
|
|
|
||||||
Consolidated ratio
|
63.5
|
%
|
|
60.4
|
%
|
|
3.1
|
|
pts
|
|||
Specialty P&C
|
63.6
|
%
|
|
58.7
|
%
|
|
4.9
|
|
pts
|
|||
Workers' Compensation
|
59.9
|
%
|
|
63.6
|
%
|
|
(3.7
|
)
|
pts
|
|||
Lloyd's Syndicate
|
77.3
|
%
|
|
62.4
|
%
|
|
14.9
|
|
pts
|
|||
Favorable net loss development, prior accident years
|
|
|
|
|
|
|
||||||
Consolidated
|
$
|
134.4
|
|
|
$
|
143.8
|
|
|
$
|
(9.4
|
)
|
|
Specialty P&C
|
$
|
119.3
|
|
|
$
|
137.2
|
|
|
$
|
(17.9
|
)
|
|
Workers' Compensation
|
$
|
14.3
|
|
|
$
|
6.1
|
|
|
$
|
8.2
|
|
|
Lloyd's Syndicate
|
$
|
0.8
|
|
|
$
|
0.5
|
|
|
$
|
0.3
|
|
|
|
Book Value Per Share
|
||
Book Value Per Share at December 31, 2016
|
$
|
33.78
|
|
Increase (decrease) to book value per share during the year ended December 31, 2017 attributable to:
|
|
||
Dividends declared
|
(5.93
|
)
|
|
Net income
|
2.01
|
|
|
Decrease in AOCI
|
(0.05
|
)
|
|
Other
|
0.02
|
|
|
Book Value Per Share at December 31, 2017
|
$
|
29.83
|
|
|
Year Ended December 31
|
||||||
(In thousands, except per share data)
|
2017
|
|
2016
|
||||
Net income
|
$
|
107,264
|
|
|
$
|
151,081
|
|
Items excluded in the calculation of Non-GAAP operating income:
|
|
|
|
||||
Net realized investment (gains) losses
|
(16,409
|
)
|
|
(34,875
|
)
|
||
Net realized gains (losses) attributable to SPCs which no profit/loss is retained
(1)
|
3,083
|
|
|
2,049
|
|
||
Guaranty fund assessments (recoupments)
|
(157
|
)
|
|
153
|
|
||
Pre-tax effect of exclusions
|
(13,483
|
)
|
|
(32,673
|
)
|
||
Tax effect, at 35%
(2)
|
4,719
|
|
|
11,436
|
|
||
After-tax effect of exclusions
|
(8,764
|
)
|
|
(21,237
|
)
|
||
Non-GAAP operating income, before tax reform adjustments
|
98,500
|
|
|
129,844
|
|
||
Tax reform adjustments on our deferred tax balances excluded in the calculation of Non-GAAP operating income:
|
|
|
|
||||
Adjustment of deferred taxes upon the change in corporate tax rate
(3)
|
6,541
|
|
|
—
|
|
||
Adjustment of deferred taxes upon the change in limitation of future deductibility of certain executive compensation
(3)
|
3,497
|
|
|
—
|
|
||
Non-GAAP operating income
|
$
|
108,538
|
|
|
$
|
129,844
|
|
Per diluted common share:
|
|
|
|
||||
Net income
|
$
|
2.00
|
|
|
$
|
2.83
|
|
Effect of exclusions
|
0.02
|
|
|
(0.40
|
)
|
||
Non-GAAP operating income per diluted common share
|
$
|
2.02
|
|
|
$
|
2.43
|
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Net premiums written
|
$
|
470,535
|
|
|
$
|
458,681
|
|
|
$
|
11,854
|
|
|
2.6
|
%
|
|
|
|
|
|
|
|
|
|||||||
Net premiums earned
|
$
|
453,921
|
|
|
$
|
457,816
|
|
|
$
|
(3,895
|
)
|
|
(0.9
|
%)
|
Other income
|
5,688
|
|
|
5,306
|
|
|
382
|
|
|
7.2
|
%
|
|||
Net losses and loss adjustment expenses
|
(288,701
|
)
|
|
(268,579
|
)
|
|
(20,122
|
)
|
|
7.5
|
%
|
|||
Underwriting, policy acquisition and operating expenses
|
(108,830
|
)
|
|
(104,333
|
)
|
|
(4,497
|
)
|
|
4.3
|
%
|
|||
Segregated portfolio cells dividend (expense) income
|
(4,970
|
)
|
|
(144
|
)
|
|
(4,826
|
)
|
|
3,351.4
|
%
|
|||
Segment operating results
|
$
|
57,108
|
|
|
$
|
90,066
|
|
|
$
|
(32,958
|
)
|
|
(36.6
|
%)
|
|
|
|
|
|
|
|
|
|||||||
Net loss ratio
|
63.6%
|
|
58.7%
|
|
4.9
|
|
pts
|
|||||||
Underwriting expense ratio
|
24.0%
|
|
22.8%
|
|
1.2
|
|
pts
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Gross premiums written
|
$
|
549,323
|
|
|
$
|
535,725
|
|
|
$
|
13,598
|
|
|
2.5
|
%
|
Less: Ceded premiums written
|
78,788
|
|
|
77,044
|
|
|
1,744
|
|
|
2.3
|
%
|
|||
Net premiums written
|
$
|
470,535
|
|
|
$
|
458,681
|
|
|
$
|
11,854
|
|
|
2.6
|
%
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Professional liability
|
|
|
|
|
|
|
|
|||||||
Physicians
(1)(7)
|
|
|
|
|
|
|
|
|||||||
Twelve month term
|
$
|
360,232
|
|
|
$
|
344,150
|
|
|
$
|
16,082
|
|
|
4.7
|
%
|
Twenty-four month term
|
27,370
|
|
|
21,869
|
|
|
5,501
|
|
|
25.2
|
%
|
|||
Total Physicians
|
387,602
|
|
|
366,019
|
|
|
21,583
|
|
|
5.9
|
%
|
|||
Healthcare facilities
(2)(7)
|
47,697
|
|
|
59,361
|
|
|
(11,664
|
)
|
|
(19.6
|
%)
|
|||
Other healthcare providers
(3)
|
32,599
|
|
|
33,353
|
|
|
(754
|
)
|
|
(2.3
|
%)
|
|||
Legal professionals
(4)
|
25,628
|
|
|
25,351
|
|
|
277
|
|
|
1.1
|
%
|
|||
Tail coverages
(5)
|
21,206
|
|
|
18,092
|
|
|
3,114
|
|
|
17.2
|
%
|
|||
Total professional liability
|
514,732
|
|
|
502,176
|
|
|
12,556
|
|
|
2.5
|
%
|
|||
Medical technology liability
(6)
|
34,164
|
|
|
33,067
|
|
|
1,097
|
|
|
3.3
|
%
|
|||
Other
|
427
|
|
|
482
|
|
|
(55
|
)
|
|
(11.4
|
%)
|
|||
Total
|
$
|
549,323
|
|
|
$
|
535,725
|
|
|
$
|
13,598
|
|
|
2.5
|
%
|
(1)
|
Physician policies were our greatest source of premium revenues in both
2017
and
2016
. The increase in twelve month term policies in
2017
was primarily driven by new business written, including the addition of several large policies, and timing differences related to the renewal of certain policies, largely offset by retention losses. In addition, written premium reflected an increase in renewal pricing, driven by an increase in exposures for a few large policies. We offer twenty-four month term policies to our physician insureds in one selected jurisdiction. The increase in twenty-four month premium, as compared to
2016
, primarily reflected the normal cycle of renewals (policies subject to renewal in
2017
were previously written in
2015
rather than in
2016
).
|
(2)
|
Our healthcare facilities premium (which includes hospitals, surgery centers and other facilities)
decline
d in
2017
as compared to
2016
driven by the effect of a novation agreement entered into during the fourth quarter of
2016
. A novation represents a legal replacement of one insurer by another extinguishing the ceding entity's liability to the policyholder. The novation resulted in approximately
$11.8 million
of one-time gross premiums written and earned during the fourth quarter of 2016 as all the underlying loss events covered by the policy occurred in the past. After removing the impact of the novation, our healthcare facilities premium was relatively flat compared to 2016 due to several offsetting factors. While an increase in renewal pricing and new business written, including one large policy, increased written premium in
2017
, the impact was offset by a timing difference related to the renewal of one large policy and retention losses during the period. Renewal pricing increased during
2017
due to changes in loss experience related to a few large policies.
|
(3)
|
Our other healthcare providers are primarily dentists, chiropractors and allied health professionals.
|
(4)
|
Our legal professionals policies are primarily individual and small group policies in select areas of practice. The increase in
2017
as compared to 2016 was primarily due to new business written and, to a lesser extent, an increase in the rate charged for certain renewed policies, largely offset by retention losses. Retention losses were primarily driven by competitive market conditions.
|
(5)
|
We offer extended reporting endorsement or "tail" coverage to insureds who discontinue their claims-made coverage with us, and we also periodically offer tail coverage through custom policies. The amount of tail coverage premium written can vary widely from period to period. The increase in
2017
as compared to
2016
was driven by the purchase of tail coverage for a few large claims-made policies in one jurisdiction that were rewritten to occurrence coverage in
2017
. These policies are part of one of our shared risk arrangements and therefore, a large portion of the premium written was ceded during the current period (see further discussion in the Ceded Premiums Written section that follows).
|
(6)
|
Our
medical technology liability
business is marketed throughout the U.S.; coverage is offered on a primary basis, within specified limits, to manufacturers and distributors of medical technology and life sciences products including entities conducting human clinical trials. In addition to the previously listed factors that affect our premium volume, our
medical technology liability
premium volume is impacted by the sales volume of insureds. The increase in
2017
primarily reflected new business written, including two large policies during the fourth quarter of
2017
, partially offset by retention losses, including the loss of one large policy in the first quarter of
2017
. Retention losses in
2017
are largely attributable to price competition and merger activity within the industry.
|
(7)
|
During 2016, we expanded our alternative market solutions by writing new healthcare premium in certain
SPC
s at Eastern Re. We wrote approximately
$1.2 million
of healthcare professional liability premium in our physicians line of business in each of the
years ended
December 31, 2017
and
2016
. We wrote healthcare professional liability premium in our healthcare facilities line of business of approximately
$3.1 million
and
$2.9 million
for the
years ended
December 31, 2017
and
2016
, respectively. All or a portion of the premium written was ceded to the
SPC
s at our wholly owned Cayman Islands reinsurance subsidiary,
Eastern Re
. Under the
SPC
structure, the operating results of each cell, net of any participation we have taken in the
SPC
s, accrue to the benefit of the external owners of that cell. Our
Specialty P&C
segment does not currently participate in the cells that write
HCPL
premium, and therefore retains no underwriting profit or loss. Additional information regarding the
SPC
s is included under the heading "Underwriting, Policy Acquisition and Operating Expense" in the section that follows.
|
|
Year Ended December 31
|
||||||
(In millions)
|
2017
|
|
2016
|
||||
Physicians
|
$
|
31.6
|
|
|
$
|
32.8
|
|
Healthcare facilities
|
5.8
|
|
|
17.4
|
|
||
Other healthcare providers
|
2.1
|
|
|
3.4
|
|
||
Legal professionals
|
3.6
|
|
|
3.8
|
|
||
Medical technology liability
|
5.4
|
|
|
5.1
|
|
||
Total
|
$
|
48.5
|
|
|
$
|
62.5
|
|
|
Year Ended December 31
|
|
|
2017
|
|
Physicians
(1)
|
1
|
%
|
Healthcare facilities
(1)(2)
|
8
|
%
|
Other healthcare providers
(1)
|
2
|
%
|
Legal professionals
(2)
|
3
|
%
|
Medical technology liability
|
1
|
%
|
(1)
Excludes certain policies written on an excess and surplus lines basis.
|
||
(2)
See Gross Premiums Written section for further explanation of renewal pricing increase.
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Excess of loss reinsurance arrangements
(1)
|
$
|
31,853
|
|
|
$
|
30,037
|
|
|
$
|
1,816
|
|
|
6.0
|
%
|
Premium ceded to Syndicate 1729
(2)
|
13,983
|
|
|
23,832
|
|
|
(9,849
|
)
|
|
(41.3
|
%)
|
|||
Other shared risk arrangements
(3)
|
30,780
|
|
|
26,737
|
|
|
4,043
|
|
|
15.1
|
%
|
|||
Other ceded premiums written
|
3,361
|
|
|
3,521
|
|
|
(160
|
)
|
|
(4.5
|
%)
|
|||
Adjustment to premiums owed under reinsurance agreements, prior accident years, net
(4)
|
(1,189
|
)
|
|
(7,083
|
)
|
|
5,894
|
|
|
(83.2
|
%)
|
|||
Total ceded premiums written
|
$
|
78,788
|
|
|
$
|
77,044
|
|
|
$
|
1,744
|
|
|
2.3
|
%
|
(1)
|
We generally reinsure risks under our excess of loss reinsurance arrangements pursuant to which the reinsurers agree to assume all or a portion of all risks that we insure above our individual risk retention levels, up to the maximum individual limits offered. In the majority of our excess of loss reinsurance arrangements, the premium due to the reinsurer is determined by the loss experience of that business reinsured, subject to certain minimum and maximum amounts. The increase in ceded premiums written under our excess of loss reinsurance arrangements for
2017
was primarily due to revised contract terms on our
medical technology liability
reinsurance arrangement effective January 1, 2017, which reduced the amount of excess premium we retain from 20% to 10%.
|
(2)
|
As previously discussed, we are the majority participant in
Syndicate 1729
and normally record our pro rata share of its operating results in our
Lloyd's
Syndicate segment on a quarter delay, except when information is available that is material to the current period. We also record the cession to the Lloyd's Syndicate segment from our
Specialty P&C
segment on a quarter delay as the amounts are not material and this permits the cession to be reported by both the Lloyd's Syndicate segment and the
Specialty P&C
segment in the same reporting period. The decrease in ceded premiums to
Syndicate 1729
for the
year ended
December 31, 2017
reflected the revised contract terms effective January 1, 2017 which reduced the premiums ceded by essentially half. We did not renew our quota share agreement with
Syndicate 1729
on January 1, 2018, however the impact will not be reflected in ceded premiums until the second quarter of 2018 due to the previously mentioned quarter delay. See Lloyd's Syndicate segment results for further discussion on the quota share agreement. As our premiums are earned, we recognize the related ceding commission income which reduces underwriting expense by offsetting
DPAC
amortization. For the
years ended
December 31, 2017
and
2016
, the related ceding commission income was approximately
27%
of ceded premiums written. For our consolidated results, eliminations of the inter-segment portion (58% of the
Specialty P&C
cession) of the transactions are also recorded on a quarter delay.
|
(3)
|
We have entered into various shared risk arrangements, including quota share, fronting, and captive arrangements, with certain large healthcare systems and other insurance entities. These arrangements include our Ascension Health and CAPAssurance programs. While we cede a large portion of the premium written under these arrangements, they provide us an opportunity to grow net premium through strategic partnerships. The increase in
2017
was primarily driven by a few large tail endorsements that were written, and substantially ceded, related to one of these shared risk arrangements, as previously discussed. The remaining increase was due to growth in our Ascension Health and CAPAssurance programs.
|
(4)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance arrangement are known. As a part of the process of estimating our loss reserve we also make estimates regarding the amounts recoverable under our reinsurance arrangements. As previously discussed, the premiums ultimately ceded under certain of our excess of loss reinsurance arrangements are subject to the losses ceded under the arrangements. Based upon adjustments in 2017 and 2016 to our estimate of expected losses and associated recoveries for prior year ceded losses, we reduced our estimate of ceded premiums owed to reinsurers. However, prior accident year ceded premium reductions were lower in 2017 as compared to 2016. In addition, the lower prior accident year ceded premium reduction in 2017 reflected an overall change in expected loss recoveries attributable to one large claim during the second quarter of 2017. We do not believe this isolated claim indicates a change in overall loss trends for us or the industry. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the changes in estimates occur.
|
|
Year Ended December 31
|
||||||||
|
2017
|
|
2016
|
|
Change
|
||||
Ceded premiums ratio, as reported
|
14.3
|
%
|
|
14.4
|
%
|
|
(0.1
|
)
|
pts
|
Less the effect of adjustments in premiums owed under reinsurance agreements, prior accident years (as previously discussed)
|
(0.2
|
%)
|
|
(1.3
|
%)
|
|
1.1
|
|
pts
|
Ratio, current accident year
|
14.5
|
%
|
|
15.7
|
%
|
|
(1.2
|
)
|
pts
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Gross premiums earned
|
$
|
537,583
|
|
|
$
|
535,931
|
|
|
$
|
1,652
|
|
|
0.3
|
%
|
Less: Ceded premiums earned
|
83,662
|
|
|
78,115
|
|
|
5,547
|
|
|
7.1
|
%
|
|||
Net premiums earned
|
$
|
453,921
|
|
|
$
|
457,816
|
|
|
$
|
(3,895
|
)
|
|
(0.9
|
%)
|
|
Net Loss Ratios
(1)
|
|||||||
|
Year Ended December 31
|
|||||||
|
2017
|
|
2016
|
|
Change
|
|||
Calendar year net loss ratio
|
63.6
|
%
|
|
58.7
|
%
|
|
4.9
|
pts
|
Less impact of prior accident years on the net loss ratio
|
(26.3
|
%)
|
|
(29.9
|
%)
|
|
3.6
|
pts
|
Current accident year net loss ratio
|
89.9
|
%
|
|
88.6
|
%
|
|
1.3
|
pts
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
||
Ceded premium adjustments, prior accident years
(2)
|
(0.2
|
%)
|
|
(1.4
|
%)
|
|
1.2
|
pts
|
Current accident year net loss ratio, excluding the effect of prior year ceded premium
(3)
|
90.1
|
%
|
|
90.0
|
%
|
|
0.1
|
pts
|
(1)
|
Net losses, as specified, divided by net premiums earned.
|
(2)
|
Reductions to premiums owed under reinsurance agreements for prior accident years increased net premiums earned (the denominator of the current accident year ratio) in both
2017
and
2016
, however, the reduction was substantially less in
2017
than in
2016
. See the discussion in the Premiums section for our
Specialty P&C
segment under the heading "Ceded Premiums Written" for additional information.
|
(3)
|
The current accident year net loss ratio was relatively unchanged as compared to
2016
primarily due to offsetting factors. Changes in the mix of business resulted in an
1.2
percentage point increase in the current accident year net loss ratio in
2017
as compared to
2016
. However, the effect of a
DDR
reinsurance commutation during the fourth quarter of
2017
(reduction in current year net losses) partially offset the increase by
0.5
percentage points and the effect of a prior year novation (net premiums earned at a high loss ratio) partially offset the increase by
0.4
percentage points. Additional information regarding the prior year novation is included in the Premiums section for our Specialty P&C segment under the heading "Gross Premiums Written."
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Specialty P&C segment:
|
|
|
|
|
|
|
|
|||||||
DPAC amortization
|
$
|
48,469
|
|
|
$
|
45,019
|
|
|
$
|
3,450
|
|
|
7.7
|
%
|
Management fees
|
6,620
|
|
|
6,447
|
|
|
173
|
|
|
2.7
|
%
|
|||
Other underwriting and operating expenses
|
53,741
|
|
|
52,867
|
|
|
874
|
|
|
1.7
|
%
|
|||
Total
|
$
|
108,830
|
|
|
$
|
104,333
|
|
|
$
|
4,497
|
|
|
4.3
|
%
|
|
Year Ended December 31
|
|||||||
|
2017
|
|
2016
|
|
Change
|
|||
Underwriting expense ratio
|
24.0
|
%
|
|
22.8
|
%
|
|
1.2
|
pts
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2017
|
|
2016
|
|
Change
|
||||||
SPC dividend (expense) income
|
$
|
(4,970
|
)
|
|
$
|
(144
|
)
|
|
$
|
(4,826
|
)
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Gross premiums written
|
|
|
|
|
|
|
|
|||||||
Traditional business*
|
$
|
182,847
|
|
|
$
|
172,025
|
|
|
$
|
10,822
|
|
|
6.3
|
%
|
Alternative market business
|
80,544
|
|
|
75,915
|
|
|
4,629
|
|
|
6.1
|
%
|
|||
Segment results
|
263,391
|
|
|
247,940
|
|
|
15,451
|
|
|
6.2
|
%
|
|||
Less: Ceded premiums written
|
|
|
|
|
|
|
|
|
||||||
Traditional business
|
9,937
|
|
|
9,446
|
|
|
491
|
|
|
5.2
|
%
|
|||
Alternative market business*
|
14,940
|
|
|
14,916
|
|
|
24
|
|
|
0.2
|
%
|
|||
Segment results
|
24,877
|
|
|
24,362
|
|
|
515
|
|
|
2.1
|
%
|
|||
Net premiums written
|
|
|
|
|
|
|
|
|
||||||
Traditional business
|
172,910
|
|
|
162,579
|
|
|
10,331
|
|
|
6.4
|
%
|
|||
Alternative market business
|
65,604
|
|
|
60,999
|
|
|
4,605
|
|
|
7.5
|
%
|
|||
Segment results
|
$
|
238,514
|
|
|
$
|
223,578
|
|
|
$
|
14,936
|
|
|
6.7
|
%
|
* Traditional gross premiums written and alternative market ceded premiums written are reported net of alternative market premiums assumed by our traditional business totaling $0.7 million and $0.9 million for the years ended December 31, 2017 and 2016, respectively.
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
Premiums ceded to external reinsurers
|
|
|
|
|
|||||||
Traditional business
|
$
|
9,823
|
|
$
|
10,255
|
|
$
|
(432
|
)
|
(4.2
|
%)
|
Alternative market business
|
8,156
|
|
7,258
|
|
898
|
|
12.4
|
%
|
|||
Segment results
|
17,979
|
|
17,513
|
|
466
|
|
2.7
|
%
|
|||
Change in return premium estimate under external reinsurance
|
|
|
|
|
|||||||
Traditional business
|
114
|
|
(809
|
)
|
923
|
|
114.1
|
%
|
|||
Alternative market business
|
—
|
|
—
|
|
—
|
|
nm
|
|
|||
Segment results
|
114
|
|
(809
|
)
|
923
|
|
114.1
|
%
|
|||
Premiums ceded to unaffiliated captive insurers
|
|
|
|
|
|||||||
Traditional business
|
—
|
|
—
|
|
—
|
|
nm
|
|
|||
Alternative market business
|
6,784
|
|
7,658
|
|
(874
|
)
|
(11.4
|
%)
|
|||
Segment results
|
6,784
|
|
7,658
|
|
(874
|
)
|
(11.4
|
%)
|
|||
Total ceded premiums written
|
|
|
|
|
|||||||
Traditional business
|
9,937
|
|
9,446
|
|
491
|
|
5.2
|
%
|
|||
Alternative market business
|
14,940
|
|
14,916
|
|
24
|
|
0.2
|
%
|
|||
Segment results
|
$
|
24,877
|
|
$
|
24,362
|
|
$
|
515
|
|
2.1
|
%
|
|
Year Ended December 31
|
||||||||||||
|
2017
|
|
2016
|
||||||||||
|
Traditional Business
|
Alternative Market Business
|
Segment
Results
|
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
||||||
Ceded premiums ratio, as reported
|
5.4
|
%
|
18.5
|
%
|
9.4
|
%
|
|
5.5
|
%
|
19.6
|
%
|
9.8
|
%
|
Less the effect of:
|
|
|
|
|
|
|
|
||||||
Return premium estimated under external reinsurance
|
0.1
|
%
|
—
|
%
|
—
|
%
|
|
(0.5
|
%)
|
—
|
%
|
(0.3
|
%)
|
Premiums ceded to unaffiliated captive insurers (100%)
|
—
|
%
|
7.5
|
%
|
2.4
|
%
|
|
—
|
%
|
9.0
|
%
|
2.9
|
%
|
Ceded premiums ratio, less the effects of above
|
5.3
|
%
|
11.0
|
%
|
7.0
|
%
|
|
6.0
|
%
|
10.6
|
%
|
7.2
|
%
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
Traditional business
|
$
|
51,038
|
|
$
|
52,207
|
|
$
|
(1,169
|
)
|
(2.2
|
%)
|
Alternative market business
|
19,907
|
|
18,257
|
|
1,650
|
|
9.0
|
%
|
|||
Underwriting, policy acquisition and operating expenses
|
$
|
70,945
|
|
$
|
70,464
|
|
$
|
481
|
|
0.7
|
%
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
Net premiums earned
|
$
|
64,099
|
|
$
|
58,826
|
|
$
|
5,273
|
|
9.0
|
%
|
Other income
|
115
|
|
18
|
|
97
|
|
538.9
|
%
|
|||
Less: Net losses and loss adjustment expenses
|
34,003
|
|
32,743
|
|
1,260
|
|
3.8
|
%
|
|||
Less: Underwriting, policy acquisition and operating expenses
|
19,907
|
|
18,258
|
|
1,649
|
|
9.0
|
%
|
|||
SPC net operating results - profit/(loss)
|
10,304
|
|
7,843
|
|
2,461
|
|
31.4
|
%
|
|||
Less: Eastern participation - profit/(loss)
|
4,476
|
|
3,081
|
|
1,395
|
|
45.3
|
%
|
|||
SPC dividend expense (income)
|
$
|
5,828
|
|
$
|
4,762
|
|
$
|
1,066
|
|
22.4
|
%
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
Gross premiums written
|
$
|
70,224
|
|
$
|
65,157
|
|
$
|
5,067
|
|
7.8
|
%
|
Ceded premiums written
|
(15,255
|
)
|
(8,883
|
)
|
(6,372
|
)
|
71.7
|
%
|
|||
Net premiums written
|
$
|
54,969
|
|
$
|
56,274
|
|
$
|
(1,305
|
)
|
(2.3
|
%)
|
|
|
|
|
|
|||||||
Net premiums earned
|
$
|
57,202
|
|
$
|
54,650
|
|
$
|
2,552
|
|
4.7
|
%
|
Net investment income
|
1,736
|
|
1,410
|
|
326
|
|
23.1
|
%
|
|||
Net realized gains (losses)
|
107
|
|
76
|
|
31
|
|
40.8
|
%
|
|||
Other income
|
(1,476
|
)
|
1,415
|
|
(2,891
|
)
|
(204.3
|
%)
|
|||
Net losses and loss adjustment expenses
|
(44,220
|
)
|
(34,116
|
)
|
(10,104
|
)
|
29.6
|
%
|
|||
Underwriting, policy acquisition and operating expenses
|
(26,963
|
)
|
(22,832
|
)
|
(4,131
|
)
|
18.1
|
%
|
|||
Income tax benefit (expense)
|
568
|
|
(384
|
)
|
952
|
|
(247.9
|
%)
|
|||
Segment operating results
|
$
|
(13,046
|
)
|
$
|
219
|
|
$
|
(13,265
|
)
|
(6,057.1
|
%)
|
|
|
|
|
|
|||||||
Net loss ratio
|
77.3
|
%
|
62.4
|
%
|
14.9
|
|
pts
|
||||
Underwriting expense ratio
|
47.1
|
%
|
41.8
|
%
|
5.3
|
|
pts
|
(In thousands)
|
Year Ended
December 31, 2017
|
||
Gross premiums written
|
$
|
234
|
|
Ceded premiums written
|
(2,209
|
)
|
|
Net premiums written
|
$
|
(1,975
|
)
|
Net premiums earned
|
$
|
(1,975
|
)
|
Gross losses
|
(36,297
|
)
|
|
Reinsurance recoveries
|
31,198
|
|
|
Net losses and loss adjustment expenses
|
(5,099
|
)
|
|
Segment operating results, before tax
|
$
|
(7,074
|
)
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Net investment income
|
$
|
93,926
|
|
|
$
|
98,602
|
|
|
$
|
(4,676
|
)
|
|
(4.7
|
%)
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
8,033
|
|
|
$
|
(5,762
|
)
|
|
$
|
13,795
|
|
|
239.4
|
%
|
Net realized gains (losses)
|
$
|
16,302
|
|
|
$
|
34,799
|
|
|
$
|
(18,497
|
)
|
|
(53.2
|
%)
|
Operating expense
|
$
|
29,275
|
|
|
$
|
30,807
|
|
|
$
|
(1,532
|
)
|
|
(5.0
|
%)
|
Segregated portfolio cells dividend expense (income)
(1)
|
$
|
4,973
|
|
|
$
|
3,236
|
|
|
$
|
1,737
|
|
|
53.7
|
%
|
Interest expense
|
$
|
16,844
|
|
|
$
|
15,032
|
|
|
$
|
1,812
|
|
|
12.1
|
%
|
Income tax expense (benefit)
|
$
|
21,927
|
|
|
$
|
24,736
|
|
|
$
|
(2,809
|
)
|
|
(11.4
|
%)
|
(1)
Represents the investment results attributable to the SPCs at Eastern Re
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Fixed maturities
|
$
|
73,944
|
|
|
$
|
84,386
|
|
|
$
|
(10,442
|
)
|
|
(12.4
|
%)
|
Equities
|
17,198
|
|
|
14,887
|
|
|
2,311
|
|
|
15.5
|
%
|
|||
Other investments, including Short-term
|
7,662
|
|
|
3,353
|
|
|
4,309
|
|
|
128.5
|
%
|
|||
BOLI
|
1,979
|
|
|
2,008
|
|
|
(29
|
)
|
|
(1.4
|
%)
|
|||
Investment fees and expenses
|
(6,857
|
)
|
|
(6,032
|
)
|
|
(825
|
)
|
|
13.7
|
%
|
|||
Net investment income
|
$
|
93,926
|
|
|
$
|
98,602
|
|
|
$
|
(4,676
|
)
|
|
(4.7
|
%)
|
|
Year Ended December 31
|
||
|
2017
|
|
2016
|
Average income yield
|
3.1%
|
|
3.3%
|
Average tax equivalent income yield
|
3.5%
|
|
3.8%
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
Equity method investments, primarily LPs/LLCs
|
$
|
28,685
|
|
|
$
|
19,055
|
|
|
$
|
9,630
|
|
|
50.5
|
%
|
Tax credit partnerships
|
(20,652
|
)
|
|
(24,817
|
)
|
|
4,165
|
|
|
(16.8
|
%)
|
|||
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
8,033
|
|
|
$
|
(5,762
|
)
|
|
$
|
13,795
|
|
|
239.4
|
%
|
|
Year Ended December 31
|
||||||
(In millions)
|
2017
|
|
2016
|
||||
Tax credits recognized during the period
|
$
|
23.1
|
|
|
$
|
27.5
|
|
Tax benefit of tax credit partnership operating losses
|
$
|
7.2
|
|
|
$
|
8.7
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2017
|
|
2016
|
||||
GAAP net investment result:
|
|
|
|
||||
Net investment income
|
$
|
93,926
|
|
|
$
|
98,602
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
8,033
|
|
|
(5,762
|
)
|
||
GAAP net investment result
|
$
|
101,959
|
|
|
$
|
92,840
|
|
|
|
|
|
||||
Pro forma tax-equivalent investment result
|
$
|
149,612
|
|
|
$
|
149,959
|
|
|
|
|
|
||||
Reconciliation of pro forma and GAAP tax-equivalent investment result:
|
|
|
|
||||
GAAP net investment result
|
$
|
101,959
|
|
|
$
|
92,840
|
|
Taxable equivalent adjustments, calculated using the 35% federal statutory tax rate:
|
|
|
|
||||
State and municipal bonds
|
9,103
|
|
|
11,698
|
|
||
BOLI
|
1,065
|
|
|
1,081
|
|
||
Dividends received
|
1,930
|
|
|
1,957
|
|
||
Tax credit partnerships
|
35,555
|
|
|
42,383
|
|
||
Pro forma tax-equivalent investment result
|
$
|
149,612
|
|
|
$
|
149,959
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2017
|
|
2016
|
||||
OTTI losses, total:
|
|
|
|
||||
State and municipal bonds
|
$
|
(850
|
)
|
|
$
|
(100
|
)
|
Corporate debt
|
(419
|
)
|
|
(7,604
|
)
|
||
Investment in unconsolidated subsidiaries
|
(11,931
|
)
|
|
—
|
|
||
Other investments
|
—
|
|
|
(3,130
|
)
|
||
Portion of OTTI losses recognized in other comprehensive income before taxes:
|
|
|
|
||||
Corporate debt
|
248
|
|
|
1,068
|
|
||
Net impairment losses recognized in earnings
|
(12,952
|
)
|
|
(9,766
|
)
|
||
Gross realized gains, available-for-sale securities
|
6,622
|
|
|
12,402
|
|
||
Gross realized (losses), available-for-sale securities
|
(3,113
|
)
|
|
(7,029
|
)
|
||
Net realized gains (losses), trading securities
|
10,724
|
|
|
6,632
|
|
||
Net realized gains (losses), other investments
|
2,963
|
|
|
1,115
|
|
||
Change in unrealized holding gains (losses), trading securities
|
11,157
|
|
|
30,521
|
|
||
Change in unrealized holding gains (losses), convertible securities, carried at fair value as a part of Other investments
|
896
|
|
|
899
|
|
||
Other
|
5
|
|
|
25
|
|
||
Net realized investment gains (losses)
|
$
|
16,302
|
|
|
$
|
34,799
|
|
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
|
2017
|
|
2016
|
|
Change
|
|||||||||
Operating expenses
|
|
$
|
44,034
|
|
|
$
|
45,116
|
|
|
$
|
(1,082
|
)
|
|
(2.4
|
%)
|
Management fee offset
|
|
(14,759
|
)
|
|
(14,309
|
)
|
|
(450
|
)
|
|
3.1
|
%
|
|||
Segment Total
|
|
$
|
29,275
|
|
|
$
|
30,807
|
|
|
$
|
(1,532
|
)
|
|
(5.0
|
%)
|
|
Year Ended
December 31 |
||||||
(In thousands)
|
2017
|
|
2016
|
||||
Corporate segment income tax expense (benefit)
|
$
|
21,927
|
|
|
$
|
24,736
|
|
Lloyd's Syndicate segment income tax expense (benefit)
|
(568
|
)
|
|
384
|
|
||
Consolidated income tax expense (benefit)
|
$
|
21,359
|
|
|
$
|
25,120
|
|
|
Year Ended December 31
|
|||||||||||
($ in thousands, except per share data)
|
2016
|
|
2015
|
|
Change
|
|||||||
Revenues:
|
|
|
|
|
|
|
||||||
Net premiums written
|
$
|
738,533
|
|
|
$
|
709,285
|
|
|
$
|
29,248
|
|
|
Net premiums earned
|
$
|
733,281
|
|
|
$
|
694,149
|
|
|
$
|
39,132
|
|
|
Net investment result
|
94,250
|
|
|
112,342
|
|
|
(18,092
|
)
|
|
|||
Net realized investment gains (losses)
|
34,875
|
|
|
(41,639
|
)
|
|
76,514
|
|
|
|||
Other income
|
7,808
|
|
|
7,227
|
|
|
581
|
|
|
|||
Total revenues
|
870,214
|
|
|
772,079
|
|
|
98,135
|
|
|
|||
|
|
|
|
|
|
|
||||||
Expenses:
|
|
|
|
|
|
|
||||||
Losses and loss adjustment expenses
|
515,242
|
|
|
456,862
|
|
|
58,380
|
|
|
|||
Reinsurance recoveries
|
(72,013
|
)
|
|
(46,151
|
)
|
|
(25,862
|
)
|
|
|||
Net losses and loss adjustment expenses
|
443,229
|
|
|
410,711
|
|
|
32,518
|
|
|
|||
Underwriting, policy acquisition and operating expenses
|
227,610
|
|
|
217,064
|
|
|
10,546
|
|
|
|||
Segregated portfolio cells dividend expense (income)
|
8,142
|
|
|
853
|
|
|
7,289
|
|
|
|||
Interest expense
|
15,032
|
|
|
14,596
|
|
|
436
|
|
|
|||
Total expenses
|
694,013
|
|
|
643,224
|
|
|
50,789
|
|
|
|||
Income before income taxes
|
176,201
|
|
|
128,855
|
|
|
47,346
|
|
|
|||
Income tax expense (benefit)
|
25,120
|
|
|
12,658
|
|
|
12,462
|
|
|
|||
Net income
|
$
|
151,081
|
|
|
$
|
116,197
|
|
|
$
|
34,884
|
|
|
Non-GAAP operating income
|
$
|
129,844
|
|
|
$
|
142,629
|
|
|
$
|
(12,785
|
)
|
|
Earnings per share:
|
|
|
|
|
|
|
||||||
Basic
|
$
|
2.84
|
|
|
$
|
2.12
|
|
|
$
|
0.72
|
|
|
Diluted
|
$
|
2.83
|
|
|
$
|
2.11
|
|
|
$
|
0.72
|
|
|
Non-GAAP operating earnings per share:
|
|
|
|
|
|
|
||||||
Basic
|
$
|
2.44
|
|
|
$
|
2.60
|
|
|
$
|
(0.16
|
)
|
|
Diluted
|
$
|
2.43
|
|
|
$
|
2.59
|
|
|
$
|
(0.16
|
)
|
|
Net loss ratio
|
60.4
|
%
|
|
59.2
|
%
|
|
1.2
|
|
pts
|
|||
Underwriting expense ratio
|
31.0
|
%
|
|
31.3
|
%
|
|
(0.3
|
)
|
pts
|
|||
Combined ratio
|
91.4
|
%
|
|
90.5
|
%
|
|
0.9
|
|
pts
|
|||
Operating ratio
|
77.8
|
%
|
|
74.8
|
%
|
|
3.0
|
|
pts
|
|||
Effective tax rate
|
14.3
|
%
|
|
9.8
|
%
|
|
4.5
|
|
pts
|
|||
Return on equity
|
8.0
|
%
|
|
5.6
|
%
|
|
2.4
|
|
pts
|
|||
In all tables that follow, that abbreviation "nm" indicates that the information or the percentage change is not meaningful.
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Net Premiums Earned
|
|
|
|
|
|
|
|
|||||||
Specialty P&C
|
$
|
457,816
|
|
|
$
|
443,313
|
|
|
$
|
14,503
|
|
|
3.3
|
%
|
Workers' Compensation
|
220,815
|
|
|
213,161
|
|
|
7,654
|
|
|
3.6
|
%
|
|||
Lloyd's Syndicate
|
54,650
|
|
|
37,675
|
|
|
16,975
|
|
|
45.1
|
%
|
|||
Consolidated total
|
$
|
733,281
|
|
|
$
|
694,149
|
|
|
$
|
39,132
|
|
|
5.6
|
%
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Net investment income
|
$
|
100,012
|
|
|
$
|
108,660
|
|
|
$
|
(8,648
|
)
|
|
(8.0
|
%)
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
(5,762
|
)
|
|
3,682
|
|
|
(9,444
|
)
|
|
(256.5
|
%)
|
|||
Net investment result
|
$
|
94,250
|
|
|
$
|
112,342
|
|
|
$
|
(18,092
|
)
|
|
(16.1
|
%)
|
|
Year Ended December 31
|
|||||||||||
($ in millions)
|
2016
|
|
2015
|
|
Change
|
|||||||
Current accident year net loss ratio
|
|
|
|
|
|
|
||||||
Consolidated ratio
|
80.1
|
%
|
|
82.4
|
%
|
|
(2.3
|
)
|
pts
|
|||
Specialty P&C
|
88.6
|
%
|
|
92.3
|
%
|
|
(3.7
|
)
|
pts
|
|||
Workers' Compensation
|
66.4
|
%
|
|
67.1
|
%
|
|
(0.7
|
)
|
pts
|
|||
Lloyd's Syndicate
|
63.3
|
%
|
|
66.8
|
%
|
|
(3.5
|
)
|
pts
|
|||
Calendar year net loss ratio
|
|
|
|
|
|
|
||||||
Consolidated ratio
|
60.4
|
%
|
|
59.2
|
%
|
|
1.2
|
|
pts
|
|||
Specialty P&C
|
58.7
|
%
|
|
56.4
|
%
|
|
2.3
|
|
pts
|
|||
Workers' Compensation
|
63.6
|
%
|
|
66.0
|
%
|
|
(2.4
|
)
|
pts
|
|||
Lloyd's Syndicate
|
62.4
|
%
|
|
66.8
|
%
|
|
(4.4
|
)
|
pts
|
|||
Favorable net loss development, prior accident years
|
|
|
|
|
|
|
||||||
Consolidated
|
$
|
143.8
|
|
|
$
|
161.2
|
|
|
$
|
(17.4
|
)
|
|
Specialty P&C
|
$
|
137.2
|
|
|
$
|
159.0
|
|
|
$
|
(21.8
|
)
|
|
Workers' Compensation
|
$
|
6.1
|
|
|
$
|
2.2
|
|
|
$
|
3.9
|
|
|
Lloyd's Syndicate
|
$
|
0.5
|
|
|
$
|
—
|
|
|
$
|
0.5
|
|
|
•
|
Increase in consolidated DPAC amortization by $8.8 million particularly in the Lloyd's Syndicate segment.
|
•
|
Increase in operating expenses in our Corporate segment by $6.3 million primarily related to costs associated with a pre-acquisition liability from a discontinued operation and an increase in share-based compensation expenses resulting from an adjustment of the projected award value based upon the improvement, in the period, of one of the performance metrics associated with a particular year's award.
|
•
|
Increase in operating expenses in our Workers' Compensation segment of $3.5 million primarily due to an increase in compensation and related benefit costs, state assessments and pension settlement charges.
|
|
Book Value Per Share
|
||
Book Value Per Share at December 31, 2015
|
$
|
36.88
|
|
Increase (decrease) to book value per share during the year ended December 31, 2016 attributable to:
|
|
||
Dividends declared
|
(5.93
|
)
|
|
Cumulative repurchase of shares
|
(0.47
|
)
|
|
Capital management activities
|
(6.40
|
)
|
|
Net income
|
2.84
|
|
|
Decrease in AOCI
|
(0.12
|
)
|
|
Other
|
0.58
|
|
|
Book Value Per Share at December 31, 2016
|
$
|
33.78
|
|
|
Year Ended December 31
|
||||||
(In thousands, except per share data)
|
2016
|
|
2015
|
||||
Net income
|
$
|
151,081
|
|
|
$
|
116,197
|
|
Items excluded in the calculation of Non-GAAP operating income:
|
|
|
|
||||
Net realized investment (gains) losses
|
(34,875
|
)
|
|
41,639
|
|
||
Net realized gains (losses) attributable to SPCs which no profit/loss is retained
(1)
|
2,049
|
|
|
(1,192
|
)
|
||
Guaranty fund assessments (recoupments)
|
153
|
|
|
218
|
|
||
Pre-tax effect of exclusions
|
(32,673
|
)
|
|
40,665
|
|
||
Tax effect, at 35%
(2)
|
11,436
|
|
|
(14,233
|
)
|
||
Non-GAAP operating income
|
$
|
129,844
|
|
|
$
|
142,629
|
|
Per diluted common share:
|
|
|
|
||||
Net income
|
$
|
2.83
|
|
|
$
|
2.11
|
|
Effect of exclusions
|
(0.40
|
)
|
|
0.48
|
|
||
Non-GAAP operating income per diluted common share
|
$
|
2.43
|
|
|
$
|
2.59
|
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Net premiums written
|
$
|
458,681
|
|
|
$
|
442,126
|
|
|
$
|
16,555
|
|
|
3.7
|
%
|
|
|
|
|
|
|
|
|
|||||||
Net premiums earned
|
$
|
457,816
|
|
|
$
|
443,313
|
|
|
$
|
14,503
|
|
|
3.3
|
%
|
Other income
|
5,306
|
|
|
4,561
|
|
|
745
|
|
|
16.3
|
%
|
|||
Net losses and loss adjustment expenses
|
(268,579
|
)
|
|
(250,168
|
)
|
|
(18,411
|
)
|
|
7.4
|
%
|
|||
Underwriting, policy acquisition and operating expenses
|
(104,333
|
)
|
|
(105,574
|
)
|
|
1,241
|
|
|
(1.2
|
%)
|
|||
Segregated portfolio cells dividend (expense) income
|
(144
|
)
|
|
—
|
|
|
(144
|
)
|
|
nm
|
|
|||
Segment operating results
|
$
|
90,066
|
|
|
$
|
92,132
|
|
|
$
|
(2,066
|
)
|
|
(2.2
|
%)
|
|
|
|
|
|
|
|
|
|||||||
Net loss ratio
|
58.7%
|
|
56.4%
|
|
2.3
|
|
pts
|
|||||||
Underwriting expense ratio
|
22.8%
|
|
23.8%
|
|
(1.0
|
)
|
pts
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Gross premiums written
|
$
|
535,725
|
|
|
$
|
526,296
|
|
|
$
|
9,429
|
|
|
1.8
|
%
|
Less: Ceded premiums written
|
77,044
|
|
|
84,170
|
|
|
(7,126
|
)
|
|
(8.5
|
%)
|
|||
Net premiums written
|
$
|
458,681
|
|
|
$
|
442,126
|
|
|
$
|
16,555
|
|
|
3.7
|
%
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Professional liability
|
|
|
|
|
|
|
|
|||||||
Physicians
(1)(7)
|
|
|
|
|
|
|
|
|||||||
Twelve month term
|
$
|
344,150
|
|
|
$
|
345,363
|
|
|
$
|
(1,213
|
)
|
|
(0.4
|
%)
|
Twenty-four month term
|
21,869
|
|
|
29,707
|
|
|
(7,838
|
)
|
|
(26.4
|
%)
|
|||
Total Physicians
|
366,019
|
|
|
375,070
|
|
|
(9,051
|
)
|
|
(2.4
|
%)
|
|||
Healthcare facilities
(2)(7)
|
59,361
|
|
|
36,840
|
|
|
22,521
|
|
|
61.1
|
%
|
|||
Other healthcare providers
(3)(7)
|
33,353
|
|
|
32,503
|
|
|
850
|
|
|
2.6
|
%
|
|||
Legal professionals
(4)
|
25,351
|
|
|
27,879
|
|
|
(2,528
|
)
|
|
(9.1
|
%)
|
|||
Tail coverages
(5)
|
18,092
|
|
|
19,520
|
|
|
(1,428
|
)
|
|
(7.3
|
%)
|
|||
Total professional liability
|
502,176
|
|
|
491,812
|
|
|
10,364
|
|
|
2.1
|
%
|
|||
Medical technology liability
(6)
|
33,067
|
|
|
33,237
|
|
|
(170
|
)
|
|
(0.5
|
%)
|
|||
Other
|
482
|
|
|
1,247
|
|
|
(765
|
)
|
|
(61.3
|
%)
|
|||
Total
|
$
|
535,725
|
|
|
$
|
526,296
|
|
|
$
|
9,429
|
|
|
1.8
|
%
|
(1)
|
Physician policies were our greatest source of premium revenues in both 2016 and 2015. The decline in twelve month term policies in 2016 was primarily due to retention losses, including the non-renewal of a few large policies in 2016, and the shifting of certain policies from a twelve month term to a twenty-four month term, largely offset by new business written. We offer twenty-four month term policies to our physician insureds in one selected jurisdiction. The net decline in twenty-four month premium, as compared to 2015, primarily reflected the normal cycle of renewals (policies subject to renewal in 2016 were previously written in 2014 rather than in 2015).
|
(2)
|
Our healthcare facilities premium (which includes hospitals, surgery centers and other facilities) increased in 2016 primarily due to new business written, which includes premiums written in our SPCs (see discussion in footnote 7 below). In addition, the increase also reflected a novation agreement entered into during the fourth quarter of 2016. A novation represents a legal replacement of one insurer by another extinguishing the ceding entity's liability to the policyholder. The novation resulted in approximately $11.8 million of one-time gross premiums written and earned at the inception of the agreement as all the underlying loss events covered by the policy occurred in the past. The increase was partially offset by retention losses, including the non-renewal of one large policy in the first quarter of 2016.
|
(3)
|
Our other healthcare providers are primarily dentists, chiropractors and allied health professionals.
|
(4)
|
Our legal professionals policies are primarily individual and small group policies in select areas of practice. The decline in 2016 was primarily due to retention losses, partially offset by new business written. Retention losses were primarily driven by an increase in renewal pricing in certain jurisdictions as well as stricter underwriting standards.
|
(5)
|
We offer extended reporting endorsement or "tail" coverage to insureds who discontinue their claims-made coverage with us, and we also periodically offer tail coverage through custom policies. The amount of tail coverage premium written can vary widely from period to period.
|
(6)
|
Our medical technology liability business is marketed throughout the U.S.; coverage is offered on a primary basis, within specified limits, to manufacturers and distributors of medical technology and life sciences products including entities conducting human clinical trials. In addition to the previously listed factors that affect our premium volume, our medical technology liability premium volume is impacted by the sales volume of insureds. The slight decline in 2016 was primarily driven by retention losses and, to a lesser extent, a decrease in the rate charged for certain renewed policies, almost entirely offset by new business written.
|
(7)
|
During 2016, we expanded our alternative market solutions by writing new healthcare premium in certain SPCs. We added approximately $4.1 million in healthcare professional liability premium during the year ended 2016 which included $1.2 million written in our physicians line of business, $2.9 million in our healthcare facilities line of business and a nominal amount written in our other healthcare providers line of business. All or a portion of the premium written was ceded to the SPCs at our wholly owned Cayman Islands reinsurance subsidiary, Eastern Re. Under the SPC structure, the net operating results of each cell, net of any participation we have taken in the SPCs, are due to the external owners of that cell. Our Specialty P&C segment does not currently participate in the cells that write HCPL premium, and therefore retains no underwriting profit or loss. However, we receive ceding commissions on the
|
|
Year Ended December 31
|
||||||
(In millions)
|
2016
|
|
2015
|
||||
Physicians
|
$
|
32.8
|
|
|
$
|
23.0
|
|
Healthcare facilities
|
17.4
|
|
|
5.9
|
|
||
Other healthcare providers
|
3.4
|
|
|
2.3
|
|
||
Legal professionals
|
3.8
|
|
|
4.5
|
|
||
Medical technology liability
|
5.1
|
|
|
3.7
|
|
||
Total
|
$
|
62.5
|
|
|
$
|
39.4
|
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Excess of loss reinsurance arrangements
(1)
|
$
|
30,037
|
|
|
$
|
32,627
|
|
|
$
|
(2,590
|
)
|
|
(7.9
|
%)
|
Premium ceded to Syndicate 1729
(2)
|
23,832
|
|
|
24,718
|
|
|
(886
|
)
|
|
(3.6
|
%)
|
|||
Other shared risk arrangements
(3)
|
26,737
|
|
|
24,401
|
|
|
2,336
|
|
|
9.6
|
%
|
|||
Other ceded premiums written
|
3,521
|
|
|
3,542
|
|
|
(21
|
)
|
|
(0.6
|
%)
|
|||
Reduction in premiums owed under reinsurance agreements, prior accident years, net
(4)
|
(7,083
|
)
|
|
(1,118
|
)
|
|
(5,965
|
)
|
|
533.5
|
%
|
|||
Total ceded premiums written
|
$
|
77,044
|
|
|
$
|
84,170
|
|
|
$
|
(7,126
|
)
|
|
(8.5
|
%)
|
(1)
|
We generally reinsure risks under our excess of loss reinsurance arrangements pursuant to which the reinsurers agree to assume all or a portion of all risks that we insure above our individual risk retention levels, up to the maximum individual limits offered. The decrease in ceded premiums written under our excess of loss reinsurance arrangements during 2016 was primarily due to more favorable contract terms on our 2015 core treaty which renewed in October 2016 with similar terms.
|
(2)
|
As previously discussed, we are a 58% participant in Syndicate 1729 and record our pro rata share of its operating results in our Lloyd's Syndicate segment on a quarter delay. We also record the cession within the Specialty P&C segment on a quarter delay as the amounts are not material and this permits the cession to be reported by both the Lloyd's Syndicate segment and the Specialty P&C segment in the same reporting period. As our premiums are earned, we recognize the related ceding commission income which reduces underwriting expense by offsetting DPAC amortization. The related ceding commission income was approximately 27% of ceded premiums written. For our consolidated results, eliminations of the inter-segment portion (58% of the Specialty P&C cession) of the transactions are also recorded on a quarter delay.
|
(3)
|
We have entered into various shared risk arrangements, including quota share, fronting, and captive arrangements, with certain large healthcare systems and other insurance entities. While we cede a large portion of the premium written under these arrangements, they provide us an opportunity to grow net premium through strategic partnerships. The increase in 2016 was primarily driven by growth in our Ascension Health and CAPAssurance programs.
|
(4)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance arrangement are known. As a part of the process of estimating our loss reserve we also make estimates regarding the amounts recoverable under our reinsurance arrangements. As previously discussed, the premiums ultimately ceded under our excess of loss reinsurance arrangements are subject to the losses ceded under the arrangements. In both 2016 and 2015, on a net basis, we reduced our estimate of expected losses and associated recoveries for prior year ceded losses, as well as our estimate of ceded premiums owed to reinsurers. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the changes in estimates occur.
|
|
Year Ended December 31
|
||||||||
|
2016
|
|
2015
|
|
Change
|
||||
Ceded premiums ratio, as reported
|
14.4
|
%
|
|
16.0
|
%
|
|
(1.6
|
)
|
pts
|
Less the effect of reduction in premiums owed under reinsurance agreements, prior accident years (as previously discussed)
|
(1.3
|
%)
|
|
(0.2
|
%)
|
|
(1.1
|
)
|
pts
|
Ratio, current accident year
|
15.7
|
%
|
|
16.2
|
%
|
|
(0.5
|
)
|
pts
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Gross premiums earned
|
$
|
535,931
|
|
|
$
|
528,118
|
|
|
$
|
7,813
|
|
|
1.5
|
%
|
Less: Ceded premiums earned
|
78,115
|
|
|
84,805
|
|
|
(6,690
|
)
|
|
(7.9
|
%)
|
|||
Net premiums earned
|
$
|
457,816
|
|
|
$
|
443,313
|
|
|
$
|
14,503
|
|
|
3.3
|
%
|
(1)
|
Net losses, as specified, divided by net premiums earned.
|
(2)
|
Reductions to premiums owed under reinsurance agreements for prior accident years increased net premiums earned (the denominator of the current accident year ratio) in both 2016 and 2015. See the discussion in the Premiums section for our Specialty P&C segment under the heading "Ceded Premiums Written" for additional information.
|
(3)
|
The decrease in the current accident year net loss ratio primarily reflected changes in expected loss costs related to mass tort litigation and, to a lesser extent, changes in the mix of business. While we increased our reserves related to mass tort litigation in both 2016 and 2015 the increase was substantially less in 2016, resulting in approximately 1.9 percentage points of the decrease. Slightly offsetting the decrease by approximately 0.4 percentage points was the effect of a novation (net premiums earned at a high loss ratio) entered into during the fourth quarter 2016. Additional information regarding the novation is included in the Premiums section for our Specialty P&C segment under the heading "Gross Premiums Written."
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Specialty P&C segment:
|
|
|
|
|
|
|
|
|||||||
DPAC amortization
|
$
|
45,019
|
|
|
$
|
45,459
|
|
|
$
|
(440
|
)
|
|
(1.0
|
%)
|
Management fees
|
6,447
|
|
|
6,931
|
|
|
(484
|
)
|
|
(7.0
|
%)
|
|||
Other underwriting and operating expenses
|
52,867
|
|
|
53,184
|
|
|
(317
|
)
|
|
(0.6
|
%)
|
|||
Total
|
$
|
104,333
|
|
|
$
|
105,574
|
|
|
$
|
(1,241
|
)
|
|
(1.2
|
%)
|
|
Year Ended December 31
|
||||||||
|
2016
|
|
2015
|
|
Change
|
||||
Underwriting expense ratio
|
22.8
|
%
|
|
23.8
|
%
|
|
(1.0
|
)
|
pts
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2016
|
2015
|
Change
|
||||||||
Gross premiums written
|
|
|
|
|
|||||||
Traditional business*
|
$
|
172,025
|
|
$
|
172,977
|
|
$
|
(952
|
)
|
(0.6
|
%)
|
Alternative market business
|
75,915
|
|
70,631
|
|
5,284
|
|
7.5
|
%
|
|||
Segment results
|
247,940
|
|
243,608
|
|
4,332
|
|
1.8
|
%
|
|||
Less: Ceded premiums written
|
|
|
|
|
|||||||
Traditional business
|
9,446
|
|
10,307
|
|
(861
|
)
|
(8.4
|
%)
|
|||
Alternative market business*
|
14,916
|
|
14,963
|
|
(47
|
)
|
(0.3
|
%)
|
|||
Segment results
|
24,362
|
|
25,270
|
|
(908
|
)
|
(3.6
|
%)
|
|||
Net premiums written
|
|
|
|
|
|||||||
Traditional business
|
162,579
|
|
162,670
|
|
(91
|
)
|
(0.1
|
%)
|
|||
Alternative market business
|
60,999
|
|
55,668
|
|
5,331
|
|
9.6
|
%
|
|||
Segment results
|
$
|
223,578
|
|
$
|
218,338
|
|
$
|
5,240
|
|
2.4
|
%
|
* Traditional gross premiums written and alternative market ceded premiums written for 2016 are reported net of alternative market premiums assumed by our traditional business totaling $0.9 million
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2016
|
2015
|
Change
|
||||||||
Premiums ceded to external reinsurers
|
|
|
|
|
|||||||
Traditional business
|
$
|
10,255
|
|
$
|
9,922
|
|
$
|
333
|
|
3.4
|
%
|
Alternative market business
|
7,258
|
|
7,205
|
|
53
|
|
0.7
|
%
|
|||
Segment results
|
17,513
|
|
17,127
|
|
386
|
|
2.3
|
%
|
|||
Change in return premium estimate under external reinsurance
|
|
|
|
|
|||||||
Traditional business
|
(809
|
)
|
385
|
|
(1,194
|
)
|
(310.1
|
%)
|
|||
Alternative market business
|
—
|
|
—
|
|
—
|
|
nm
|
|
|||
Segment results
|
(809
|
)
|
385
|
|
(1,194
|
)
|
(310.1
|
%)
|
|||
Premiums ceded to an unaffiliated captive insurer
|
|
|
|
|
|||||||
Traditional business
|
—
|
|
—
|
|
—
|
|
nm
|
|
|||
Alternative market business
|
7,658
|
|
7,758
|
|
(100
|
)
|
(1.3
|
%)
|
|||
Segment results
|
7,658
|
|
7,758
|
|
(100
|
)
|
(1.3
|
%)
|
|||
Total ceded premiums written
|
|
|
|
|
|||||||
Traditional business
|
9,446
|
|
10,307
|
|
(861
|
)
|
(8.4
|
%)
|
|||
Alternative market business
|
14,916
|
|
14,963
|
|
(47
|
)
|
(0.3
|
%)
|
|||
Segment results
|
$
|
24,362
|
|
$
|
25,270
|
|
$
|
(908
|
)
|
(3.6
|
%)
|
|
Year Ended December 31
|
||||||||||||
|
2016
|
|
2015
|
||||||||||
|
Traditional Business
|
Alternative Market Business
|
Segment
Results
|
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
||||||
Ceded premiums ratio, as reported
|
5.5
|
%
|
19.6
|
%
|
9.8
|
%
|
|
6.0
|
%
|
21.2
|
%
|
10.4
|
%
|
Less the effect of:
|
|
|
|
|
|
|
|
||||||
Return premium estimated under external reinsurance
|
(0.5
|
%)
|
—
|
%
|
(0.3
|
%)
|
|
0.2
|
%
|
—
|
%
|
0.2
|
%
|
Premiums ceded to unaffiliated captive insurer (100%)
|
—
|
%
|
9.0
|
%
|
2.9
|
%
|
|
—
|
%
|
9.7
|
%
|
2.9
|
%
|
Ceded premiums ratio, less the effects of above
|
6.0
|
%
|
10.6
|
%
|
7.2
|
%
|
|
5.8
|
%
|
11.5
|
%
|
7.3
|
%
|
|
Net Loss Ratios
|
||||||||||||||||||
|
Year Ended December 31
|
||||||||||||||||||
|
2016
|
|
2015
|
|
Change
|
||||||||||||||
|
Traditional Business
|
Alternative Market Business
|
Segment
Results
|
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
||||||||
Calendar year net loss ratio *
|
66.5
|
%
|
55.7
|
%
|
63.6
|
%
|
|
65.5
|
%
|
67.5
|
%
|
66.0
|
%
|
|
1.0
|
(11.8
|
)
|
(2.4
|
)
|
Less impact of prior accident years on the net loss ratio
|
(1.0
|
%)
|
(7.8
|
%)
|
(2.8
|
%)
|
|
(1.0
|
%)
|
(1.2
|
%)
|
(1.1
|
%)
|
|
—
|
(6.6
|
)
|
(1.7
|
)
|
Current accident year net loss ratio
|
67.5
|
%
|
63.5
|
%
|
66.4
|
%
|
|
66.5
|
%
|
68.7
|
%
|
67.1
|
%
|
|
1.0
|
(5.2
|
)
|
(0.7
|
)
|
Less impact of audit premium on loss ratio
|
—
|
%
|
(1.2
|
%)
|
(0.3
|
%)
|
|
—
|
%
|
(1.2
|
%)
|
(0.3
|
%)
|
|
—
|
—
|
|
—
|
|
Current accident year net loss ratio, excluding the effect of audit and return premium
|
67.5
|
%
|
64.7
|
%
|
66.7
|
%
|
|
66.5
|
%
|
69.9
|
%
|
67.4
|
%
|
|
1.0
|
(5.2
|
)
|
(0.7
|
)
|
* The net loss ratios for 2016 in the above table are calculated before the impact of the $0.9 million of premiums earned that is assumed by and ceded from the traditional and alternative market business, respectively.
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2016
|
2015
|
Change
|
||||||||
Traditional business
|
$
|
52,207
|
|
$
|
47,343
|
|
$
|
4,864
|
|
10.3
|
%
|
Alternative market business
|
18,257
|
|
16,310
|
|
1,947
|
|
11.9
|
%
|
|||
Underwriting, policy acquisition and operating expenses
|
$
|
70,464
|
|
$
|
63,653
|
|
$
|
6,811
|
|
10.7
|
%
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2016
|
2015
|
Change
|
||||||||
Net premiums earned
|
$
|
58,826
|
|
$
|
51,905
|
|
$
|
6,921
|
|
13.3
|
%
|
Other income
|
18
|
|
3
|
|
15
|
|
500.0
|
%
|
|||
Less: Net losses and loss adjustment expenses
|
32,743
|
|
35,059
|
|
(2,316
|
)
|
(6.6
|
%)
|
|||
Less: Underwriting, policy acquisition and operating expenses
|
18,258
|
|
16,310
|
|
1,948
|
|
11.9
|
%
|
|||
SPC net operating results - profit/(loss)
|
7,843
|
|
539
|
|
7,304
|
|
1,355.1
|
%
|
|||
Less: Eastern participation - profit/(loss)
|
3,081
|
|
(1,345
|
)
|
4,426
|
|
329.1
|
%
|
|||
SPC dividend expense (income)
|
$
|
4,762
|
|
$
|
1,884
|
|
$
|
2,878
|
|
152.8
|
%
|
|
Year Ended December 31
|
||||||||||
($ in thousands)
|
2016
|
2015
|
Change
|
||||||||
Gross premiums written
|
$
|
65,157
|
|
$
|
56,929
|
|
$
|
8,228
|
|
14.5
|
%
|
Ceded premiums written
|
(8,883
|
)
|
(8,108
|
)
|
(775
|
)
|
9.6
|
%
|
|||
Net premiums written
|
$
|
56,274
|
|
$
|
48,821
|
|
$
|
7,453
|
|
15.3
|
%
|
|
|
|
|
|
|||||||
Net premiums earned
|
$
|
54,650
|
|
$
|
37,675
|
|
$
|
16,975
|
|
45.1
|
%
|
Net investment income
|
1,410
|
|
928
|
|
482
|
|
51.9
|
%
|
|||
Net realized gains (losses)
|
76
|
|
24
|
|
52
|
|
216.7
|
%
|
|||
Other income
|
1,415
|
|
698
|
|
717
|
|
102.7
|
%
|
|||
Net losses and loss adjustment expenses
|
(34,116
|
)
|
(25,181
|
)
|
(8,935
|
)
|
35.5
|
%
|
|||
Underwriting, policy acquisition and operating expenses
|
(22,832
|
)
|
(18,518
|
)
|
(4,314
|
)
|
23.3
|
%
|
|||
Income tax benefit (expense)
|
(384
|
)
|
(1,240
|
)
|
856
|
|
(69.0
|
%)
|
|||
Segment operating results
|
$
|
219
|
|
$
|
(5,614
|
)
|
$
|
5,833
|
|
103.9
|
%
|
|
|
|
|
|
|||||||
Net loss ratio
|
62.4
|
%
|
66.8
|
%
|
(4.4
|
)
|
pts
|
||||
Underwriting expense ratio
|
41.8
|
%
|
49.2
|
%
|
(7.4
|
)
|
pts
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Net investment income
|
$
|
98,602
|
|
|
$
|
107,732
|
|
|
$
|
(9,130
|
)
|
|
(8.5
|
%)
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
(5,762
|
)
|
|
$
|
3,682
|
|
|
$
|
(9,444
|
)
|
|
(256.5
|
%)
|
Net realized gains (losses)
|
$
|
34,799
|
|
|
$
|
(41,663
|
)
|
|
$
|
76,462
|
|
|
183.5
|
%
|
Operating expense
|
$
|
30,807
|
|
|
$
|
24,518
|
|
|
$
|
6,289
|
|
|
25.7
|
%
|
Segregated portfolio cells dividend expense (income)
(1)
|
$
|
3,236
|
|
|
$
|
1,031
|
|
|
$
|
2,205
|
|
|
213.9
|
%
|
Interest expense
|
$
|
15,032
|
|
|
$
|
14,596
|
|
|
$
|
436
|
|
|
3.0
|
%
|
Income tax expense (benefit)
|
$
|
24,736
|
|
|
$
|
11,418
|
|
|
$
|
13,318
|
|
|
116.6
|
%
|
(1)
Represents the investment results attributable to the SPCs at Eastern Re
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Fixed maturities
|
$
|
84,386
|
|
|
$
|
96,315
|
|
|
$
|
(11,929
|
)
|
|
(12.4
|
%)
|
Equities
|
14,887
|
|
|
13,317
|
|
|
1,570
|
|
|
11.8
|
%
|
|||
Other investments, including Short-term
|
3,353
|
|
|
2,035
|
|
|
1,318
|
|
|
64.8
|
%
|
|||
BOLI
|
2,008
|
|
|
2,053
|
|
|
(45
|
)
|
|
(2.2
|
%)
|
|||
Investment fees and expenses
|
(6,032
|
)
|
|
(5,988
|
)
|
|
(44
|
)
|
|
0.7
|
%
|
|||
Net investment income
|
$
|
98,602
|
|
|
$
|
107,732
|
|
|
$
|
(9,130
|
)
|
|
(8.5
|
%)
|
|
Year Ended December 31
|
||
|
2016
|
|
2015
|
Average income yield
|
3.3%
|
|
3.4%
|
Average tax equivalent income yield
|
3.8%
|
|
4.0%
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Investment LPs/LLCs
|
$
|
19,055
|
|
|
$
|
13,970
|
|
|
$
|
5,085
|
|
|
36.4
|
%
|
Tax credit partnerships
|
(24,817
|
)
|
|
(10,288
|
)
|
|
(14,529
|
)
|
|
141.2
|
%
|
|||
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
(5,762
|
)
|
|
$
|
3,682
|
|
|
$
|
(9,444
|
)
|
|
(256.5
|
%)
|
|
Year Ended December 31
|
||||||
(In millions)
|
2016
|
|
2015
|
||||
Tax credits recognized during the period
|
$
|
27.5
|
|
|
$
|
22.4
|
|
Tax benefit of tax credit partnership operating losses
|
$
|
8.7
|
|
|
$
|
3.6
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2016
|
|
2015
|
||||
GAAP net investment result:
|
|
|
|
||||
Net investment income
|
$
|
98,602
|
|
|
$
|
107,732
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
(5,762
|
)
|
|
3,682
|
|
||
GAAP net investment result
|
$
|
92,840
|
|
|
$
|
111,414
|
|
|
|
|
|
||||
Pro forma tax-equivalent investment result
|
$
|
149,959
|
|
|
$
|
164,756
|
|
|
|
|
|
||||
Reconciliation of pro forma and GAAP tax-equivalent investment result:
|
|
|
|
||||
GAAP net investment result
|
$
|
92,840
|
|
|
$
|
111,414
|
|
Taxable equivalent adjustments, calculated using the 35% federal statutory tax rate:
|
|
|
|
||||
State and municipal bonds
|
11,698
|
|
|
14,449
|
|
||
BOLI
|
1,081
|
|
|
1,105
|
|
||
Dividends received
|
1,957
|
|
|
3,316
|
|
||
Tax credit partnerships
|
42,383
|
|
|
34,472
|
|
||
Pro forma tax-equivalent investment result
|
$
|
149,959
|
|
|
$
|
164,756
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2016
|
|
2015
|
||||
OTTI losses, total:
|
|
|
|
||||
State and municipal bonds
|
$
|
(100
|
)
|
|
$
|
—
|
|
Corporate debt
|
(7,604
|
)
|
|
(11,781
|
)
|
||
Other investments
|
(3,130
|
)
|
|
(8,136
|
)
|
||
Portion recognized in OCI:
|
|
|
|
||||
Corporate debt
|
1,068
|
|
|
4,572
|
|
||
Net impairments recognized in earnings
|
(9,766
|
)
|
|
(15,345
|
)
|
||
Gross realized gains, available-for-sale securities
|
12,402
|
|
|
11,910
|
|
||
Gross realized (losses), available-for-sale securities
|
(7,029
|
)
|
|
(11,479
|
)
|
||
Net realized gains (losses), trading securities
|
6,632
|
|
|
1,080
|
|
||
Net realized gains (losses), other investments
|
1,115
|
|
|
464
|
|
||
Change in unrealized holding gains (losses), trading securities
|
30,521
|
|
|
(28,343
|
)
|
||
Change in unrealized holding gains (losses), convertible securities, carried at fair value as a part of Other investments
|
899
|
|
|
(896
|
)
|
||
Other
|
25
|
|
|
946
|
|
||
Net realized investment gains (losses)
|
$
|
34,799
|
|
|
$
|
(41,663
|
)
|
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
|
2016
|
|
2015
|
|
Change
|
|||||||||
Operating expenses
|
|
$
|
45,116
|
|
|
$
|
38,646
|
|
|
$
|
6,470
|
|
|
16.7
|
%
|
Management fee offset
|
|
(14,309
|
)
|
|
(14,128
|
)
|
|
(181
|
)
|
|
1.3
|
%
|
|||
Segment Total
|
|
$
|
30,807
|
|
|
$
|
24,518
|
|
|
$
|
6,289
|
|
|
25.7
|
%
|
|
Year Ended December 31
|
|||||||||||||
(In thousands)
|
2016
|
|
2015
|
|
Change
|
|||||||||
Senior Notes due 2023
|
$
|
13,429
|
|
|
$
|
13,428
|
|
|
$
|
1
|
|
|
—
|
%
|
Revolving Credit Agreement (including fees and amortization)
|
1,564
|
|
|
1,130
|
|
|
434
|
|
|
38.4
|
%
|
|||
Other
|
39
|
|
|
38
|
|
|
1
|
|
|
2.6
|
%
|
|||
|
$
|
15,032
|
|
|
$
|
14,596
|
|
|
$
|
436
|
|
|
3.0
|
%
|
|
Year Ended
December 31 |
||||||
(In thousands)
|
2016
|
|
2015
|
||||
Corporate segment income tax expense (benefit)
|
$
|
24,736
|
|
|
$
|
11,418
|
|
Lloyd's Syndicate segment income tax expense (benefit)
|
384
|
|
|
1,240
|
|
||
Consolidated income tax expense (benefit)
|
$
|
25,120
|
|
|
$
|
12,658
|
|
•
|
A portion of our investment income was tax-exempt.
|
•
|
We utilized tax credits transferred to us from our tax credit partnership investments.
|
•
|
We did not recognize U.S. or U.K. tax expense relative to our pro rata portion of the operating profits of Syndicate 1729 in 2016 as we were able to utilize Syndicate 1729 operating losses from prior years as an offset. We did not recognize a tax benefit for our U.K.operating losses in 2015 as no tax benefit was currently available and it was not more likely than not that a future benefit would be realized.
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
December 31, 2017
|
||||||||||||||||||
($ in millions)
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
Fair Value:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
$
|
142
|
|
|
$
|
138
|
|
|
$
|
134
|
|
|
$
|
130
|
|
|
$
|
126
|
|
U.S. Government-sponsored enterprise obligations
|
22
|
|
|
21
|
|
|
21
|
|
|
20
|
|
|
19
|
|
|||||
State and municipal bonds
|
683
|
|
|
657
|
|
|
632
|
|
|
609
|
|
|
585
|
|
|||||
Corporate debt
|
1,249
|
|
|
1,208
|
|
|
1,167
|
|
|
1,128
|
|
|
1,090
|
|
|||||
Asset-backed securities
|
341
|
|
|
335
|
|
|
326
|
|
|
315
|
|
|
302
|
|
|||||
All fixed maturity securities
|
$
|
2,437
|
|
|
$
|
2,359
|
|
|
$
|
2,280
|
|
|
$
|
2,202
|
|
|
$
|
2,122
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
3.11
|
|
|
3.02
|
|
|
2.94
|
|
|
2.86
|
|
|
2.79
|
|
|||||
U.S. Government-sponsored enterprise obligations
|
1.38
|
|
|
1.34
|
|
|
3.59
|
|
|
4.58
|
|
|
4.87
|
|
|||||
State and municipal bonds
|
3.83
|
|
|
3.79
|
|
|
3.78
|
|
|
3.80
|
|
|
3.85
|
|
|||||
Corporate debt
|
3.37
|
|
|
3.33
|
|
|
3.38
|
|
|
3.38
|
|
|
3.34
|
|
|||||
Asset-backed securities
|
1.72
|
|
|
2.21
|
|
|
3.15
|
|
|
3.89
|
|
|
4.24
|
|
|||||
All fixed maturity securities
|
3.23
|
|
|
3.26
|
|
|
3.43
|
|
|
3.55
|
|
|
3.59
|
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
December 31, 2016
|
||||||||||||||||||
($ in millions)
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
Fair Value:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
$
|
155
|
|
|
$
|
151
|
|
|
$
|
147
|
|
|
$
|
142
|
|
|
$
|
138
|
|
U.S. Government-sponsored enterprise obligations
|
31
|
|
|
31
|
|
|
30
|
|
|
29
|
|
|
29
|
|
|||||
State and municipal bonds
|
865
|
|
|
832
|
|
|
800
|
|
|
770
|
|
|
740
|
|
|||||
Corporate debt
|
1,365
|
|
|
1,321
|
|
|
1,279
|
|
|
1,238
|
|
|
1,198
|
|
|||||
Asset-backed securities
|
373
|
|
|
368
|
|
|
357
|
|
|
344
|
|
|
331
|
|
|||||
All fixed maturity securities
|
$
|
2,789
|
|
|
$
|
2,703
|
|
|
$
|
2,613
|
|
|
$
|
2,523
|
|
|
$
|
2,436
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
3.00
|
|
|
2.93
|
|
|
2.85
|
|
|
2.78
|
|
|
2.72
|
|
|||||
U.S. Government-sponsored enterprise obligations
|
1.55
|
|
|
1.70
|
|
|
2.39
|
|
|
2.67
|
|
|
2.70
|
|
|||||
State and municipal bonds
|
3.85
|
|
|
3.82
|
|
|
3.83
|
|
|
3.87
|
|
|
3.91
|
|
|||||
Corporate debt
|
3.21
|
|
|
3.20
|
|
|
3.22
|
|
|
3.22
|
|
|
3.18
|
|
|||||
Asset-backed securities
|
1.75
|
|
|
2.48
|
|
|
3.38
|
|
|
3.86
|
|
|
4.10
|
|
|||||
All fixed maturity securities
|
3.18
|
|
|
3.26
|
|
|
3.40
|
|
|
3.47
|
|
|
3.49
|
|
Index to Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Financial Statements
. The following consolidated financial statements of ProAssurance Corporation and subsidiaries are included herein in accordance with Item 8 of Part II of this report.
|
(b)
|
The exhibits required to be filed by Item 15(b) are listed herein in the Exhibit Index.
|
PROASSURANCE CORPORATION
|
|
|
|
By:
|
/
S
/ W. S
TANCIL
S
TARNES
|
|
W. Stancil Starnes
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/
S
/ W. S
TANCIL
S
TARNES
, J.D.
|
|
Chairman of the Board, Chief Executive Officer
|
|
February 21, 2018
|
|
W. Stancil Starnes, J.D.
|
|
(Principal Executive Officer) and President
|
|
|
|
|
|
|
|
|
|
/
S
/ E
DWARD
L. R
AND
, J
R
.
|
|
Chief Operating Officer and Chief Financial
|
|
February 21, 2018
|
|
Edward L. Rand, Jr.
|
|
Officer
|
|
|
|
|
|
|
|
|
|
/
S
/ S
AMUEL
A. D
I
P
IAZZA,
J
R.
|
|
Director
|
|
February 21, 2018
|
|
Samuel A. Di Piazza, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ R
OBERT
E. F
LOWERS,
M.D
.
|
|
Director
|
|
February 21, 2018
|
|
Robert E. Flowers, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ M. J
AMES
G
ORRIE
|
|
Director
|
|
February 21, 2018
|
|
M. James Gorrie
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ B
RUCE
D. A
NGIOLILLO, J.D.
|
|
Director
|
|
February 21, 2018
|
|
Bruce D. Angiolillo
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ J
OHN
J. M
C
M
AHON
J
R.
|
|
Director
|
|
February 21, 2018
|
|
John J. McMahon
|
|
|
|
|
|
|
|
|
|
|
|
/S/ K
ATISHA
T. V
ANCE
|
|
Director
|
|
February 21, 2018
|
|
Katisha T. Vance
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ F
RANK
A. S
PINOSA
, D.P.M.
|
|
Director
|
|
February 21, 2018
|
|
Frank A. Spinosa, D.P.M.
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ Z
IAD
R. H
AYDAR
, M.D.
|
|
Director
|
|
February 21, 2018
|
|
Ziad R. Haydar, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ T
HOMAS
A.S. W
ILSON
, J
R
., M.D.
|
|
Director
|
|
February 21, 2018
|
|
Thomas A. S. Wilson, Jr., M.D.
|
|
|
|
|
|
December 31,
2017 |
|
December 31,
2016 |
||||
Assets
|
|
|
|
||||
Investments
|
|
|
|
||||
Fixed maturities, available for sale, at fair value; amortized cost, $2,257,188 and $2,586,821, respectively
|
$
|
2,280,242
|
|
|
$
|
2,613,406
|
|
Equity securities, trading, at fair value; cost, $425,942 and $353,744, respectively
|
470,609
|
|
|
387,274
|
|
||
Short-term investments
|
432,126
|
|
|
442,084
|
|
||
Business owned life insurance
|
62,113
|
|
|
60,134
|
|
||
Investment in unconsolidated subsidiaries
|
330,591
|
|
|
340,906
|
|
||
Other investments, $52,301 and $31,501 at fair value, respectively, otherwise at cost or amortized cost
|
110,847
|
|
|
81,892
|
|
||
Total Investments
|
3,686,528
|
|
|
3,925,696
|
|
||
Cash and cash equivalents
|
134,495
|
|
|
117,347
|
|
||
Premiums receivable
|
238,085
|
|
|
223,480
|
|
||
Receivable from reinsurers on paid losses and loss adjustment expenses
|
7,317
|
|
|
5,446
|
|
||
Receivable from reinsurers on unpaid losses and loss adjustment expenses
|
335,585
|
|
|
273,475
|
|
||
Prepaid reinsurance premiums
|
39,916
|
|
|
39,723
|
|
||
Deferred policy acquisition costs
|
50,261
|
|
|
46,809
|
|
||
Deferred tax asset, net
|
9,930
|
|
|
10,256
|
|
||
Real estate, net
|
31,975
|
|
|
31,814
|
|
||
Intangible assets, net
|
82,952
|
|
|
84,406
|
|
||
Goodwill
|
210,725
|
|
|
210,725
|
|
||
Other assets
|
101,428
|
|
|
96,004
|
|
||
Total Assets
|
$
|
4,929,197
|
|
|
$
|
5,065,181
|
|
|
|
|
|
||||
Liabilities and Shareholders’ Equity
|
|
|
|
||||
Liabilities
|
|
|
|
||||
Policy liabilities and accruals
|
|
|
|
||||
Reserve for losses and loss adjustment expenses
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
Unearned premiums
|
398,884
|
|
|
372,563
|
|
||
Reinsurance premiums payable
|
37,726
|
|
|
30,001
|
|
||
Total Policy Liabilities
|
2,484,991
|
|
|
2,395,992
|
|
||
Other liabilities
|
437,600
|
|
|
422,285
|
|
||
Debt less debt issuance costs
|
411,811
|
|
|
448,202
|
|
||
Total Liabilities
|
3,334,402
|
|
|
3,266,479
|
|
||
Shareholders’ Equity
|
|
|
|
||||
Common shares, par value $0.01 per share, 100,000,000 shares authorized, 62,824,523 and 62,660,234 shares issued, respectively
|
628
|
|
|
627
|
|
||
Additional paid-in capital
|
383,077
|
|
|
376,518
|
|
||
Accumulated other comprehensive income (loss), net of deferred tax expense (benefit) of $5,218 and $9,894, respectively
|
14,911
|
|
|
17,399
|
|
||
Retained earnings
|
1,614,186
|
|
|
1,824,088
|
|
||
Treasury shares, at cost, 9,367,502 shares and 9,408,977 shares, respectively
|
(418,007
|
)
|
|
(419,930
|
)
|
||
Total Shareholders’ Equity
|
1,594,795
|
|
|
1,798,702
|
|
||
Total Liabilities and Shareholders’ Equity
|
$
|
4,929,197
|
|
|
$
|
5,065,181
|
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
Balance at January 1, 2015
|
$
|
623
|
|
|
$
|
359,577
|
|
|
$
|
58,204
|
|
|
$
|
1,991,704
|
|
|
$
|
(252,164
|
)
|
|
$
|
2,157,944
|
|
Common shares reacquired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(169,793
|
)
|
|
(169,793
|
)
|
||||||
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
1,232
|
|
|
—
|
|
|
—
|
|
|
2,397
|
|
|
3,629
|
|
||||||
Share-based compensation
|
—
|
|
|
9,166
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,166
|
|
||||||
Net effect of restricted and performance shares issued and stock options exercised
|
2
|
|
|
(4,576
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,574
|
)
|
||||||
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(119,866
|
)
|
|
—
|
|
|
(119,866
|
)
|
||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(34,349
|
)
|
|
—
|
|
|
—
|
|
|
(34,349
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
116,197
|
|
|
—
|
|
|
116,197
|
|
||||||
Balance at December 31, 2015
|
625
|
|
|
365,399
|
|
|
23,855
|
|
|
1,988,035
|
|
|
(419,560
|
)
|
|
1,958,354
|
|
||||||
Common shares reacquired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,106
|
)
|
|
(2,106
|
)
|
||||||
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
1,696
|
|
|
—
|
|
|
—
|
|
|
1,736
|
|
|
3,432
|
|
||||||
Share-based compensation
|
—
|
|
|
12,455
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,455
|
|
||||||
Net effect of restricted and performance shares issued and stock options exercised
|
2
|
|
|
(3,032
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,030
|
)
|
||||||
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(315,028
|
)
|
|
—
|
|
|
(315,028
|
)
|
||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(6,456
|
)
|
|
—
|
|
|
—
|
|
|
(6,456
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
151,081
|
|
|
—
|
|
|
151,081
|
|
||||||
Balance at December 31, 2016
|
627
|
|
|
376,518
|
|
|
17,399
|
|
|
1,824,088
|
|
|
(419,930
|
)
|
|
1,798,702
|
|
||||||
Cumulative-effect adjustment-
ASU 2016-09 adoption* |
—
|
|
|
425
|
|
|
—
|
|
|
(276
|
)
|
|
—
|
|
|
149
|
|
||||||
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
957
|
|
|
—
|
|
|
—
|
|
|
1,923
|
|
|
2,880
|
|
||||||
Share-based compensation
|
—
|
|
|
10,615
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,615
|
|
||||||
Net effect of restricted and performance shares issued
|
1
|
|
|
(5,438
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,437
|
)
|
||||||
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(316,890
|
)
|
|
—
|
|
|
(316,890
|
)
|
||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(2,488
|
)
|
|
—
|
|
|
—
|
|
|
(2,488
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
107,264
|
|
|
—
|
|
|
107,264
|
|
||||||
Balance at December 31, 2017
|
$
|
628
|
|
|
$
|
383,077
|
|
|
$
|
14,911
|
|
|
$
|
1,614,186
|
|
|
$
|
(418,007
|
)
|
|
$
|
1,594,795
|
|
|
Year Ended December 31
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Revenues
|
|
|
|
|
|
||||||
Net premiums earned
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
$
|
694,149
|
|
Net investment income
|
95,662
|
|
|
100,012
|
|
|
108,660
|
|
|||
Equity in earnings (loss) of unconsolidated subsidiaries
|
8,033
|
|
|
(5,762
|
)
|
|
3,682
|
|
|||
Net realized investment gains (losses):
|
|
|
|
|
|
||||||
OTTI losses
|
(13,200
|
)
|
|
(10,834
|
)
|
|
(19,917
|
)
|
|||
Portion of OTTI losses recognized in other comprehensive income before taxes
|
248
|
|
|
1,068
|
|
|
4,572
|
|
|||
Net impairment losses recognized in earnings
|
(12,952
|
)
|
|
(9,766
|
)
|
|
(15,345
|
)
|
|||
Other net realized investment gains (losses)
|
29,361
|
|
|
44,641
|
|
|
(26,294
|
)
|
|||
Total net realized investment gains (losses)
|
16,409
|
|
|
34,875
|
|
|
(41,639
|
)
|
|||
Other income
|
7,514
|
|
|
7,808
|
|
|
7,227
|
|
|||
|
|
|
|
|
|
||||||
Total revenues
|
866,149
|
|
|
870,214
|
|
|
772,079
|
|
|||
|
|
|
|
|
|
||||||
Expenses
|
|
|
|
|
|
||||||
Net losses and loss adjustment expenses
|
469,158
|
|
|
443,229
|
|
|
410,711
|
|
|||
Underwriting, policy acquisition and operating expenses
|
|
|
|
|
|
||||||
Operating expense
|
140,002
|
|
|
139,232
|
|
|
137,508
|
|
|||
DPAC Amortization
|
95,751
|
|
|
88,378
|
|
|
79,556
|
|
|||
Segregated portfolio cells dividend expense (income)
|
15,771
|
|
|
8,142
|
|
|
853
|
|
|||
Interest expense
|
16,844
|
|
|
15,032
|
|
|
14,596
|
|
|||
|
|
|
|
|
|
||||||
Total expenses
|
737,526
|
|
|
694,013
|
|
|
643,224
|
|
|||
|
|
|
|
|
|
||||||
|
|
|
|
|
|
||||||
Income before income taxes
|
128,623
|
|
|
176,201
|
|
|
128,855
|
|
|||
|
|
|
|
|
|
||||||
Provision for income taxes
|
|
|
|
|
|
||||||
Current expense (benefit)
|
19,666
|
|
|
16,586
|
|
|
28,652
|
|
|||
Deferred expense (benefit)
|
1,693
|
|
|
8,534
|
|
|
(15,994
|
)
|
|||
Total income tax expense (benefit)
|
21,359
|
|
|
25,120
|
|
|
12,658
|
|
|||
|
|
|
|
|
|
||||||
Net income
|
107,264
|
|
|
151,081
|
|
|
116,197
|
|
|||
|
|
|
|
|
|
||||||
Other comprehensive income (loss), after tax, net of reclassification adjustments
|
(2,488
|
)
|
|
(6,456
|
)
|
|
(34,349
|
)
|
|||
|
|
|
|
|
|
||||||
Comprehensive income
|
$
|
104,776
|
|
|
$
|
144,625
|
|
|
$
|
81,848
|
|
|
|
|
|
|
|
||||||
Earnings per share:
|
|
|
|
|
|
||||||
Basic
|
$
|
2.01
|
|
|
$
|
2.84
|
|
|
$
|
2.12
|
|
Diluted
|
$
|
2.00
|
|
|
$
|
2.83
|
|
|
$
|
2.11
|
|
|
|
|
|
|
|
||||||
Weighted average number of common shares outstanding:
|
|
|
|
|
|
||||||
Basic
|
53,393
|
|
|
53,216
|
|
|
54,795
|
|
|||
Diluted
|
53,611
|
|
|
53,448
|
|
|
55,017
|
|
|||
|
|
|
|
|
|
||||||
Cash dividends declared per common share
|
$
|
5.93
|
|
|
$
|
5.93
|
|
|
$
|
2.24
|
|
|
Year Ended December 31
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Operating Activities
|
|
|
|
|
|
||||||
Net income
|
$
|
107,264
|
|
|
$
|
151,081
|
|
|
$
|
116,197
|
|
Adjustments to reconcile income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
Depreciation and amortization, net of accretion
|
28,796
|
|
|
32,789
|
|
|
36,218
|
|
|||
(Increase) decrease in cash surrender value of BOLI
|
(1,979
|
)
|
|
(2,008
|
)
|
|
(2,032
|
)
|
|||
Net realized investment (gains) losses
|
(16,409
|
)
|
|
(34,875
|
)
|
|
41,639
|
|
|||
Share-based compensation
|
10,615
|
|
|
12,455
|
|
|
9,166
|
|
|||
Deferred income taxes
|
1,693
|
|
|
8,534
|
|
|
(15,994
|
)
|
|||
Policy acquisition costs, net of amortization (net deferral)
|
(3,452
|
)
|
|
(2,421
|
)
|
|
(5,598
|
)
|
|||
Equity in (earnings) loss of unconsolidated subsidiaries
|
(8,033
|
)
|
|
5,762
|
|
|
(3,682
|
)
|
|||
Other
|
108
|
|
|
1,772
|
|
|
466
|
|
|||
Other changes in assets and liabilities:
|
|
|
|
|
|
||||||
Premiums receivable
|
(14,605
|
)
|
|
(6,446
|
)
|
|
(14,506
|
)
|
|||
Reinsurance related assets and liabilities
|
(56,449
|
)
|
|
(26,108
|
)
|
|
(3,411
|
)
|
|||
Other assets
|
(792
|
)
|
|
15,665
|
|
|
(10,458
|
)
|
|||
Reserve for losses and loss adjustment expenses
|
54,953
|
|
|
(11,898
|
)
|
|
(52,940
|
)
|
|||
Unearned premiums
|
26,321
|
|
|
10,497
|
|
|
16,238
|
|
|||
Other liabilities
|
20,965
|
|
|
14,321
|
|
|
(179
|
)
|
|||
Net cash provided (used) by operating activities
|
148,996
|
|
|
169,120
|
|
|
111,124
|
|
|||
Investing Activities
|
|
|
|
|
|
||||||
Purchases of:
|
|
|
|
|
|
||||||
Fixed maturities, available for sale
|
(614,440
|
)
|
|
(636,377
|
)
|
|
(580,577
|
)
|
|||
Equity securities, trading
|
(207,857
|
)
|
|
(112,912
|
)
|
|
(271,608
|
)
|
|||
Other investments
|
(50,362
|
)
|
|
(18,613
|
)
|
|
(33,366
|
)
|
|||
Funding of qualified affordable housing project tax credit partnerships
|
(507
|
)
|
|
(1,019
|
)
|
|
(12,477
|
)
|
|||
Investment in unconsolidated subsidiaries
|
(42,183
|
)
|
|
(50,890
|
)
|
|
(61,444
|
)
|
|||
Proceeds from sales or maturities of:
|
|
|
|
|
|
||||||
Fixed maturities, available for sale
|
932,070
|
|
|
752,516
|
|
|
886,886
|
|
|||
Equity securities, trading
|
146,356
|
|
|
85,226
|
|
|
236,476
|
|
|||
Other investments
|
25,372
|
|
|
13,797
|
|
|
33,638
|
|
|||
Distributions from unconsolidated subsidiaries
|
56,931
|
|
|
16,947
|
|
|
28,017
|
|
|||
Net sales or maturities (purchases) of short-term investments
|
4,167
|
|
|
(322,872
|
)
|
|
11,932
|
|
|||
Unsettled security transactions, net change
|
(2,031
|
)
|
|
1,388
|
|
|
2,339
|
|
|||
Purchases of capital assets
|
(10,485
|
)
|
|
(10,922
|
)
|
|
(9,524
|
)
|
|||
Purchases of intangible assets
|
(2,984
|
)
|
|
—
|
|
|
—
|
|
|||
Other
|
(9,380
|
)
|
|
4,792
|
|
|
(2,505
|
)
|
|||
Net cash provided (used) by investing activities
|
224,667
|
|
|
(278,939
|
)
|
|
227,787
|
|
|||
Continued on following page.
|
|
|
|
|
|
|
Year Ended December 31
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Continued from the previous page.
|
|
|
|
|
|
||||||
Financing Activities
|
|
|
|
|
|
||||||
Borrowings (repayments) under Revolving Credit Agreement
|
(77,000
|
)
|
|
100,000
|
|
|
100,000
|
|
|||
Proceeds from Mortgage Loans
|
40,460
|
|
|
—
|
|
|
—
|
|
|||
Repurchase of common stock
|
—
|
|
|
(2,106
|
)
|
|
(172,772
|
)
|
|||
Dividends to shareholders
|
(315,228
|
)
|
|
(118,812
|
)
|
|
(217,626
|
)
|
|||
External capital contribution received for segregated portfolio cells
|
2,936
|
|
|
9,952
|
|
|
836
|
|
|||
Other
|
(7,683
|
)
|
|
(2,968
|
)
|
|
(5,289
|
)
|
|||
Net cash provided (used) by financing activities
|
(356,515
|
)
|
|
(13,934
|
)
|
|
(294,851
|
)
|
|||
Increase (decrease) in cash and cash equivalents
|
17,148
|
|
|
(123,753
|
)
|
|
44,060
|
|
|||
Cash and cash equivalents at beginning of period
|
117,347
|
|
|
241,100
|
|
|
197,040
|
|
|||
Cash and cash equivalents at end of period
|
$
|
134,495
|
|
|
$
|
117,347
|
|
|
$
|
241,100
|
|
|
|
|
|
|
|
||||||
Supplemental Disclosure of Cash Flow Information
|
|
|
|
|
|
||||||
Cash paid during the year for income taxes, net of refunds
|
$
|
17,193
|
|
|
$
|
(8,683
|
)
|
|
$
|
42,784
|
|
Cash paid during the year for interest
|
$
|
15,892
|
|
|
$
|
14,732
|
|
|
$
|
13,996
|
|
|
|
|
|
|
|
||||||
Significant Non-Cash Transactions
|
|
|
|
|
|
||||||
Dividends declared and not yet paid
|
$
|
267,292
|
|
|
$
|
265,659
|
|
|
$
|
69,447
|
|
•
|
if there is intent to sell the security;
|
•
|
if it is more likely than not that the security will be required to be sold before full recovery of its amortized cost basis; and
|
•
|
if the entire amortized basis of the security is not expected to be recovered.
|
•
|
third-party research and credit rating reports;
|
•
|
the current credit standing of the issuer, including credit rating downgrades, whether before or after the balance sheet date;
|
•
|
the extent to which the decline in fair value is attributable to credit risk specifically associated with the security or its issuer;
|
•
|
internal assessments and the assessments of external portfolio managers regarding specific circumstances surrounding an investment, which indicate the investment is more or less likely to recover its amortized cost than other investments with a similar structure;
|
•
|
for asset-backed securities, the origination date of the underlying loans, the remaining average life, the probability that credit performance of the underlying loans will deteriorate in the future, and our assessment of the quality of the collateral underlying the loan;
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
•
|
any changes to the rating of the security by a rating agency; and
|
•
|
recoveries or additional declines in fair value subsequent to the balance sheet date.
|
|
Gross Carrying Value
|
|
Accumulated Amortization
|
|
Amortization Expense
|
||||||||||||||||||||||
|
December 31
|
|
December 31
|
|
Year Ended December 31
|
||||||||||||||||||||||
(In millions)
|
2017
|
|
2016
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||||
Intangible Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Non-amortizable
|
$
|
25.8
|
|
|
$
|
25.8
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Amortizable *
|
97.5
|
|
|
93.6
|
|
|
$
|
40.3
|
|
|
$
|
35.0
|
|
|
$
|
5.8
|
|
|
$
|
8.1
|
|
|
$
|
8.3
|
|
||
Total Intangible Assets
|
$
|
123.3
|
|
|
$
|
119.4
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
* At December 31, 2017, the gross carrying value included intangible assets acquired during the third quarter of 2017.
|
(In thousands)
|
|
2017
|
|
2016
|
||||
SPC dividends payable
|
|
$
|
46,925
|
|
|
$
|
34,289
|
|
Unpaid dividends
|
|
267,292
|
|
|
265,659
|
|
||
All other
|
|
123,383
|
|
|
122,337
|
|
||
Total other liabilities
|
|
$
|
437,600
|
|
|
$
|
422,285
|
|
|
Level 1:
|
quoted (unadjusted) market prices in active markets for identical assets and liabilities. For ProAssurance, Level 1 inputs are generally quotes for debt or equity securities actively traded in exchange or over-the-counter markets.
|
|
Level 2:
|
market data obtained from sources independent of the reporting entity (observable inputs). For ProAssurance, Level 2 inputs generally include quoted prices in markets that are not active, quoted prices for similar assets or liabilities, and results from pricing models that use observable inputs such as interest rates and yield curves that are generally available at commonly quoted intervals.
|
|
Level 3:
|
the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances (non-observable inputs). For ProAssurance, Level 3 inputs are used in situations where little or no Level 1 or 2 inputs are available or are inappropriate given the particular circumstances. Level 3 inputs include results from pricing models for which some or all of the inputs are not observable, discounted cash flow methodologies, single non-binding broker quotes and adjustments to externally quoted prices that are based on management judgment or estimation.
|
|
December 31, 2017
|
||||||||||||||
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
133,627
|
|
|
$
|
—
|
|
|
$
|
133,627
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
20,956
|
|
|
—
|
|
|
20,956
|
|
||||
State and municipal bonds
|
—
|
|
|
632,243
|
|
|
—
|
|
|
632,243
|
|
||||
Corporate debt, multiple observable inputs
|
2,371
|
|
|
1,151,084
|
|
|
—
|
|
|
1,153,455
|
|
||||
Corporate debt, limited observable inputs
|
—
|
|
|
—
|
|
|
13,703
|
|
|
13,703
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
196,789
|
|
|
1,055
|
|
|
197,844
|
|
||||
Agency commercial mortgage-backed securities
|
—
|
|
|
10,742
|
|
|
—
|
|
|
10,742
|
|
||||
Other commercial mortgage-backed securities
|
—
|
|
|
15,961
|
|
|
—
|
|
|
15,961
|
|
||||
Other asset-backed securities
|
—
|
|
|
97,780
|
|
|
3,931
|
|
|
101,711
|
|
||||
Equity securities
|
|
|
|
|
|
|
|
||||||||
Financial
|
76,051
|
|
|
—
|
|
|
—
|
|
|
76,051
|
|
||||
Utilities/Energy
|
54,388
|
|
|
—
|
|
|
—
|
|
|
54,388
|
|
||||
Consumer oriented
|
54,529
|
|
|
—
|
|
|
—
|
|
|
54,529
|
|
||||
Industrial
|
53,936
|
|
|
—
|
|
|
—
|
|
|
53,936
|
|
||||
Bond funds
|
156,563
|
|
|
—
|
|
|
—
|
|
|
156,563
|
|
||||
All other
|
75,142
|
|
|
—
|
|
|
—
|
|
|
75,142
|
|
||||
Short-term investments
|
404,204
|
|
|
27,922
|
|
|
—
|
|
|
432,126
|
|
||||
Other investments
|
607
|
|
|
31,155
|
|
|
409
|
|
|
32,171
|
|
||||
Other assets
|
—
|
|
|
1,731
|
|
|
—
|
|
|
1,731
|
|
||||
Total assets categorized within the fair value hierarchy
|
$
|
877,791
|
|
|
$
|
2,319,990
|
|
|
$
|
19,098
|
|
|
3,216,879
|
|
|
LP/LLC and investment fund interests carried at NAV which approximates fair value. These interests, reported as a part of Investment in unconsolidated subsidiaries and Other investments, respectively, are not categorized within the fair value hierarchy.
|
|
|
|
|
|
|
230,889
|
|
|||||||
Total assets at fair value
|
|
|
|
|
|
|
$
|
3,447,768
|
|
|
December 31, 2016
|
||||||||||||||
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
146,539
|
|
|
$
|
—
|
|
|
$
|
146,539
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
30,235
|
|
|
—
|
|
|
30,235
|
|
||||
State and municipal bonds
|
—
|
|
|
800,463
|
|
|
—
|
|
|
800,463
|
|
||||
Corporate debt, multiple observable inputs
|
2,339
|
|
|
1,261,842
|
|
|
—
|
|
|
1,264,181
|
|
||||
Corporate debt, limited observable inputs
|
—
|
|
|
—
|
|
|
14,810
|
|
|
14,810
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
217,906
|
|
|
—
|
|
|
217,906
|
|
||||
Agency commercial mortgage-backed securities
|
—
|
|
|
12,783
|
|
|
—
|
|
|
12,783
|
|
||||
Other commercial mortgage-backed securities
|
—
|
|
|
19,611
|
|
|
—
|
|
|
19,611
|
|
||||
Other asset-backed securities
|
—
|
|
|
103,871
|
|
|
3,007
|
|
|
106,878
|
|
||||
Equity securities
|
|
|
|
|
|
|
|
||||||||
Financial
|
81,749
|
|
|
—
|
|
|
—
|
|
|
81,749
|
|
||||
Utilities/Energy
|
52,869
|
|
|
—
|
|
|
—
|
|
|
52,869
|
|
||||
Consumer oriented
|
61,284
|
|
|
—
|
|
|
—
|
|
|
61,284
|
|
||||
Industrial
|
54,265
|
|
|
—
|
|
|
—
|
|
|
54,265
|
|
||||
Bond funds
|
79,843
|
|
|
10,159
|
|
|
—
|
|
|
90,002
|
|
||||
All other
|
27,181
|
|
|
19,924
|
|
|
—
|
|
|
47,105
|
|
||||
Short-term investments
|
437,580
|
|
|
4,504
|
|
|
—
|
|
|
442,084
|
|
||||
Other investments
|
1,956
|
|
|
29,542
|
|
|
3
|
|
|
31,501
|
|
||||
Total assets categorized within the fair value hierarchy
|
$
|
799,066
|
|
|
$
|
2,657,379
|
|
|
$
|
17,820
|
|
|
3,474,265
|
|
|
LP/LLC interests carried at NAV which approximates fair value. These interests, reported as a part of Investment in unconsolidated subsidiaries, are not categorized within the fair value hierarchy.
|
|
|
|
|
|
|
204,719
|
|
|||||||
Total assets at fair value
|
|
|
|
|
|
|
$
|
3,678,984
|
|
•
|
Level 3 securities are priced by the Chief Investment Officer.
|
•
|
Level 3 valuations are computed quarterly. Prices are evaluated quarterly against prior period prices and the expected change in prices.
|
•
|
ProAssurance's Level 3 securities are primarily
NRSRO
rated debt instruments for which comparable market inputs are commonly available for evaluating the securities in question. Valuation of these debt instruments is not overly sensitive to changes in the unobservable inputs used.
|
|
|
Fair Value at
|
|
|
|
|
|
|
||
(In thousands)
|
|
December 31, 2017
|
|
December 31, 2016
|
|
Valuation Technique
|
|
Unobservable Input
|
|
Range
(Weighted Average) |
Assets:
|
|
|
|
|
|
|
|
|
|
|
Corporate debt, limited observable inputs
|
|
$13,703
|
|
$14,810
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
Residential mortgage-backed and other asset-backed securities
|
|
$4,986
|
|
$3,007
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
Other investments
|
|
$409
|
|
$3
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 10% (5%)
|
|
December 31, 2017
|
||||||||||||||||||
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||||||
(In thousands)
|
State and Municipal Bonds
|
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||||
Balance December 31, 2016
|
$
|
—
|
|
|
$
|
14,810
|
|
|
$
|
3,007
|
|
|
$
|
3
|
|
|
$
|
17,820
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
|
|
||||||||||
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
|
|
||||||||||
Net investment income
|
—
|
|
|
(163
|
)
|
|
—
|
|
|
—
|
|
|
(163
|
)
|
|||||
Net realized investment gains (losses)
|
—
|
|
|
13
|
|
|
—
|
|
|
(143
|
)
|
|
(130
|
)
|
|||||
Included in other comprehensive income
|
—
|
|
|
(369
|
)
|
|
(71
|
)
|
|
140
|
|
|
(300
|
)
|
|||||
Purchases
|
—
|
|
|
13,016
|
|
|
2,627
|
|
|
—
|
|
|
15,643
|
|
|||||
Sales
|
—
|
|
|
(4,837
|
)
|
|
—
|
|
|
(912
|
)
|
|
(5,749
|
)
|
|||||
Transfers in
|
—
|
|
|
999
|
|
|
—
|
|
|
1,321
|
|
|
2,320
|
|
|||||
Transfers out
|
—
|
|
|
(9,766
|
)
|
|
(577
|
)
|
|
—
|
|
|
(10,343
|
)
|
|||||
Balance December 31, 2017
|
$
|
—
|
|
|
$
|
13,703
|
|
|
$
|
4,986
|
|
|
$
|
409
|
|
|
$
|
19,098
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
December 31, 2016
|
||||||||||||||||||
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||||||
(In thousands)
|
State and Municipal Bonds
|
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||||
Balance December 31, 2015
|
$
|
—
|
|
|
$
|
14,500
|
|
|
$
|
757
|
|
|
$
|
—
|
|
|
$
|
15,257
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
|
|
||||||||||
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
|
|
||||||||||
Net investment income
|
—
|
|
|
(93
|
)
|
|
—
|
|
|
(9
|
)
|
|
(102
|
)
|
|||||
Net realized investment gains (losses)
|
(490
|
)
|
|
(75
|
)
|
|
—
|
|
|
—
|
|
|
(565
|
)
|
|||||
Included in other comprehensive income
|
—
|
|
|
531
|
|
|
8
|
|
|
47
|
|
|
586
|
|
|||||
Purchases
|
—
|
|
|
8,900
|
|
|
6,500
|
|
|
1,753
|
|
|
17,153
|
|
|||||
Sales
|
(410
|
)
|
|
(3,837
|
)
|
|
(1,452
|
)
|
|
(1,550
|
)
|
|
(7,249
|
)
|
|||||
Transfers in
|
900
|
|
|
—
|
|
|
1,000
|
|
|
918
|
|
|
2,818
|
|
|||||
Transfers out
|
—
|
|
|
(5,116
|
)
|
|
(3,806
|
)
|
|
(1,156
|
)
|
|
(10,078
|
)
|
|||||
Balance December 31, 2016
|
$
|
—
|
|
|
$
|
14,810
|
|
|
$
|
3,007
|
|
|
$
|
3
|
|
|
$
|
17,820
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Unfunded
Commitments |
|
Fair Value
|
||||||||
(In thousands)
|
December 31,
2017 |
|
December 31,
2017 |
|
December 31,
2016 |
||||||
Investments in LPs/LLCs:
|
|
|
|
|
|
||||||
Private debt funds
(1)
|
$
|
5,005
|
|
|
$
|
42,206
|
|
|
$
|
55,637
|
|
Long equity fund
(2)
|
None
|
|
|
7,847
|
|
|
6,268
|
|
|||
Long/short equity funds
(3)
|
None
|
|
|
31,352
|
|
|
28,926
|
|
|||
Non-public equity funds
(4)
|
$
|
77,626
|
|
|
100,062
|
|
|
89,691
|
|
||
Multi-strategy fund of funds
(5)
|
None
|
|
|
9,100
|
|
|
8,448
|
|
|||
Structured credit fund
(6)
|
None
|
|
|
6,561
|
|
|
4,273
|
|
|||
Long/short commodities fund
(7)
|
None
|
|
|
13,025
|
|
|
11,476
|
|
|||
Strategy focused fund
(8)
|
$
|
4,304
|
|
|
606
|
|
|
—
|
|
||
Other investments:
|
|
|
|
|
|
||||||
Mortgage fund
(9)
|
None
|
|
|
20,130
|
|
|
—
|
|
|||
|
|
|
$
|
230,889
|
|
|
$
|
204,719
|
|
(1)
|
The investment is comprised of interests in
two
unrelated
LP
funds that are structured to provide interest distributions primarily through diversified portfolios of private debt instruments.
One
LP
allows redemption by special consent; the other does not permit redemption. Income and capital are to be periodically distributed at the discretion of the
LP
s over an anticipated time frame that spans from
three
to
eight
years.
|
(2)
|
The fund is a
LP
that holds long equities of public international companies. Redemptions are allowed at the end of any calendar month with a prior notice requirement of
15 days
and are paid within
10 days
of the end of the calendar month of the redemption request.
|
(3)
|
The investment is comprised of interests in multiple unrelated
LP
funds. The funds hold primarily long and short North American equities and target absolute returns using strategies designed to take advantage of market opportunities. The funds generally permit quarterly or semi-annual capital redemptions subject to notice requirements of
30
to
90 days
. For some funds, redemptions above specified thresholds (lowest threshold is
90%
) may be only partially payable until after a fund audit is completed and are then payable within
30 days
.
|
(4)
|
The investment is comprised of interests in multiple unrelated
LP
funds, each structured to provide capital appreciation through diversified investments in private equity, which can include investments in buyout, venture capital, debt including senior, second lien and mezzanine, distressed debt and other private equity-oriented
LP
s. Two of the
LP
s allow redemption by terms set forth in the
LP
agreements; the others do not permit redemption. Income and capital are to be periodically distributed at the discretion of the
LP
over time frames that are anticipated to span up to
nine
years.
|
(5)
|
This fund is a
LLC
structured to build and manage low volatility, multi-manager portfolios that have little or no correlation to the broader fixed income and equity security markets. Redemptions are not permitted but offers to repurchase units of the
LLC
may be extended periodically.
|
(6)
|
This fund is a
LP
seeking to obtain superior risk-adjusted absolute returns by acquiring and actively managing a diversified portfolio of debt securities, including bonds, loans and other asset-backed instruments. Redemptions are allowed at any quarter-end with a prior notice requirement of
90 days
.
|
(7)
|
This fund is a
LLC
invested across a broad range of commodities and focuses primarily on market neutral, relative value strategies, seeking to generate absolute returns with low correlation to broad commodity, equity and fixed income markets. Following an initial
one
-year lock-up period, redemptions are allowed with a prior notice requirement of
30 days
and are payable within
30 days
.
|
(8)
|
This fund is a
LLC
focused on investing in consumer products companies. The fund will invest in North American companies, comprised of equity and equity-related securities, as well as debt instruments. Redemptions are not permitted.
|
(9)
|
This investment fund is focused on the structured mortgage market. The fund will primarily invest in U.S. Agency mortgage-backed securities. Redemptions are allowed at the end of any calendar quarter with a prior notice requirement of
65 days
and are paid within
45 days
at the end of the redemption dealing day.
|
|
December 31, 2017
|
||||||||||||||
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
Fixed maturities
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
134,323
|
|
|
$
|
485
|
|
|
$
|
1,181
|
|
|
$
|
133,627
|
|
U.S. Government-sponsored enterprise obligations
|
21,089
|
|
|
73
|
|
|
206
|
|
|
20,956
|
|
||||
State and municipal bonds
|
618,414
|
|
|
14,248
|
|
|
419
|
|
|
632,243
|
|
||||
Corporate debt
|
1,157,660
|
|
|
15,205
|
|
|
5,707
|
|
|
1,167,158
|
|
||||
Residential mortgage-backed securities
|
196,741
|
|
|
2,438
|
|
|
1,335
|
|
|
197,844
|
|
||||
Agency commercial mortgage-backed securities
|
10,827
|
|
|
23
|
|
|
108
|
|
|
10,742
|
|
||||
Other commercial mortgage-backed securities
|
16,004
|
|
|
91
|
|
|
134
|
|
|
15,961
|
|
||||
Other asset-backed securities
|
102,130
|
|
|
47
|
|
|
466
|
|
|
101,711
|
|
||||
|
$
|
2,257,188
|
|
|
$
|
32,610
|
|
|
$
|
9,556
|
|
|
$
|
2,280,242
|
|
|
|
|
|
|
|
|
|
||||||||
|
December 31, 2016
|
||||||||||||||
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
Fixed maturities
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
146,186
|
|
|
$
|
1,264
|
|
|
$
|
911
|
|
|
$
|
146,539
|
|
U.S. Government-sponsored enterprise obligations
|
30,038
|
|
|
388
|
|
|
191
|
|
|
30,235
|
|
||||
State and municipal bonds
|
790,154
|
|
|
17,261
|
|
|
6,952
|
|
|
800,463
|
|
||||
Corporate debt
|
1,264,812
|
|
|
22,659
|
|
|
8,480
|
|
|
1,278,991
|
|
||||
Residential mortgage-backed securities
|
216,285
|
|
|
3,667
|
|
|
2,046
|
|
|
217,906
|
|
||||
Agency commercial mortgage-backed securities
|
12,837
|
|
|
89
|
|
|
143
|
|
|
12,783
|
|
||||
Other commercial mortgage-backed securities
|
19,571
|
|
|
177
|
|
|
137
|
|
|
19,611
|
|
||||
Other asset-backed securities
|
106,938
|
|
|
207
|
|
|
267
|
|
|
106,878
|
|
||||
|
$
|
2,586,821
|
|
|
$
|
45,712
|
|
|
$
|
19,127
|
|
|
$
|
2,613,406
|
|
(In thousands)
|
Amortized
Cost |
|
Due in one
year or less |
|
Due after
one year through five years |
|
Due after
five years through ten years |
|
Due after
ten years |
|
Total Fair
Value |
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
134,323
|
|
|
$
|
24,284
|
|
|
$
|
85,173
|
|
|
$
|
21,203
|
|
|
$
|
2,967
|
|
|
$
|
133,627
|
|
U.S. Government-sponsored enterprise obligations
|
21,089
|
|
|
249
|
|
|
8,277
|
|
|
12,290
|
|
|
140
|
|
|
20,956
|
|
||||||
State and municipal bonds
|
618,414
|
|
|
48,925
|
|
|
206,946
|
|
|
274,994
|
|
|
101,378
|
|
|
632,243
|
|
||||||
Corporate debt
|
1,157,660
|
|
|
87,973
|
|
|
680,773
|
|
|
372,952
|
|
|
25,460
|
|
|
1,167,158
|
|
||||||
Residential mortgage-backed securities
|
196,741
|
|
|
|
|
|
|
|
|
|
|
197,844
|
|
||||||||||
Agency commercial mortgage-backed securities
|
10,827
|
|
|
|
|
|
|
|
|
|
|
10,742
|
|
||||||||||
Other commercial mortgage-backed securities
|
16,004
|
|
|
|
|
|
|
|
|
|
|
15,961
|
|
||||||||||
Other asset-backed securities
|
102,130
|
|
|
|
|
|
|
|
|
|
|
101,711
|
|
||||||||||
|
$
|
2,257,188
|
|
|
|
|
|
|
|
|
|
|
$
|
2,280,242
|
|
|
December 31, 2017
|
|
Carrying Value
|
|||||||
(In thousands)
|
Percentage
Ownership |
|
December 31,
2017 |
|
December 31,
2016 |
|||||
Equity method investments:
|
|
|
|
|
|
|
||||
Qualified affordable housing project tax credit partnerships
|
See below
|
|
$
|
84,607
|
|
|
$
|
102,313
|
|
|
Other tax credit partnerships
|
See below
|
|
6,118
|
|
|
11,459
|
|
|||
All other investments, primarily LPs/LLCs
|
See below
|
|
239,866
|
|
|
227,134
|
|
|||
|
|
|
|
$
|
330,591
|
|
|
$
|
340,906
|
|
(In thousands)
|
December 31,
2017 |
|
December 31,
2016 |
||||
Investments in LPs/LLCs, at cost
|
$
|
55,058
|
|
|
$
|
46,852
|
|
Convertible securities, at fair value
|
32,171
|
|
|
31,501
|
|
||
Investment funds, at fair value
|
20,130
|
|
|
—
|
|
||
Other, principally FHLB capital stock, at cost or amortized cost
|
3,488
|
|
|
3,539
|
|
||
|
$
|
110,847
|
|
|
$
|
81,892
|
|
|
December 31, 2017
|
||||||||||||||||||||||
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
110,788
|
|
|
$
|
1,181
|
|
|
$
|
67,135
|
|
|
$
|
554
|
|
|
$
|
43,653
|
|
|
$
|
627
|
|
U.S. Government-sponsored enterprise obligations
|
17,032
|
|
|
206
|
|
|
10,182
|
|
|
64
|
|
|
6,850
|
|
|
142
|
|
||||||
State and municipal bonds
|
23,122
|
|
|
419
|
|
|
15,168
|
|
|
102
|
|
|
7,954
|
|
|
317
|
|
||||||
Corporate debt
|
487,578
|
|
|
5,707
|
|
|
365,541
|
|
|
2,730
|
|
|
122,037
|
|
|
2,977
|
|
||||||
Residential mortgage-backed securities
|
109,659
|
|
|
1,335
|
|
|
64,121
|
|
|
402
|
|
|
45,538
|
|
|
933
|
|
||||||
Agency commercial mortgage-backed securities
|
4,423
|
|
|
108
|
|
|
2,458
|
|
|
34
|
|
|
1,965
|
|
|
74
|
|
||||||
Other commercial mortgage-backed securities
|
12,878
|
|
|
134
|
|
|
7,939
|
|
|
82
|
|
|
4,939
|
|
|
52
|
|
||||||
Other asset-backed securities
|
85,358
|
|
|
466
|
|
|
70,924
|
|
|
346
|
|
|
14,434
|
|
|
120
|
|
||||||
|
$
|
850,838
|
|
|
$
|
9,556
|
|
|
$
|
603,468
|
|
|
$
|
4,314
|
|
|
$
|
247,370
|
|
|
$
|
5,242
|
|
|
December 31, 2016
|
||||||||||||||||||||||
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
79,833
|
|
|
$
|
911
|
|
|
$
|
79,833
|
|
|
$
|
911
|
|
|
$
|
—
|
|
|
$
|
—
|
|
U.S. Government-sponsored enterprise obligations
|
11,746
|
|
|
191
|
|
|
11,746
|
|
|
191
|
|
|
—
|
|
|
—
|
|
||||||
State and municipal bonds
|
224,884
|
|
|
6,952
|
|
|
219,276
|
|
|
6,444
|
|
|
5,608
|
|
|
508
|
|
||||||
Corporate debt
|
469,632
|
|
|
8,480
|
|
|
424,721
|
|
|
5,662
|
|
|
44,911
|
|
|
2,818
|
|
||||||
Residential mortgage-backed securities
|
103,680
|
|
|
2,046
|
|
|
100,542
|
|
|
1,982
|
|
|
3,138
|
|
|
64
|
|
||||||
Agency commercial mortgage-backed securities
|
4,579
|
|
|
143
|
|
|
4,192
|
|
|
114
|
|
|
387
|
|
|
29
|
|
||||||
Other commercial mortgage-backed securities
|
9,822
|
|
|
137
|
|
|
9,179
|
|
|
134
|
|
|
643
|
|
|
3
|
|
||||||
Other asset-backed securities
|
44,343
|
|
|
267
|
|
|
39,079
|
|
|
256
|
|
|
5,264
|
|
|
11
|
|
||||||
|
$
|
948,519
|
|
|
$
|
19,127
|
|
|
$
|
888,568
|
|
|
$
|
15,694
|
|
|
$
|
59,951
|
|
|
$
|
3,433
|
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2017
|
|
2016
|
|
2015
|
||||||
Fixed maturities
|
$
|
75,669
|
|
|
$
|
85,818
|
|
|
$
|
97,348
|
|
Equities
|
17,198
|
|
|
14,887
|
|
|
13,317
|
|
|||
Other investments, including Short-term
|
7,793
|
|
|
3,402
|
|
|
2,049
|
|
|||
BOLI
|
1,979
|
|
|
2,008
|
|
|
2,053
|
|
|||
Investment fees and expenses
|
(6,977
|
)
|
|
(6,103
|
)
|
|
(6,107
|
)
|
|||
Net investment income
|
$
|
95,662
|
|
|
$
|
100,012
|
|
|
$
|
108,660
|
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2017
|
|
2016
|
|
2015
|
||||||
Total OTTI losses:
|
|
|
|
|
|
||||||
State and municipal bonds
|
$
|
(850
|
)
|
|
$
|
(100
|
)
|
|
$
|
—
|
|
Corporate debt
|
(419
|
)
|
|
(7,604
|
)
|
|
(11,781
|
)
|
|||
Investment in unconsolidated subsidiaries
|
(11,931
|
)
|
|
—
|
|
|
—
|
|
|||
Other investments
|
—
|
|
|
(3,130
|
)
|
|
(8,136
|
)
|
|||
Portion of OTTI losses recognized in other comprehensive income before taxes:
|
|
|
|
|
|
||||||
Corporate debt
|
248
|
|
|
1,068
|
|
|
4,572
|
|
|||
Net impairment losses recognized in earnings
|
(12,952
|
)
|
|
(9,766
|
)
|
|
(15,345
|
)
|
|||
Gross realized gains, available-for-sale securities
|
6,653
|
|
|
12,451
|
|
|
11,936
|
|
|||
Gross realized (losses), available-for-sale securities
|
(3,123
|
)
|
|
(7,038
|
)
|
|
(11,481
|
)
|
|||
Net realized gains (losses), Short-term investments
|
(2
|
)
|
|
18
|
|
|
(1
|
)
|
|||
Net realized gains (losses), trading securities
|
10,724
|
|
|
6,632
|
|
|
1,080
|
|
|||
Net realized gains (losses), Other investments
|
2,963
|
|
|
1,115
|
|
|
464
|
|
|||
Change in unrealized holding gains (losses), trading securities
|
11,243
|
|
|
30,557
|
|
|
(28,343
|
)
|
|||
Change in unrealized holding gains (losses), Other investments, carried at fair value
|
896
|
|
|
899
|
|
|
(896
|
)
|
|||
Other
|
7
|
|
|
7
|
|
|
947
|
|
|||
Net realized investment gains (losses)
|
$
|
16,409
|
|
|
$
|
34,875
|
|
|
$
|
(41,639
|
)
|
(In thousands)
|
2017
|
|
2016
|
|
2015
|
||||||
Balance January 1
|
$
|
1,158
|
|
|
$
|
5,751
|
|
|
$
|
232
|
|
Additional credit losses recognized during the period, related to securities for which:
|
|
|
|
|
|
||||||
No OTTI has been previously recognized
|
171
|
|
|
2,398
|
|
|
3,648
|
|
|||
OTTI has been previously recognized
|
—
|
|
|
2,154
|
|
|
2,645
|
|
|||
Reductions due to:
|
|
|
|
|
|
||||||
Securities sold during the period (realized)
|
(16
|
)
|
|
(9,145
|
)
|
|
(774
|
)
|
|||
Balance December 31
|
$
|
1,313
|
|
|
$
|
1,158
|
|
|
$
|
5,751
|
|
|
Year Ended December 31
|
||||||||
(In millions)
|
2017
|
2016
|
2015
|
||||||
Proceeds from sales (exclusive of maturities and paydowns)
|
$
|
530.2
|
|
$
|
361.8
|
|
$
|
481.8
|
|
Purchases
|
$
|
614.4
|
|
$
|
636.4
|
|
$
|
580.6
|
|
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
|
2017
|
|
2016
|
|
2015
|
||||||
Direct
|
|
$
|
842,968
|
|
|
$
|
794,377
|
|
|
$
|
780,982
|
|
Assumed
|
|
31,908
|
|
|
40,637
|
|
|
31,236
|
|
|||
Ceded
|
|
(110,858
|
)
|
|
(96,481
|
)
|
|
(102,933
|
)
|
|||
Net premiums written
|
|
$
|
764,018
|
|
|
$
|
738,533
|
|
|
$
|
709,285
|
|
|
|
|
|
|
|
|
||||||
Direct
|
|
$
|
821,249
|
|
|
$
|
790,791
|
|
|
$
|
772,968
|
|
Assumed
|
|
27,629
|
|
|
37,805
|
|
|
22,691
|
|
|||
Ceded
|
|
(110,347
|
)
|
|
(95,315
|
)
|
|
(101,510
|
)
|
|||
Net premiums earned
|
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
$
|
694,149
|
|
|
|
|
|
|
|
|
||||||
Losses and loss adjustment expenses
|
|
$
|
592,218
|
|
|
$
|
515,242
|
|
|
$
|
456,862
|
|
Reinsurance recoveries
|
|
(123,060
|
)
|
|
(72,013
|
)
|
|
(46,151
|
)
|
|||
Net losses and loss adjustment expenses
|
|
$
|
469,158
|
|
|
$
|
443,229
|
|
|
$
|
410,711
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2017
|
|
2016
|
||||
Deferred tax assets
|
|
|
|
||||
Unpaid loss discount
|
$
|
20,368
|
|
|
$
|
39,746
|
|
Unearned premium adjustment
|
14,449
|
|
|
22,847
|
|
||
Compensation related
|
11,467
|
|
|
20,190
|
|
||
Intangibles
|
514
|
|
|
1,001
|
|
||
Foreign NOL
|
4,116
|
|
|
1,962
|
|
||
Total gross deferred tax assets
|
50,914
|
|
|
85,746
|
|
||
Valuation allowance
|
(4,116
|
)
|
|
(1,962
|
)
|
||
Total deferred tax assets, net of valuation allowance
|
46,798
|
|
|
83,784
|
|
||
Deferred tax liabilities
|
|
|
|
||||
Deferred policy acquisition costs
|
(6,333
|
)
|
|
(9,754
|
)
|
||
Unrealized gains on investments, net
|
(5,166
|
)
|
|
(9,797
|
)
|
||
Fixed assets
|
(826
|
)
|
|
(1,291
|
)
|
||
Basis differentials–investments
|
(10,397
|
)
|
|
(25,512
|
)
|
||
Intangibles
|
(12,548
|
)
|
|
(22,067
|
)
|
||
Other
|
(1,598
|
)
|
|
(5,107
|
)
|
||
Total deferred tax liabilities
|
(36,868
|
)
|
|
(73,528
|
)
|
||
Net deferred tax assets (liabilities)
|
$
|
9,930
|
|
|
$
|
10,256
|
|
(In thousands)
|
|
2017
|
|
2016
|
|
2015
|
||||||
Balance at January 1
|
|
$
|
8,353
|
|
|
$
|
8,195
|
|
|
$
|
577
|
|
Increases for tax positions taken during the current year
|
|
—
|
|
|
361
|
|
|
7,618
|
|
|||
(Decreases) for tax positions taken during the current year
|
|
(3,500
|
)
|
|
—
|
|
|
—
|
|
|||
Increases for tax positions taken during prior years
|
|
700
|
|
|
—
|
|
|
—
|
|
|||
(Decreases) relating to a lapse of the applicable statute of limitations
|
|
(212
|
)
|
|
(203
|
)
|
|
—
|
|
|||
Balance at December 31
|
|
$
|
5,341
|
|
|
$
|
8,353
|
|
|
$
|
8,195
|
|
(In thousands)
|
|
2017
|
|
2016
|
|
2015
|
||||||
Provision for income taxes
|
|
|
|
|
|
|
||||||
Current expense (benefit)
|
|
|
|
|
|
|
||||||
Federal and foreign
|
|
$
|
19,546
|
|
|
$
|
15,857
|
|
|
$
|
27,653
|
|
State
|
|
120
|
|
|
729
|
|
|
999
|
|
|||
Total current expense (benefit)
|
|
19,666
|
|
|
16,586
|
|
|
28,652
|
|
|||
Deferred expense (benefit)
|
|
|
|
|
|
|
||||||
Federal and foreign
|
|
1,331
|
|
|
8,284
|
|
|
(15,185
|
)
|
|||
State
|
|
362
|
|
|
250
|
|
|
(809
|
)
|
|||
Total deferred expense (benefit)
|
|
1,693
|
|
|
8,534
|
|
|
(15,994
|
)
|
|||
Total income tax expense (benefit)
|
|
$
|
21,359
|
|
|
$
|
25,120
|
|
|
$
|
12,658
|
|
(In thousands)
|
|
2017
|
|
2016
|
|
2015
|
||||||
Computed “expected” tax expense
|
|
$
|
45,018
|
|
|
$
|
61,670
|
|
|
$
|
45,099
|
|
Tax-exempt income
|
|
(8,356
|
)
|
|
(9,917
|
)
|
|
(12,913
|
)
|
|||
Tax credits
|
|
(23,111
|
)
|
|
(27,549
|
)
|
|
(22,407
|
)
|
|||
Non-U.S. operating results
|
|
918
|
|
|
(1,688
|
)
|
|
720
|
|
|||
Excess tax benefit on share-based compensation
|
|
(2,762
|
)
|
|
—
|
|
|
—
|
|
|||
Change in federal corporate tax rate
|
|
6,541
|
|
|
—
|
|
|
—
|
|
|||
Change in limitation of future deductibility of certain executive compensation
|
|
3,497
|
|
|
—
|
|
|
—
|
|
|||
Other
|
|
(386
|
)
|
|
2,604
|
|
|
2,159
|
|
|||
Total income tax expense (benefit)
|
|
$
|
21,359
|
|
|
$
|
25,120
|
|
|
$
|
12,658
|
|
(In thousands)
|
2017
|
|
2016
|
|
2015
|
||||||
Balance, beginning of year
|
$
|
1,993,428
|
|
|
$
|
2,005,326
|
|
|
$
|
2,058,266
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
273,475
|
|
|
249,350
|
|
|
237,966
|
|
|||
Net balance, beginning of year
|
1,719,953
|
|
|
1,755,976
|
|
|
1,820,300
|
|
|||
Net losses:
|
|
|
|
|
|
||||||
Current year
|
603,518
|
|
|
587,007
|
|
|
571,891
|
|
|||
Favorable development of reserves established in prior years, net
|
(134,360
|
)
|
|
(143,778
|
)
|
|
(161,180
|
)
|
|||
Total
|
469,158
|
|
|
443,229
|
|
|
410,711
|
|
|||
Paid related to:
|
|
|
|
|
|
||||||
Current year
|
(106,633
|
)
|
|
(96,190
|
)
|
|
(84,186
|
)
|
|||
Prior years
|
(369,682
|
)
|
|
(383,062
|
)
|
|
(390,849
|
)
|
|||
Total paid
|
(476,315
|
)
|
|
(479,252
|
)
|
|
(475,035
|
)
|
|||
Net balance, end of year
|
1,712,796
|
|
|
1,719,953
|
|
|
1,755,976
|
|
|||
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
335,585
|
|
|
273,475
|
|
|
249,350
|
|
|||
Balance, end of year
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
$
|
2,005,326
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2017
|
||||||||||||||||||||||||||||||||||
($ in thousands)
|
Year Ended December 31
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
||||||||||||||||||||||||||||||||
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
|
|||||||||||||||||||||||||
Accident Year
|
Unaudited
|
|
|
|||||||||||||||||||||||||||||||||
2008
|
$
|
402,293
|
|
$
|
397,571
|
|
$
|
391,214
|
|
$
|
345,855
|
|
$
|
298,849
|
|
$
|
269,462
|
|
$
|
259,272
|
|
$
|
247,123
|
|
$
|
240,472
|
|
$
|
240,877
|
|
|
$
|
889
|
|
3,737
|
|
2009
|
—
|
|
$
|
379,259
|
|
$
|
370,642
|
|
$
|
345,714
|
|
$
|
320,368
|
|
$
|
284,511
|
|
$
|
265,478
|
|
$
|
246,146
|
|
$
|
230,849
|
|
224,768
|
|
|
$
|
(592
|
)
|
3,826
|
|
||
2010
|
—
|
|
—
|
|
$
|
364,996
|
|
$
|
354,787
|
|
$
|
338,170
|
|
$
|
312,813
|
|
$
|
291,553
|
|
$
|
279,713
|
|
$
|
270,484
|
|
258,466
|
|
|
$
|
190
|
|
3,846
|
|
|||
2011
|
—
|
|
—
|
|
—
|
|
$
|
348,916
|
|
$
|
344,808
|
|
$
|
331,884
|
|
$
|
305,540
|
|
$
|
289,400
|
|
$
|
278,258
|
|
264,777
|
|
|
$
|
731
|
|
3,532
|
|
||||
2012
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
341,289
|
|
$
|
324,418
|
|
$
|
319,613
|
|
$
|
306,956
|
|
$
|
291,075
|
|
279,589
|
|
|
$
|
(429
|
)
|
3,707
|
|
|||||
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
315,346
|
|
$
|
304,209
|
|
$
|
296,550
|
|
$
|
287,140
|
|
272,364
|
|
|
$
|
1,422
|
|
3,807
|
|
||||||
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
290,020
|
|
$
|
289,397
|
|
$
|
280,043
|
|
267,442
|
|
|
$
|
(3,635
|
)
|
3,352
|
|
|||||||
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
276,492
|
|
$
|
269,980
|
|
271,138
|
|
|
$
|
(15,351
|
)
|
3,307
|
|
||||||||
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
271,765
|
|
274,643
|
|
|
$
|
(7,499
|
)
|
3,398
|
|
|||||||||
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
283,746
|
|
|
$
|
119,172
|
|
3,217
|
|
||||||||||
Total
|
|
|
|
|
|
|
|
|
|
$
|
2,637,810
|
|
|
|
|
|||||||||||||||||||||
* Includes expected development on reported claims
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||
(In thousands)
|
Year Ended December 31
|
|||||||||||||||||||||||||||||
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
||||||||||||||||||||
Accident Year
|
Unaudited
|
|
||||||||||||||||||||||||||||
2008
|
$
|
14,214
|
|
$
|
67,971
|
|
$
|
128,800
|
|
$
|
166,544
|
|
$
|
197,042
|
|
$
|
212,789
|
|
$
|
221,150
|
|
$
|
226,903
|
|
$
|
232,598
|
|
$
|
234,704
|
|
2009
|
—
|
|
$
|
15,051
|
|
$
|
71,272
|
|
$
|
114,318
|
|
$
|
153,563
|
|
$
|
178,445
|
|
$
|
191,420
|
|
$
|
200,425
|
|
$
|
205,372
|
|
209,016
|
|
||
2010
|
—
|
|
—
|
|
$
|
15,464
|
|
$
|
69,551
|
|
$
|
137,712
|
|
$
|
180,432
|
|
$
|
209,777
|
|
$
|
221,693
|
|
$
|
236,171
|
|
240,945
|
|
|||
2011
|
—
|
|
—
|
|
—
|
|
$
|
14,417
|
|
$
|
71,208
|
|
$
|
133,004
|
|
$
|
177,089
|
|
$
|
198,112
|
|
$
|
214,502
|
|
224,982
|
|
||||
2012
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
15,382
|
|
$
|
73,571
|
|
$
|
145,488
|
|
$
|
190,997
|
|
$
|
215,220
|
|
231,652
|
|
|||||
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
16,938
|
|
$
|
69,657
|
|
$
|
127,496
|
|
$
|
171,681
|
|
197,265
|
|
||||||
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
16,764
|
|
$
|
59,485
|
|
$
|
116,791
|
|
154,236
|
|
|||||||
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,172
|
|
$
|
55,731
|
|
111,741
|
|
||||||||
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,027
|
|
51,869
|
|
|||||||||
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
16,309
|
|
||||||||||
Total
|
|
|
|
|
|
|
|
|
|
1,672,719
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
All outstanding liabilities before 2008, net of reinsurance
|
|
|
14,660
|
|
||||||||||||||||||||||||||
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
|
|
$
|
979,751
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2017
|
||||||||||||||||||||||||||||||||||
($ in thousands)
|
Year Ended December 31
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
||||||||||||||||||||||||||||||||
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
|
|||||||||||||||||||||||||
Accident Year
|
Unaudited
|
|
|
|||||||||||||||||||||||||||||||||
2008
|
$
|
42,258
|
|
$
|
45,006
|
|
$
|
47,019
|
|
$
|
43,676
|
|
$
|
35,458
|
|
$
|
29,492
|
|
$
|
28,887
|
|
$
|
26,126
|
|
$
|
23,473
|
|
$
|
21,710
|
|
|
$
|
976
|
|
283
|
|
2009
|
—
|
|
$
|
34,450
|
|
$
|
35,366
|
|
$
|
36,802
|
|
$
|
37,437
|
|
$
|
34,099
|
|
$
|
32,675
|
|
$
|
28,731
|
|
$
|
26,340
|
|
24,572
|
|
|
$
|
1,794
|
|
246
|
|
||
2010
|
—
|
|
—
|
|
$
|
41,721
|
|
$
|
43,238
|
|
$
|
43,195
|
|
$
|
42,233
|
|
$
|
37,920
|
|
$
|
35,831
|
|
$
|
33,361
|
|
29,338
|
|
|
$
|
3,014
|
|
290
|
|
|||
2011
|
—
|
|
—
|
|
—
|
|
$
|
45,882
|
|
$
|
44,956
|
|
$
|
41,453
|
|
$
|
39,917
|
|
$
|
37,150
|
|
$
|
35,004
|
|
32,343
|
|
|
$
|
4,240
|
|
343
|
|
||||
2012
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
45,703
|
|
$
|
46,513
|
|
$
|
44,848
|
|
$
|
40,692
|
|
$
|
34,774
|
|
32,691
|
|
|
$
|
5,573
|
|
396
|
|
|||||
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
32,746
|
|
$
|
36,602
|
|
$
|
35,624
|
|
$
|
34,393
|
|
30,906
|
|
|
$
|
3,797
|
|
355
|
|
||||||
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
30,420
|
|
$
|
29,918
|
|
$
|
32,143
|
|
29,869
|
|
|
$
|
8,234
|
|
340
|
|
|||||||
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
35,648
|
|
$
|
35,347
|
|
37,346
|
|
|
$
|
10,172
|
|
315
|
|
||||||||
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
29,609
|
|
28,790
|
|
|
$
|
21,178
|
|
245
|
|
|||||||||
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
24,571
|
|
|
$
|
28,886
|
|
129
|
|
||||||||||
Total
|
|
|
|
|
|
|
|
|
|
$
|
292,136
|
|
|
|
|
|||||||||||||||||||||
* Includes expected development on reported claims
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
||||||||||
|
||||||||||
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|
Unaudited
|
|||||||||
Healthcare Professional Liability Claims-Made
|
5.4%
|
19.8%
|
22.9%
|
16.1%
|
10.2%
|
5.8%
|
4.3%
|
2.1%
|
2.0%
|
0.9%
|
Healthcare Professional Liability Occurrence
|
(2.3%)
|
5.6%
|
13.8%
|
15.7%
|
14.8%
|
10.8%
|
8.1%
|
2.8%
|
3.3%
|
—%
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
|||||||||||||||||||
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|||||||||
|
Unaudited
|
||||||||||||||||||
Medical technology liability
|
3.7
|
%
|
18.7
|
%
|
21.1
|
%
|
14.0
|
%
|
7.9
|
%
|
2.9
|
%
|
1.4
|
%
|
6.2
|
%
|
3.7
|
%
|
—%
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
||||||||||||||||||||
|
||||||||||||||||||||
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
||||||||||
|
Unaudited
|
|||||||||||||||||||
Workers' Compensation
|
32.3
|
%
|
36.7
|
%
|
14.9
|
%
|
7.2
|
%
|
3.4
|
%
|
1.5
|
%
|
0.9
|
%
|
0.3
|
%
|
0.2
|
%
|
0.6
|
%
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2017
|
||||||||||||||||
($ in thousands)
|
Year Ended December 31
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
||||||||||||||
|
2014
|
2015
|
2016
|
2017
|
|
|||||||||||||
Accident Year
|
Unaudited
|
|
|
|||||||||||||||
2014
|
$
|
892
|
|
$
|
1,091
|
|
$
|
890
|
|
$
|
866
|
|
|
$
|
1,145
|
|
118
|
|
2015
|
—
|
|
$
|
5,540
|
|
$
|
5,940
|
|
6,221
|
|
|
$
|
2,981
|
|
893
|
|
||
2016
|
—
|
|
—
|
|
$
|
11,942
|
|
13,223
|
|
|
$
|
8,248
|
|
2,268
|
|
|||
2017
|
—
|
|
—
|
|
—
|
|
15,005
|
|
|
$
|
16,083
|
|
2,723
|
|
||||
Total
|
|
|
|
$
|
35,315
|
|
|
|
|
|||||||||
* Includes expected development on reported claims
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2017
|
|||||||||||||||
($ in thousands)
|
Year Ended December 31
|
|
IBNR
(1)
|
Cumulative Number of Reported Claims
(2)
|
|||||||||||||
|
2014
|
2015
|
2016
|
2017
|
|
||||||||||||
Accident Year
|
Unaudited
|
|
|
||||||||||||||
2014
|
$
|
836
|
|
$
|
934
|
|
$
|
995
|
|
$
|
994
|
|
|
$
|
(1
|
)
|
nm
|
2015
|
—
|
|
$
|
2,803
|
|
$
|
2,840
|
|
2,287
|
|
|
$
|
(186
|
)
|
nm
|
||
2016
|
—
|
|
—
|
|
$
|
4,517
|
|
4,063
|
|
|
$
|
1,873
|
|
nm
|
|||
2017
|
—
|
|
—
|
|
—
|
|
6,888
|
|
|
$
|
2,073
|
|
nm
|
||||
Total
|
|
|
|
$
|
14,232
|
|
|
|
|
||||||||
(1)
Includes expected development on reported claims
|
|||||||||||||||||
(2)
The abbreviation "nm" indicates that the information is not meaningful
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
|||||||||||||||||
|
|||||||||||||||||
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|||||||
|
Unaudited
|
||||||||||||||||
Lloyd's Syndicate Casualty
|
24.7
|
%
|
49.4
|
%
|
16.7
|
%
|
6.0
|
%
|
2.0
|
%
|
0.4
|
%
|
0.4
|
%
|
—%
|
—%
|
—%
|
Lloyd's Syndicate Property Insurance
|
80.8
|
%
|
15.5
|
%
|
2.5
|
%
|
0.6
|
%
|
0.3
|
%
|
0.1
|
%
|
0.1
|
%
|
—%
|
—%
|
—%
|
Lloyd's Syndicate Property Reinsurance
|
78.6
|
%
|
16.4
|
%
|
2.8
|
%
|
1.6
|
%
|
0.4
|
%
|
0.2
|
%
|
0.1
|
%
|
—%
|
—%
|
—%
|
(In thousands)
|
December 31, 2017
|
||
Net outstanding liabilities
|
|
||
Healthcare professional liability claims-made
|
$
|
979,751
|
|
Healthcare professional liability occurrence
|
176,653
|
|
|
Medical technology liability claims-made
|
40,770
|
|
|
Workers' compensation
|
193,535
|
|
|
Lloyd's syndicate casualty
|
36,181
|
|
|
Lloyd's syndicate property insurance
|
10,422
|
|
|
Lloyd's syndicate property reinsurance
|
5,384
|
|
|
Other short-duration lines
|
92,212
|
|
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
1,534,908
|
|
|
|
|
||
Reinsurance recoverable on unpaid losses
|
|
||
Healthcare professional liability claims-made
|
140,159
|
|
|
Healthcare professional liability occurrence
|
25,960
|
|
|
Medical technology liability claims-made
|
44,458
|
|
|
Workers' compensation
|
79,800
|
|
|
Lloyd's syndicate casualty
|
—
|
|
|
Lloyd's syndicate property insurance
|
13,889
|
|
|
Lloyd's syndicate property reinsurance
|
20,670
|
|
|
Other short-duration lines
|
10,649
|
|
|
Total reinsurance recoverable on unpaid losses and loss adjustment expenses
|
335,585
|
|
|
|
|
||
Reserve for the future utilization of the DDR benefit
|
75,400
|
|
|
Unallocated loss adjustment expenses
|
106,531
|
|
|
Purchase accounting
|
3,102
|
|
|
Other
|
(7,145
|
)
|
|
|
177,888
|
|
|
Gross liability for losses and loss adjustment expenses
|
$
|
2,048,381
|
|
Operating Leases
|
|||
(In thousands)
|
|||
2018
|
$
|
5,021
|
|
2019
|
4,508
|
|
|
2020
|
3,777
|
|
|
2021
|
3,353
|
|
|
2022
|
2,530
|
|
|
Thereafter
|
9,212
|
|
|
Total minimum lease payments
|
$
|
28,401
|
|
(In thousands)
|
December 31,
2017 |
|
December 31,
2016 |
||||
Senior Notes due 2023, unsecured, interest at 5.3% annually
|
$
|
250,000
|
|
|
$
|
250,000
|
|
Revolving Credit Agreement, outstanding borrowings are fully secured, see Note 3, and carried at a weighted average interest rate of 1.91% and 1.35%, respectively. The interest rate on the borrowings is set at the time the respective borrowing is initiated or renewed. The current borrowings can be repaid or renewed in the first quarter of 2018. If renewed, the interest rate will be reset.
|
123,000
|
|
|
200,000
|
|
||
Mortgage Loans, outstanding borrowings are secured by first priority liens on two office buildings, and bear an interest rate of three-month LIBOR plus 1.325% (2.86% at December 31, 2017) determined on a quarterly basis.
|
40,460
|
|
|
—
|
|
||
Total principal
|
$
|
413,460
|
|
|
$
|
450,000
|
|
Less debt issuance costs
|
1,649
|
|
|
1,798
|
|
||
Debt less debt issuance costs
|
$
|
411,811
|
|
|
$
|
448,202
|
|
(1)
|
ProAssurance is not permitted to have a leverage ratio of Consolidated Funded Indebtedness (principally, obligations for borrowed money, obligations evidenced by instruments such as notes or acceptances, standby and commercial Letters of Credit, and contingent obligations) to Consolidated Total Capitalization (principally, total non-trade liabilities on a consolidated basis plus consolidated shareholders’ equity, exclusive of
AOCI
) greater than
0.35
to
1.0
, determined at the end of each fiscal quarter.
|
(2)
|
ProAssurance is required to maintain a minimum net worth, excluding
AOCI
, of at least
$1.3
billion.
|
(1)
|
Each of the two ProAssurance subsidiaries are not permitted to have a leverage ratio of Consolidated Funded Debt (principally, obligations for borrowed money, obligations for deferred purchase price of property or services, obligations evidenced by notes, bonds, debentures, standby and commercial Letters of Credit and contingent obligations of the subsidiary) to Consolidated Total Capitalization (principally,
SAP
Consolidated Net Worth plus Consolidated Funded Debt of the subsidiary) greater than
0.35
, determined at the end of each fiscal quarter.
|
(In thousands)
|
Principal Payments Due by Period
|
|||
2018
|
$
|
1,396
|
|
|
2019
|
1,448
|
|
||
2020
|
1,503
|
|
||
2021
|
1,559
|
|
||
2022
|
1,617
|
|
||
Thereafter
|
32,937
|
|
||
Total principal payments
|
$
|
40,460
|
|
|
Gains (Losses) Recognized in Income on Derivatives
|
|||||||||||
(In thousands)
|
Year Ended December 31
|
|||||||||||
Derivatives Not Designated as Hedging Instruments
|
Location in the Consolidated Statements of Income and Comprehensive Income
|
2017
|
|
2016
|
|
2015
|
||||||
Interest Rate Cap
|
Interest expense
|
$
|
(339
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Cash Dividends Declared, per Share
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
First Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
Second Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
Third Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
Fourth Quarter*
|
|
$
|
5.00
|
|
|
$
|
5.00
|
|
|
$
|
1.31
|
|
(In thousands)
|
2017
|
|
2016
|
|
2015
|
||||||
Reclassifications from AOCI to net income:
|
|
|
|
|
|
||||||
Realized investment gains (losses)
|
$
|
2,512
|
|
|
$
|
2,417
|
|
|
$
|
(4,475
|
)
|
Non-credit impairment losses reclassified to earnings, due to sale of securities or reclassification as a credit loss
|
(3
|
)
|
|
(3,641
|
)
|
|
(2,279
|
)
|
|||
Unrecognized losses in defined benefit plan liabilities reclassified to earnings, due to the termination and settlement of the plan
|
—
|
|
|
(1,500
|
)
|
|
—
|
|
|||
Total gains (losses) reclassified, before-tax effect
|
2,509
|
|
|
(2,724
|
)
|
|
(6,754
|
)
|
|||
Tax effect (at 35%)
|
(878
|
)
|
|
953
|
|
|
2,364
|
|
|||
Net reclassification adjustments
|
$
|
1,631
|
|
|
$
|
(1,771
|
)
|
|
$
|
(4,390
|
)
|
|
|
|
|
|
|
||||||
Deferred tax expense (benefit) included in OCI
|
$
|
(4,676
|
)
|
|
$
|
(3,078
|
)
|
|
$
|
(18,370
|
)
|
|
|
Share-Based
Compensation Expense |
|
Unrecognized Compensation Cost
|
||||||||||||||
|
|
Year Ended December 31
|
|
December 31, 2017
|
||||||||||||||
($ in millions, except remaining recognition period)
|
|
2017
|
|
2016
|
|
2015
|
|
Amount
|
|
Weighted Average Remaining
Recognition Period |
||||||||
Restricted Share Units
|
|
$
|
4.5
|
|
|
$
|
3.7
|
|
|
$
|
2.5
|
|
|
$
|
4.8
|
|
|
1.7
|
Performance Share Units
|
|
5.0
|
|
|
7.6
|
|
|
5.9
|
|
|
3.6
|
|
|
1.5
|
||||
Purchase Match Units
|
|
1.1
|
|
|
1.2
|
|
|
0.8
|
|
|
2.1
|
|
|
2.2
|
||||
Total share-based compensation expense
|
|
$
|
10.6
|
|
|
$
|
12.5
|
|
|
$
|
9.2
|
|
|
$
|
10.5
|
|
|
|
Tax benefit recognized
|
|
$
|
3.7
|
|
|
$
|
4.4
|
|
|
$
|
3.2
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||
|
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
Beginning non-vested balance
|
|
240,149
|
|
|
$
|
44.07
|
|
|
178,468
|
|
|
$
|
43.13
|
|
|
136,802
|
|
|
$
|
42.03
|
|
Granted
|
|
84,565
|
|
|
$
|
58.35
|
|
|
109,181
|
|
|
$
|
45.59
|
|
|
91,943
|
|
|
$
|
42.79
|
|
Forfeited
|
|
(4,087
|
)
|
|
$
|
52.35
|
|
|
(5,954
|
)
|
|
$
|
43.99
|
|
|
(1,342
|
)
|
|
$
|
42.81
|
|
Vested and released
|
|
(51,107
|
)
|
|
$
|
43.01
|
|
|
(41,546
|
)
|
|
$
|
44.04
|
|
|
(48,935
|
)
|
|
$
|
39.45
|
|
Ending non-vested balance
|
|
269,520
|
|
|
$
|
48.63
|
|
|
240,149
|
|
|
$
|
44.07
|
|
|
178,468
|
|
|
$
|
43.13
|
|
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||
|
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
Beginning non-vested balance
|
|
305,240
|
|
|
$
|
43.41
|
|
|
390,350
|
|
|
$
|
44.65
|
|
|
466,860
|
|
|
$
|
41.96
|
|
Granted
|
|
48,000
|
|
|
$
|
58.35
|
|
|
60,000
|
|
|
$
|
45.59
|
|
|
106,490
|
|
|
$
|
42.79
|
|
Forfeited
|
|
(227
|
)
|
|
$
|
42.79
|
|
|
(5,162
|
)
|
|
$
|
43.02
|
|
|
(2,322
|
)
|
|
$
|
46.05
|
|
Vested and released
|
|
(140,908
|
)
|
|
$
|
42.95
|
|
|
(139,948
|
)
|
|
$
|
44.05
|
|
|
(180,678
|
)
|
|
$
|
39.58
|
|
Ending non-vested balance
|
|
212,105
|
|
|
$
|
47.11
|
|
|
305,240
|
|
|
$
|
43.41
|
|
|
390,350
|
|
|
$
|
44.65
|
|
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||
|
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
Beginning non-vested balance
|
|
72,615
|
|
|
$
|
45.77
|
|
|
74,483
|
|
|
$
|
42.80
|
|
|
72,101
|
|
|
$
|
40.62
|
|
Granted
|
|
24,444
|
|
|
$
|
51.83
|
|
|
23,903
|
|
|
$
|
50.18
|
|
|
26,593
|
|
|
$
|
46.09
|
|
Forfeited
|
|
(2,012
|
)
|
|
$
|
48.29
|
|
|
(2,875
|
)
|
|
$
|
43.77
|
|
|
(3,087
|
)
|
|
$
|
41.03
|
|
Vested and released
|
|
(24,755
|
)
|
|
$
|
41.33
|
|
|
(22,896
|
)
|
|
$
|
40.88
|
|
|
(21,124
|
)
|
|
$
|
39.79
|
|
Ending non-vested balance
|
|
70,292
|
|
|
$
|
49.40
|
|
|
72,615
|
|
|
$
|
45.77
|
|
|
74,483
|
|
|
$
|
42.80
|
|
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||
|
|
Options
|
|
Weighted
Average Exercise Price |
|
Options
|
|
Weighted
Average Exercise Price |
|
Options
|
|
Weighted
Average Exercise Price |
|||||||||
Outstanding, vested and exercisable, beginning of year
|
|
—
|
|
|
$
|
—
|
|
|
2,114
|
|
|
$
|
25.02
|
|
|
4,456
|
|
|
$
|
24.64
|
|
Exercised
|
|
—
|
|
|
$
|
—
|
|
|
(2,114
|
)
|
|
$
|
25.02
|
|
|
(2,342
|
)
|
|
$
|
24.13
|
|
Outstanding, vested and exercisable, end of year
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
2,114
|
|
|
$
|
25.02
|
|
(In thousands, except per share data)
|
Year Ended December 31
|
||||||||||
2017
|
|
2016
|
|
2015
|
|||||||
Weighted average number of common shares outstanding, basic
|
53,393
|
|
|
53,216
|
|
|
54,795
|
|
|||
Dilutive effect of securities:
|
|
|
|
|
|
||||||
Restricted Share Units
|
85
|
|
|
73
|
|
|
52
|
|
|||
Performance Share Units
|
110
|
|
|
135
|
|
|
145
|
|
|||
Purchase Match Units
|
23
|
|
|
24
|
|
|
25
|
|
|||
Weighted average number of common shares outstanding, diluted
|
53,611
|
|
|
53,448
|
|
|
55,017
|
|
|||
Effect of dilutive shares on earnings per share
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
Year Ended December 31, 2017
|
||||||||||||||||||||||
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation
|
|
Lloyd's Syndicate
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||
Net premiums earned
|
$
|
453,921
|
|
|
$
|
227,408
|
|
|
$
|
57,202
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
738,531
|
|
Net investment income
|
—
|
|
|
—
|
|
|
1,736
|
|
|
93,926
|
|
|
—
|
|
|
95,662
|
|
||||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
8,033
|
|
|
—
|
|
|
8,033
|
|
||||||
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
107
|
|
|
16,302
|
|
|
—
|
|
|
16,409
|
|
||||||
Other income (expense)
|
5,688
|
|
|
674
|
|
|
(1,476
|
)
|
|
2,888
|
|
|
(260
|
)
|
|
7,514
|
|
||||||
Net losses and loss adjustment expenses
|
(288,701
|
)
|
|
(136,237
|
)
|
|
(44,220
|
)
|
|
—
|
|
|
—
|
|
|
(469,158
|
)
|
||||||
Underwriting, policy acquisition and operating expenses
|
(108,830
|
)
|
|
(70,945
|
)
|
|
(26,963
|
)
|
|
(29,275
|
)
|
|
260
|
|
|
(235,753
|
)
|
||||||
Segregated portfolio cells dividend (expense) income
(1)(2)
|
(4,970
|
)
|
|
(5,828
|
)
|
|
—
|
|
|
(4,973
|
)
|
|
—
|
|
|
(15,771
|
)
|
||||||
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,844
|
)
|
|
—
|
|
|
(16,844
|
)
|
||||||
Income tax benefit (expense)
(2)
|
—
|
|
|
—
|
|
|
568
|
|
|
(21,927
|
)
|
|
—
|
|
|
(21,359
|
)
|
||||||
Segment operating results
|
$
|
57,108
|
|
|
$
|
15,072
|
|
|
$
|
(13,046
|
)
|
|
$
|
48,130
|
|
|
$
|
—
|
|
|
$
|
107,264
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Depreciation and amortization, net of accretion
|
$
|
7,922
|
|
|
$
|
3,480
|
|
|
$
|
(20
|
)
|
|
$
|
17,414
|
|
|
$
|
—
|
|
|
$
|
28,796
|
|
|
Year Ended December 31, 2016
|
||||||||||||||||||||||
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation
|
|
Lloyd's Syndicate
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||
Net premiums earned
|
$
|
457,816
|
|
|
$
|
220,815
|
|
|
$
|
54,650
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
733,281
|
|
Net investment income
|
—
|
|
|
—
|
|
|
1,410
|
|
|
98,602
|
|
|
—
|
|
|
100,012
|
|
||||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,762
|
)
|
|
—
|
|
|
(5,762
|
)
|
||||||
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
76
|
|
|
34,799
|
|
|
—
|
|
|
34,875
|
|
||||||
Other income (expense)
|
5,306
|
|
|
844
|
|
|
1,415
|
|
|
1,069
|
|
|
(826
|
)
|
|
7,808
|
|
||||||
Net losses and loss adjustment expenses
|
(268,579
|
)
|
|
(140,534
|
)
|
|
(34,116
|
)
|
|
—
|
|
|
—
|
|
|
(443,229
|
)
|
||||||
Underwriting, policy acquisition and operating expenses
|
(104,333
|
)
|
|
(70,464
|
)
|
|
(22,832
|
)
|
|
(30,807
|
)
|
|
826
|
|
|
(227,610
|
)
|
||||||
Segregated portfolio cells dividend (expense) income
(1)
|
(144
|
)
|
|
(4,762
|
)
|
|
—
|
|
|
(3,236
|
)
|
|
—
|
|
|
(8,142
|
)
|
||||||
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
(15,032
|
)
|
|
—
|
|
|
(15,032
|
)
|
||||||
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
(384
|
)
|
|
(24,736
|
)
|
|
—
|
|
|
(25,120
|
)
|
||||||
Segment operating results
|
$
|
90,066
|
|
|
$
|
5,899
|
|
|
$
|
219
|
|
|
$
|
54,897
|
|
|
$
|
—
|
|
|
$
|
151,081
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Depreciation and amortization, net of accretion
|
$
|
7,268
|
|
|
$
|
5,600
|
|
|
$
|
132
|
|
|
$
|
19,789
|
|
|
$
|
—
|
|
|
$
|
32,789
|
|
|
Year Ended December 31, 2015
|
||||||||||||||||||||||
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation
|
|
Lloyd's Syndicate
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||
Net premiums earned
|
$
|
443,313
|
|
|
$
|
213,161
|
|
|
$
|
37,675
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
694,149
|
|
Net investment income
|
—
|
|
|
—
|
|
|
928
|
|
|
107,732
|
|
|
—
|
|
|
108,660
|
|
||||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
3,682
|
|
|
—
|
|
|
3,682
|
|
||||||
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
24
|
|
|
(41,663
|
)
|
|
—
|
|
|
(41,639
|
)
|
||||||
Other income (expense)
|
4,561
|
|
|
492
|
|
|
698
|
|
|
2,057
|
|
|
(581
|
)
|
|
7,227
|
|
||||||
Net losses and loss adjustment expenses
(3)
|
(250,168
|
)
|
|
(140,744
|
)
|
|
(25,181
|
)
|
|
—
|
|
|
5,382
|
|
|
(410,711
|
)
|
||||||
Underwriting, policy acquisition and operating expenses
(3)
|
(105,574
|
)
|
|
(63,653
|
)
|
|
(18,518
|
)
|
|
(24,518
|
)
|
|
(4,801
|
)
|
|
(217,064
|
)
|
||||||
Segregated portfolio cells dividend (expense) income
(1)
|
—
|
|
|
(1,884
|
)
|
|
—
|
|
|
1,031
|
|
|
—
|
|
|
(853
|
)
|
||||||
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,596
|
)
|
|
—
|
|
|
(14,596
|
)
|
||||||
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
(1,240
|
)
|
|
(11,418
|
)
|
|
—
|
|
|
(12,658
|
)
|
||||||
Segment operating results
|
$
|
92,132
|
|
|
$
|
7,372
|
|
|
$
|
(5,614
|
)
|
|
$
|
22,307
|
|
|
$
|
—
|
|
|
$
|
116,197
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Depreciation and amortization, net of accretion
|
$
|
8,663
|
|
|
$
|
5,696
|
|
|
$
|
417
|
|
|
$
|
21,442
|
|
|
$
|
—
|
|
|
$
|
36,218
|
|
(1)
During the first quarter of 2017, ProAssurance began reporting in the Corporate segment the portion of the SPC dividend (expense) income that is attributable to the investment results of the SPCs, all of which are reported in the Corporate segment, to better align the expense with the related investment results of the SPCs. For comparative purposes, ProAssurance has reflected the SPC dividend expense for 2016 and 2015 in the same manner.
|
|||||||||||||||||||||||
(2)
During the second quarter of 2017, ProAssurance recognized a $5.2 million pre-tax expense related to previously unrecognized SPC dividend expense for the cumulative earnings of unrelated parties that have owned segregated portfolio cells at various periods since 2003 in a Bermuda captive insurance operation managed by the Company's HCPL line of business within the Specialty P&C segment. The expense recorded in 2017 related to periods prior to the current period and is unrelated to the captive operations of the Company's Eastern Re subsidiary. The $1.8 million tax impact of the expense recognized in 2017 is included in the Corporate segment's income tax benefit (expense) for the year ended December 31, 2017.
|
|||||||||||||||||||||||
(3)
In 2015, the portion of the management fee that was allocated to ULAE was eliminated in consolidation. In 2016, ProAssurance discontinued the practice of eliminating in consolidation the portion of the management fee that was allocated to ULAE, thus there was no similar elimination in 2016 or 2017.
|
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
|
2017
|
|
2016
|
|
2015
|
||||||
Specialty P&C Segment
|
|
|
|
|
|
|
||||||
Gross premiums earned:
|
|
|
|
|
|
|
||||||
Healthcare professional liability
|
|
$
|
477,561
|
|
|
$
|
474,981
|
|
|
$
|
463,599
|
|
Legal professional liability
|
|
25,771
|
|
|
26,125
|
|
|
28,234
|
|
|||
Medical technology liability
|
|
33,836
|
|
|
34,158
|
|
|
34,838
|
|
|||
Other
|
|
415
|
|
|
667
|
|
|
1,447
|
|
|||
Ceded premiums earned
|
|
(83,662
|
)
|
|
(78,115
|
)
|
|
(84,805
|
)
|
|||
Segment net premiums earned
|
|
453,921
|
|
|
457,816
|
|
|
443,313
|
|
|||
|
|
|
|
|
|
|
||||||
Workers' Compensation Segment
|
|
|
|
|
|
|
||||||
Gross premiums earned:
|
|
|
|
|
|
|
||||||
Traditional business
|
|
172,603
|
|
|
170,492
|
|
|
172,115
|
|
|||
Alternative market business
|
|
80,698
|
|
|
75,658
|
|
|
66,168
|
|
|||
Ceded premiums earned
|
|
(25,893
|
)
|
|
(25,335
|
)
|
|
(25,122
|
)
|
|||
Segment net premiums earned
|
|
227,408
|
|
|
220,815
|
|
|
213,161
|
|
|||
|
|
|
|
|
|
|
||||||
Lloyd's Syndicate Segment
|
|
|
|
|
|
|
||||||
Gross premiums earned:
|
|
|
|
|
|
|
||||||
Property and casualty*
|
|
69,749
|
|
|
60,564
|
|
|
43,617
|
|
|||
Ceded premiums earned
|
|
(12,547
|
)
|
|
(5,914
|
)
|
|
(5,942
|
)
|
|||
Segment net premiums earned
|
|
57,202
|
|
|
54,650
|
|
|
37,675
|
|
|||
|
|
|
|
|
|
|
||||||
Consolidated net premiums earned
|
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
$
|
694,149
|
|
(In millions)
|
||||||||
Statutory Net Earnings
|
|
Statutory Capital and Surplus
|
||||||
2017
|
|
2016
|
|
2015
|
|
2017
|
|
2016
|
$139
|
|
$163
|
|
$168
|
|
$1,175
|
|
$1,403
|
|
|
December 31, 2017
|
||||||||||
Type of Investment
|
|
Recorded
Cost Basis |
|
Fair
Value |
|
Amount Which is
Presented in the Balance Sheet |
||||||
Fixed Maturities
|
|
|
|
|
|
|
||||||
Bonds:
|
|
|
|
|
|
|
||||||
U.S. Government or government agencies and authorities
|
|
$
|
155,412
|
|
|
$
|
154,583
|
|
|
$
|
154,583
|
|
States, municipalities and political subdivisions
|
|
618,414
|
|
|
632,243
|
|
|
632,243
|
|
|||
Foreign governments
|
|
15,447
|
|
|
15,406
|
|
|
15,406
|
|
|||
Public utilities
|
|
82,031
|
|
|
83,263
|
|
|
83,263
|
|
|||
All other corporate bonds
|
|
1,060,032
|
|
|
1,068,339
|
|
|
1,068,339
|
|
|||
Certificates of deposit
|
|
150
|
|
|
150
|
|
|
150
|
|
|||
Mortgage-backed securities
|
|
325,702
|
|
|
326,258
|
|
|
326,258
|
|
|||
Total Fixed Maturities
|
|
2,257,188
|
|
|
2,280,242
|
|
|
2,280,242
|
|
|||
Equity Securities, trading
|
|
|
|
|
|
|
||||||
Common Stocks:
|
|
|
|
|
|
|
||||||
Public utilities
|
|
10,570
|
|
|
12,758
|
|
|
12,758
|
|
|||
Banks, trusts and insurance companies
|
|
67,679
|
|
|
76,051
|
|
|
76,051
|
|
|||
Industrial, miscellaneous and all other
|
|
347,693
|
|
|
381,800
|
|
|
381,800
|
|
|||
Total Equity Securities, trading
|
|
425,942
|
|
|
470,609
|
|
|
470,609
|
|
|||
Other long-term investments, at cost or amortized cost
|
|
58,546
|
|
|
69,095
|
|
|
58,546
|
|
|||
Other long-term investments, at fair value
|
|
357,982
|
|
|
445,005
|
|
|
445,005
|
|
|||
Short-term investments
|
|
432,126
|
|
|
432,126
|
|
|
432,126
|
|
|||
Total Investments
|
|
$
|
3,531,784
|
|
|
$
|
3,697,077
|
|
|
$
|
3,686,528
|
|
|
December 31,
2017 |
|
December 31,
2016 |
||||
Assets
|
|
|
|
||||
Investment in subsidiaries, at equity
|
$
|
1,713,656
|
|
|
$
|
1,908,663
|
|
Fixed maturities available for sale, at fair value
|
155,094
|
|
|
267,412
|
|
||
Short-term investments
|
268,181
|
|
|
279,510
|
|
||
Investment in unconsolidated subsidiaries
|
1,200
|
|
|
845
|
|
||
Cash and cash equivalents
|
81,009
|
|
|
31,330
|
|
||
Due from subsidiaries
|
2,666
|
|
|
185
|
|
||
Other assets
|
33,829
|
|
|
33,350
|
|
||
Total Assets
|
$
|
2,255,635
|
|
|
$
|
2,521,295
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
||||
Liabilities:
|
|
|
|
||||
Dividends payable
|
$
|
267,292
|
|
|
$
|
265,659
|
|
Other liabilities
|
22,008
|
|
|
8,732
|
|
||
Debt less debt issuance costs
|
371,540
|
|
|
448,202
|
|
||
Total Liabilities
|
660,840
|
|
|
722,593
|
|
||
Shareholders’ Equity:
|
|
|
|
||||
Common stock
|
628
|
|
|
627
|
|
||
Other shareholders’ equity, including unrealized gains (losses) on securities of subsidiaries
|
1,594,167
|
|
|
1,798,075
|
|
||
Total Shareholders’ Equity
|
1,594,795
|
|
|
1,798,702
|
|
||
Total Liabilities and Shareholders’ Equity
|
$
|
2,255,635
|
|
|
$
|
2,521,295
|
|
|
Year Ended December 31
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Revenues
|
|
|
|
|
|
||||||
Net investment income
|
$
|
7,646
|
|
|
$
|
6,359
|
|
|
$
|
5,017
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
(137
|
)
|
|
(155
|
)
|
|
—
|
|
|||
Net realized investment gains (losses)
|
(8,606
|
)
|
|
405
|
|
|
4,673
|
|
|||
Other income (loss)
|
921
|
|
|
(960
|
)
|
|
378
|
|
|||
Total revenues
|
(176
|
)
|
|
5,649
|
|
|
10,068
|
|
|||
Expenses
|
|
|
|
|
|
||||||
Interest expense
|
16,440
|
|
|
15,030
|
|
|
14,596
|
|
|||
Other expenses
|
26,351
|
|
|
28,305
|
|
|
24,695
|
|
|||
Total expenses
|
42,791
|
|
|
43,335
|
|
|
39,291
|
|
|||
Income (loss) before income tax expense (benefit) and equity in net income of consolidated subsidiaries
|
(42,967
|
)
|
|
(37,686
|
)
|
|
(29,223
|
)
|
|||
Income tax expense (benefit)
|
(13,293
|
)
|
|
(12,583
|
)
|
|
(11,657
|
)
|
|||
Income (loss) before equity in net income of consolidated subsidiaries
|
(29,674
|
)
|
|
(25,103
|
)
|
|
(17,566
|
)
|
|||
Equity in net income of consolidated subsidiaries
|
136,938
|
|
|
176,184
|
|
|
133,763
|
|
|||
Net income
|
107,264
|
|
|
151,081
|
|
|
116,197
|
|
|||
Other comprehensive income
|
(2,488
|
)
|
|
(6,456
|
)
|
|
(34,349
|
)
|
|||
Comprehensive income
|
$
|
104,776
|
|
|
$
|
144,625
|
|
|
$
|
81,848
|
|
|
Year Ended December 31
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Net cash provided (used) by operating activities
|
$
|
(1,669
|
)
|
|
$
|
(10,549
|
)
|
|
$
|
(14,411
|
)
|
Investing activities
|
|
|
|
|
|
||||||
(Investments in) distributions from unconsolidated subsidiaries, net:
|
|
|
|
|
|
||||||
Other partnership investments
|
—
|
|
|
(1,000
|
)
|
|
—
|
|
|||
Proceeds from sales or maturities of:
|
|
|
|
|
|
||||||
Fixed maturities, available for sale
|
295,035
|
|
|
100,240
|
|
|
200,245
|
|
|||
Net decrease (increase) in short-term investments
|
11,811
|
|
|
(262,169
|
)
|
|
26,074
|
|
|||
Dividends from subsidiaries
|
169,142
|
|
|
122,030
|
|
|
107,870
|
|
|||
Contribution of capital to subsidiaries
|
—
|
|
|
(1,983
|
)
|
|
—
|
|
|||
Unsettled security transactions, net of change
|
1,100
|
|
|
(1,100
|
)
|
|
—
|
|
|||
Funds (advanced) repaid for Lloyd's FAL deposit
|
(25,449
|
)
|
|
—
|
|
|
(9,642
|
)
|
|||
Funds (advanced) repaid under Syndicate Credit Agreement
|
(6,883
|
)
|
|
1,695
|
|
|
(3,083
|
)
|
|||
Funds (advanced) repaid under a business investment line of credit
|
(4,066
|
)
|
|
(3,090
|
)
|
|
—
|
|
|||
Other
|
(2,276
|
)
|
|
(2,805
|
)
|
|
(289
|
)
|
|||
Net cash provided (used) by investing activities
|
438,414
|
|
|
(48,182
|
)
|
|
321,175
|
|
|||
Financing activities
|
|
|
|
|
|
||||||
Borrowings (repayments) under Revolving Credit Agreement
|
(77,000
|
)
|
|
100,000
|
|
|
100,000
|
|
|||
Repurchase of common stock
|
—
|
|
|
(2,106
|
)
|
|
(172,772
|
)
|
|||
Subsidiary payments for common shares and share-based compensation awarded to subsidiary employees
|
12,030
|
|
|
11,384
|
|
|
6,063
|
|
|||
Dividends to shareholders
|
(315,228
|
)
|
|
(118,812
|
)
|
|
(217,626
|
)
|
|||
Other
|
(6,868
|
)
|
|
(3,697
|
)
|
|
(6,337
|
)
|
|||
Net cash provided (used) by financing activities
|
(387,066
|
)
|
|
(13,231
|
)
|
|
(290,672
|
)
|
|||
Increase (decrease) in cash and cash equivalents
|
49,679
|
|
|
(71,962
|
)
|
|
16,092
|
|
|||
Cash and cash equivalents at beginning of period
|
31,330
|
|
|
103,292
|
|
|
87,200
|
|
|||
Cash and cash equivalents at end of period
|
$
|
81,009
|
|
|
$
|
31,330
|
|
|
$
|
103,292
|
|
|
|
|
|
|
|
||||||
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
||||||
Cash paid during the year for income taxes, net of refunds
|
$
|
17,193
|
|
|
$
|
(8,519
|
)
|
|
$
|
47,004
|
|
Cash paid during the year for interest
|
$
|
15,892
|
|
|
$
|
14,732
|
|
|
$
|
13,996
|
|
|
|
|
|
|
|
||||||
Significant non-cash transactions:
|
|
|
|
|
|
||||||
Dividends declared and not yet paid
|
$
|
267,292
|
|
|
$
|
265,659
|
|
|
$
|
69,447
|
|
Securities transferred at fair value as dividends from subsidiaries
|
$
|
190,709
|
|
|
$
|
174,270
|
|
|
$
|
206,880
|
|
Non-cash capital contribution to subsidiaries
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
87,719
|
|
|
2017
|
2016
|
2015
|
||||||
Net premiums earned
|
|
|
|
||||||
Specialty P&C
|
$
|
453,921
|
|
$
|
457,816
|
|
$
|
443,313
|
|
Workers' Compensation
|
227,408
|
|
220,815
|
|
213,161
|
|
|||
Lloyd's Syndicate
|
57,202
|
|
54,650
|
|
37,675
|
|
|||
Consolidated
|
$
|
738,531
|
|
$
|
733,281
|
|
$
|
694,149
|
|
Net investment income
(1)
|
|
|
|
||||||
Lloyd's Syndicate
|
$
|
1,736
|
|
$
|
1,410
|
|
$
|
928
|
|
Corporate
|
93,926
|
|
98,602
|
|
107,732
|
|
|||
Consolidated
|
$
|
95,662
|
|
$
|
100,012
|
|
$
|
108,660
|
|
Losses and loss adjustment expenses incurred related to current year, net of reinsurance
|
|
|
|
||||||
Specialty P&C
|
$
|
407,994
|
|
$
|
405,738
|
|
$
|
409,149
|
|
Workers' Compensation
|
150,492
|
|
146,654
|
|
142,943
|
|
|||
Lloyd's Syndicate
|
45,032
|
|
34,615
|
|
25,181
|
|
|||
Inter-segment eliminations
|
—
|
|
—
|
|
(5,382
|
)
|
|||
Consolidated
|
$
|
603,518
|
|
$
|
587,007
|
|
$
|
571,891
|
|
Losses and loss adjustment expenses incurred related to prior year, net of reinsurance
|
|
|
|
||||||
Specialty P&C
|
$
|
(119,293
|
)
|
$
|
(137,159
|
)
|
$
|
(158,981
|
)
|
Workers' Compensation
|
(14,255
|
)
|
(6,120
|
)
|
(2,199
|
)
|
|||
Lloyd's Syndicate
|
(812
|
)
|
(499
|
)
|
—
|
|
|||
Consolidated
|
$
|
(134,360
|
)
|
$
|
(143,778
|
)
|
$
|
(161,180
|
)
|
Paid losses and loss adjustment expenses, net of reinsurance
|
|
|
|
||||||
Specialty P&C
|
$
|
324,347
|
|
$
|
343,678
|
|
$
|
346,606
|
|
Workers' Compensation
|
122,042
|
|
114,320
|
|
126,296
|
|
|||
Lloyd's Syndicate
|
29,926
|
|
21,254
|
|
7,549
|
|
|||
Inter-segment eliminations
|
—
|
|
—
|
|
(5,416
|
)
|
|||
Consolidated
|
$
|
476,315
|
|
$
|
479,252
|
|
$
|
475,035
|
|
Amortization of DPAC
|
|
|
|
||||||
Specialty P&C
|
$
|
48,469
|
|
$
|
45,019
|
|
$
|
45,459
|
|
Workers' Compensation
|
32,088
|
|
29,590
|
|
26,232
|
|
|||
Lloyd's Syndicate
|
15,194
|
|
13,769
|
|
7,841
|
|
|||
Inter-segment eliminations
|
—
|
|
—
|
|
24
|
|
|||
Consolidated
|
$
|
95,751
|
|
$
|
88,378
|
|
$
|
79,556
|
|
Other underwriting, policy acquisition and operating expenses
|
|
|
|
||||||
Specialty P&C
|
$
|
60,361
|
|
$
|
59,314
|
|
$
|
60,115
|
|
Workers' Compensation
|
38,857
|
|
40,874
|
|
37,421
|
|
|||
Lloyd's Syndicate
|
11,769
|
|
9,063
|
|
10,677
|
|
|||
Corporate
|
29,275
|
|
30,807
|
|
24,518
|
|
|||
Inter-segment eliminations
|
(260
|
)
|
(826
|
)
|
4,777
|
|
|||
Consolidated
|
$
|
140,002
|
|
$
|
139,232
|
|
$
|
137,508
|
|
Net premiums written
|
|
|
|
||||||
Specialty P&C
|
$
|
470,535
|
|
$
|
458,681
|
|
$
|
442,126
|
|
Workers' Compensation
|
238,514
|
|
223,578
|
|
218,338
|
|
|||
Lloyd's Syndicate
|
54,969
|
|
56,274
|
|
48,821
|
|
|||
Consolidated
|
$
|
764,018
|
|
$
|
738,533
|
|
$
|
709,285
|
|
Deferred policy acquisition costs
(1)
|
$
|
50,261
|
|
$
|
46,809
|
|
$
|
44,388
|
|
Reserve for losses and loss adjustment expenses
(1)
|
$
|
2,048,381
|
|
$
|
1,993,428
|
|
$
|
2,005,326
|
|
Unearned premiums
(1)
|
$
|
398,884
|
|
$
|
372,563
|
|
$
|
362,066
|
|
|
2017
|
2016
|
2015
|
||||||
Property and Liability *
|
|
|
|
||||||
Premiums earned
|
$
|
821,249
|
|
$
|
790,791
|
|
$
|
772,968
|
|
Premiums ceded
|
(110,347
|
)
|
(95,315
|
)
|
(101,510
|
)
|
|||
Premiums assumed
|
27,629
|
|
37,805
|
|
22,691
|
|
|||
Net premiums earned
|
$
|
738,531
|
|
$
|
733,281
|
|
$
|
694,149
|
|
Percentage of amount assumed to net
|
3.74%
|
5.16%
|
3.27%
|
||||||
* All of ProAssurance’s premiums are related to property and liability coverages.
|
Exhibit Number
|
|
Description
|
|
|
|
2
|
|
Schedules to the following documents are omitted; the contents of the schedules are generally described in the documents; and ProAssurance will upon request furnish to the Commission supplementally a copy of any omitted schedule
|
|
|
|
|
Stock Purchase Agreement dated as of June 26, 2012, by and among ProAssurance Corporation, PRA Professional Liability Group, Inc. and Medmarc Mutual Insurance Company, filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Agreement and Plan of Merger by and among ProAssurance Corporation, PA Merger Company and Eastern Insurance Holdings, Inc., dated September 23, 2013, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring September 24, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Certificate of Incorporation of ProAssurance, filed as an Exhibit to ProAssurance’s Registration Statement on Form S-4 (File No. 333-49378) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Certificate of Amendment to Certificate of Incorporation of ProAssurance, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2001 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Fourth Restatement of the Bylaws of ProAssurance, effective December 2, 2015, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2015 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Indenture, dated November 21, 2013, between ProAssurance and Wilmington Trust Company, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 21, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
First Supplemental Indenture, dated November 21, 2013, between ProAssurance and Wilmington Trust Company relating to the $250,000 5.30% Senior Notes due 2023, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 21, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
ProAssurance will file with the Commission upon request pursuant to the requirements of Item 601 (b)(4) of Regulation S-K documents defining rights of holders of ProAssurance’s long-term indebtedness that has not been registered. See also the documents related to long-term indebtedness filed as material contracts under Exhibits 10.10(a), (b), (c), (d), (e) and (f) to this Form 10-K.
|
|
|
|
|
Form of Release and Severance Compensation Agreement dated as of January 1, 2008 between ProAssurance and each of the following named executive officers:*
|
|
|
|
Howard H. Friedman Jeffrey P. Lisenby
Frank B. O’Neil Edward L. Rand Jr.
|
|
|
Filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
Employment Agreement between ProAssurance and W. Stancil Starnes dated as of May 1, 2007, filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for the event occurring May 12, 2007 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Amendment to Employment Agreement with W. Stancil Starnes (May 1, 2007), effective as of January 1, 2008, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Amendment to Employment Agreement with W. Stancil Starnes (May 1, 2007), effective as of June 1, 2015, filed as an Exhibit to ProAssurance's Current Report on Form 8-K dated May 27, 2015 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Amendment to Employment Agreement with W. Stancil Starnes (May 1, 2007), effective as of June 1, 2017, filed as an Exhibit to ProAssurance's Current Report on Form 8-K dated May 31, 2017 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Form of Release and Severance Compensation Agreement dated as of September 1, 2011 between ProAssurance and Ross E. Taubman, filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) on April 11, 2008 and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Form of Indemnification Agreement between ProAssurance and each of the following named executive officers and directors of ProAssurance*:
|
|
|
|
Bruce D. Angiolillo Samuel A. Di Piazza, Jr.
Robert E. Flowers Howard H. Friedman M. James Gorrie Ziad R. Haydar
Jeffrey P. Lisenby John J. McMahon
Frank B. O’Neil Katisha T. Vance
Edward L. Rand, Jr. Frank A. Spinosa
W. Stancil Starnes Ross E. Taubman
Michael L. Boguski Thomas A. S. Wilson, Jr.
|
|
|
Filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) on April 11, 2008 and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
ProAssurance Group Employee Benefit Plan which includes the Executive Supplemental Life Insurance Program (Article VIII), filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2004 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Amendment and Restatement of the Executive Non-Qualified Excess Plan and Trust effective January 1, 2008, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Director Deferred Compensation Plan as amended and restated December 7, 2011, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Amendment No. 1 to the Amended and Restated Director Deferred Compensation Plan dated May 22, 2013, filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Revolving Credit Agreement, dated April 15, 2011, between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Amendment No. 1 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Amendment No. 2 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 8, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Form of the Augmenting Lender Supplement to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ending June 30, 2014 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Copy of the Augmenting Lender Supplement to Revolving Credit Agreement between ProAssurance and U.S. Bank N.A., Wells Fargo Bank, N.A., Branch Banking and Trust Company, First Tennessee Bank, N.A., Key Bank, Cadence Bank, N.A., and Regions Bank, N.A., dated June 19, 2015, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2015 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Amendment No. 5 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's to ProAssurance’s Annual Report on Form 10-K for the Year ended December 31, 2017 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Pledge and Security Agreement between ProAssurance and U.S. Bank National Association, filed as an Exhibit to ProAssurance’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
ProAssurance Corporation Amended and Restated 2014 Equity Incentive Plan, filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring May 14, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
ProAssurance Corporation 2014 Annual Incentive Plan, filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) filed on May 22, 2013 and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Retention and Severance Compensation Agreement effective January 1, 2013, between ProAssurance and Mary Todd Peterson, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Facility Agreement between ProAssurance and the Premiums Trust Fund of Syndicate 1729, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Amendment to Facility Agreement effective April 6, 2016, between ProAssurance and the Premiums Trust Fund of Syndicate 1729 filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Retention and Severance Compensation Agreement effective January 1, 2014, between ProAssurance and Michael L. Boguski, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
Mortgage Agreement, dated December 11, 2017, between ProAssurance Indemnity Company, Inc. and First Tennessee Bank National Association, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2017 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Mortgage Agreement, dated December 11, 2017, between Podiatry Insurance Company of America and First Tennessee Bank National Association, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the Year ended December 31, 2017 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Interest Rate Cap Agreement, dated October 23, 2017, between Podiatry Insurance Company of America and First Tennessee Bank National Association, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the Year ended December 31, 2017 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
Subsidiaries of ProAssurance Corporation
|
|
|
|
|
|
Consent of Ernst & Young LLP
|
|
|
|
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(a)
|
|
|
|
|
|
Certification of Principal Financial Officer of ProAssurance as required under SEC Rule 13a-14(a)
|
|
|
|
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as amended (18 U.S.C. 1350)
|
|
|
|
|
|
Certification of Principal Financial Officer of ProAssurance as required under SEC Rule 13a-14(b) and 18 U.S.C. 1350
|
|
|
|
|
|
XBRL Instance Document
|
|
|
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
/s/ W. Stancil Starnes
|
W. Stancil Starnes
|
Chief Executive Officer
|
|
/s/ Edward L. Rand, Jr.
|
Edward L. Rand, Jr.
|
Chief Operating Officer and Chief Financial Officer
|
|
/s/ W. Stancil Starnes
|
W. Stancil Starnes
|
Chief Executive Officer
|
|
/s/ Edward L. Rand, Jr.
|
Edward L. Rand, Jr.
|
Chief Operating Officer and Chief Financial Officer
|